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ABSTRACT 
The thesis describes synthetic studies towards the manne natural product 
diazonamide A. This unprecedented compound was recently isolated from a colonial 
ascidian and displays exceptional levels of cytotoxic activity against human cancer 
cell lines. The Introduction includes an account of how diazonamide A was isolated 
and its structure determined. This is followed by a summary of the different natural 
products which have been isolated from ascidians, and highlights the structural 
similarities between these compounds and diazonamide A. The Introduction 
concludes with a review of structurally related natural products which concentrates on 
compounds containing oxazole rings or biaryl bonds. 
The Results and Discussion section of the thesis details our general strategy for a 
synthesis of the macrocyclic aromatic core of diazonamide A. A synthesis of the two 
key fragments in this strategy, namely the benzofuran oxazole unit and the iodo 
indole unit, is then described. This is followed by the elaboration of these units 
towards the target macrocycle. A detailed discussion is presented throughout this 
section including a review of the Heck and Ullmann reactions, and methods of 
oxazole formation. This section culminates by describing our initial synthetic efforts 
on an alternative approach to the macrocyclic core of diazonamide A. 
The third chapter of the thesis is the Experimental section containing full details of 
the preparative work completed and listing spectroscopic and analytical data for all 
new compounds synthesised during the study. 
The thesis is concluded by a schematic account of the contemporaneous work towards 
a total synthesis of diazonamide A that has been conducted by four other research 
groups. 
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1. INTRODUCTION 
1 
1.1 Isolation and Structure Elucidation of the Diazonamides 
During the past twenty-five years marine natural products chemists have discovered 
many biologically important secondary metabolites which are unprecedented in 
structure. Two outstanding examples are diazonamides A (1) and B (2). These highly 
unusual, cytotoxic marine natural products were described by Fenical et aU in 1991 
following their investigations of the colonial ascidian Diazona chinensis (order 
Phlebobranchia),2 which was collected from the ceilings of small caves along the 
Northwest coast of Siquijor Island, Philippines. 
20 
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Diazonamides A (1) and B (2) are two of the structurally most attractive marine 
natural products isolated in recent years and they represent an entirely new class of 
halogenated, highly unsaturated cyclic peptides. A simplified structural representation 
of diazonamides A (1) and B (2) shows that the molecules contain two fused 
macrocycles. The northern macrocycle incorporates the peptide portion of the 
secondary metabolite, comprising a 3,4,5-trisubstituted-L-tyrosine residue and an 
L-valine residue. The southern macrocycle is particularly intriguing as it contains a 
variety of interesting structural features in a 3-dimensional array of heterocyclic and 
aromatic rings. The centrepiece of this unusual heterocyclic network is a chiral 
quaternary carbon centre located at CIO. This centre links a trisubstituted oxazole to a 
benzofuran and lies adjacent to a cyclic hemiacetal. The aforementioned trisubstituted 
oxazole forms part of an impressive bis-oxazole segment in which a second oxazole is 
further subtended to an indole nucleus; both the second oxazole and the indole units 
also incorporate chloride substituents at C27 and C25 respectively. The southern 
macrocyclic framework is completed by the inclusion of a biaryl bond connecting the 
indole to the benzofuran, which entraps the polycyclic biaryl skeleton as a single 
atropisomer. Diazonamide A (1) differs from diazonamide B (2) only in the 
substitution pattern of the northern macrocycle, containing an additional valine 
residue at NI, whilst lacking bromination at the C6 position of the tyrosine residue. 
"Northern" 
"Southern" 
Combination of IH, l3C NMR and HRFABMS techniques led to the assignment of 
several structural subunits in the diazonamides. However, the large number of singlet 
carbons and heteroatoms prevented the use of 1 H-l3C NMR correlation methods for 
connecting the fragments into a complete structure. The missing connectivities were 
established by a single-crystal X-ray diffraction analysis of the p-bromobenzamide 
derivative of diazonamide B (3), which was prepared by reacting diazonamide B (2) 
with p-bromobenzoyl chloride in pyridine. 
3 
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A direct assignment of the absolute stereochemistry of diazonamide B (2) was 
obtained from the crystal structure, with the exception of the stereochemistry at the 
C 11 position. This hemiacetal centre in diazonamide B (2) is converted into an acetal 
on formation of the p-bromobenzamide derivative (3). Molecular mechanics studies 
of the hemiacetal (2) and its corresponding aldehyde tautomer indicate a small 
preference (-lkcal/mol) for the R configuration at Cll (OH down) in the hemiacetal 
(2) and a small preference (-lkcal/mol) for aldehyde conformations in which the si 
face of the aldehyde faces 03, also leading to an R configuration at Cl1. However, 
these calculated differences are too small to assign the stereochemistry securely at this 
centre and it remains unresolved. The absolute stereochemistry of the terminal valine 
present in diazonamide A (1) is also undetermined. 
From the crystal structure of diazonamide B p-bromobenzamide (3) the two oxazole 
rings are twisted with respect to one another with a dihedral angle of 29°. The 
chlorooxazole and chloroindole rings have a dihedral angle of 60° and the chloro 
indole ring has a dihedral angle of 74° with the C12-C17 phenol. Not surprisingly, the 
UV spectra of diazonamides A (1) and B (2) show very little indication of their high 
degree of unsaturation as the strict steric requirements of the bicyclic framework 
forces the aromatic rings out of conjugation, preventing any significant 1t-orbital 
overlap. 
Remarkable cytotoxic properties have been recorded for the diazonamides,l with 
diazonamide A (1) being the more active metabolite. Diazonamide A (1) 
4 
demonstrates potent in vitro activity against HCT -116 human colon carcinoma and 
B-16 murine melanoma cancer cell lines, with 1Cso values of less than 15nglml. 
1.2 Ascidian Natural Products 
Ascidians represent the most highly evolved group of organIsms commonly 
investigated by marine natural products chemists. They are often referred to as sea 
squirts, because many species expel streams of water through a siphon when 
disturbed, or as tunicates, because their body is covered by a sack-like case or tunic. 
By appearance, they may superficially resemble marine sponges. However, the 
contractions which cause a sea squirt to spray streams of water provide a means to 
distinguish ascidians from other marine invertebrates. 
The discovery of several modified arabino nucleosides from a Tedania sponge by 
Bergmann in 1950,3 is generally credited as marking the birth of the field of marine 
natural products. However, it was not until 1974 that Fenical isolated the first ascidian 
metabolite, geranyl hydroquinone (4), an antileukemic and cytotoxic agent from 
Aplidium sp.4 The occurrence of an anticancer compound in these marine organisms 
provided a powerful incentive to further expand this area of research and since that 
time ascidians have been the source of numerous bioactive natural products. s 
OH 
4 Geranyl hydroquinone 
Seventeen years after the discovery of 4, Fenical isolated the diazonamides A (1) and 
B (2),1 which are regarded as perhaps the most unusual ascidian metabolites isolated 
to date. The diazonamides can be categorised structurally as nitrogen-containing 
peptide metabolites. Because the ascidians have demonstrated a specialised ability to 
5 
biosynthesise amino acid derivatives, this category represents the major structural 
class within the asci dian family. Perhaps the most significant of the peptide 
metabolites is the cyclic depsipeptide didemnin B (5), which was isolated from the 
tunic ate Trididemnum solidum in 1981.6 This was the first marine natural product to 
enter clinical trials as a potential anticancer agent.7 It has also been reported to be 
exceedingly active as an immunosuppressive agent, in addition to inhibiting herpes 
simplex virus types I and II and other lethal RNA viruses. 8 Didemnin B (5) was first 
synthesised by Rinehart et al9 and more recently by louille et al.1O 
we 
O ~ ~ 0 
,OH 
) .. 150 ./ 
o NH 0 
~ e e
OMe 
5 Didemnin B 
The peptide metabolites are prolific producers of cyclic peptides which contain azole 
or azoline rings in their heteronuclear framework. The oxazole ring system, which is 
present in the diazonamides, is the least abundant of these heterocyclic units in 
members of this structural class. However, a 2,4-disubstituted oxazole ring has been 
incorporated into the cyclic hexapeptides bistatramides C (6) and D (7), which were 
isolated from Lissoclinum bistratum in 1992.11 Bistatramide C (6) has been 
synthesised by Meyers and Aguilar, 12 the oxazole ring being prepared by oxidation of 
the corresponding oxazoline. 13 
6 
6 Bistatramide C 7 Bistatramide D 
Thiazoles and thiazolines, the sulfur analogues of oxazoles and oxazolines, along with 
oxazolines themselves, are extremely prevalent within this class of ascidian natural 
products. The lissoclinamides are one family of peptide metabolites which embrace 
all of these heterocyclic units. Lissoclinamide 4 (8) was isolated from Lissoclinum 
patella in 198914 and is one of a group of eight related cyclic heptapeptides which 
display mild cytotoxic activity. They differ only in the oxidation states of the 
sulfur-containing rings and the absolute stereochemistries of the amino acid 
counterparts. The structure of lissoclinamide 4 (8) was corrected six years after its 
isolation, following completion of the total synthesis by Boden and Pattenden. 15 
8 Lissoclinamide 4 
Not all of the peptide metabolites form cyclic specIes. Halocyamine A (9) was 
isolated from the blood of the solitary ascidian Halocynthia roretzi in 1990. 16 It is an 
indole-containing linear tetrapeptide, composed of several amino acids which are 
unusual to ascidian secondary metabolites. Halocyamine A (9) possesses antiviraL 
7 
antimicrobial and cytotoxic activity.17 Approaches towards the synthesis of 
halocyamine A (9) have not yet been reported. 
OH 
HO 
~ ~
N ~ ~ ~ 0 
-;?' N 
NH2 
H 0 H N 
\ ~ ~
N 
H Br 
9 Halocyamine A 
The remaining families of ascidian metabolites show very few direct structural 
similarities to the diazonamides. Several interesting tyrosine-derived metabolites 
called ecteinascidians were described independently by two research groups in 1990 
and 1991 from the Caribbean ascidian Ecteinascidia turbinata. 18 The most abundant 
member of this class is ecteinascidin 743 (10), an exceedingly potent antitumor agent 
with a tetrahydroiso-quinoline core, the same as that determined for the safracins and 
saframycins. 19 An elegant total synthesis of ecteinascidin 743 (10) was reported 
recently by Corey et aZ. 20 
OMe 
)l 
10 Ecteinascidin 743 
8 
Two unique dopamine-derived cyclic polysulfide metabolites were isolated from 
ascidians of the genus Lissoclinum in 1991.21 Varacin (11) and lissoclinotoxin A (12) 
were the first examples of naturally occurring benzopentathiepins containing five 
contiguous sulfur atoms. Both metabolites exhibit antifungal activity, whilst varacin 
(11) is also a cytotoxic agent and lissoclinotoxin A (12) displays antimicrobial 
activity. The total synthesis of varacin (11) has been reported by the research groups 
of Danishefsky,22 Davidson23 and Still,24 whilst the total synthesis of lissoclinotoxin 
A (12) has been described by Davidson et al.25 
MeO 
MeO 
s-s s/ \. 
P 
s 
11 Varacin 
MeO 
12 Lissoclinotoxin A 
The ascidian Eudistoma olivaceum has been an extraordinarily rich source of 
tryptophan-derived metabolites. The eudistomins A (13) and C (14) were isolated in 
198426 and are examples from the vast eudistomin family. All the metabolites from 
this class of natural product are derived from tryptophan and one other amino acid. 
Eudistomins A (13) and C (14) both exhibit halogenation of the indole ring and 
possess significant antiviral activity, making them the targets of much research within 
the synthetic community. 27 
HO 
Br 
13 Eudistomin A 14 Eudistomin C 
9 
Ascididemin (15) and 2-bromoleptoclinidinone (16), from Leptoclinides sp. and 
Didemnum sp. respectively, formed a new class of structurally related ascidians. the 
polycyclic aromatic alkaloids, when they were first isolated in the late 1980's.28 This 
is perhaps now the fastest growing class of ascidian metabolites. These cytotoxic 
marine natural products are based on a pyrido[k, l]acridine skeleton and exhibit a 
remarkably high degree of unsaturation. Bracher has synthesised both ascididemin 
(15)29 and 2-bromoleptoclinidinone (16),30 whilst Rees et al have also described a 
synthesis of ascididemin (15).31 
R 
15 R = H; Ascididemin 
16 R = Br; 2-bromoleptoclinidinone 
Other interesting members of this class of ascidian natural products are the segolines 
A (17) and B (18), novel polycyclic alkaloids which were isolated from the Red Sea 
tunicate Eudistoma sp. in 1989.32 These unique antiviral and antitumor bioactive 
compounds contain a substituted tetracyclic benzo-3,6-diazaphenanthroline ring 
system and glutarimide moiety. A total synthesis of the segolines has not yet been 
reported. 
H 
'1,\,'-
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o N 0 
H 
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18 Segoline B 
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The lysine-derived metabolites are composed of three different structural types of 
alkaloid. The pseudodistomins A (19) and B (20), isolated from the Okinawan 
tunicate Pseudodistoma kanoko in 1987,33 were the first piperidine alkaloids to be 
isolated from a marine source. The tunic ate Clavelina picta has been the source of 
both quinolizidine and indolizidine alkaloids. Clavapictine A (21), isolated in 1991,3'+ 
is one such quinolizidine alkaloid, whilst piclavine A (22), an antifungal and 
antimicrobial agent isolated in 1992,35 is an example from the indolizidine alkaloids. 
Piclavine A (22) is the only lysine-derived metabolite to be synthesised, an 
accomplishment reported recently by Jefford et aP6 
19 Pseudodistomin A 20 Pseudodistomin C 
~ ~
W o ~ ~
-
Bu 
Pr 
21 Clavapictine A 22 Piclavine A 
The didemnid tunicates are a particularly rich source of ascidian metabolites which 
are devoid of nitrogen. Examples of these metabolites include the didemnenones A 
(23) and B (24), Cll-cyclopentanoid natural products isolated from the Caribbean 
tunic ate Trididemnum cf. cyanophorum in 1988. 37 Synthetic interest in these 
compounds was stimulated by their challenging structure and broad-range 
antimicrobial and antileukemic activity, resulting in the total synthesis of the 
didemnenones A (23) and B (24) by the research groups of Forsyth38 and Takano. 39 
11 
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1.3 Oxazole-Containing Natural Products 
The oxazo1e ring is becoming a more prevalent characteristic in recently isolated 
natural products. The majority of molecules incorporate this 5-membered 
heteroaromatic motif as an isolated unit within a cyclic or acyclic framework. 
However, recent interest has been stimulated by natural products which contain 
contiguously linked bis- and tris-oxazole arrays. Some of the many oxazole 
containing natural products to be isolated and synthesised are highlighted here. 
Calyculin A (25) was isolated from the marine sponge Discodermi calyx in 1986.40 It 
contains a 2,4-disubstituted oxazole moiety amongst a wide variety of differing 
functionality, which includes a [5.6]spiroketal and a cyanotetraene. Calyculin A (25) 
has aroused considerable interest due to its ability to inactivate serine/threonine 
protein phosphatases 1 and 2A.41 Successful total syntheses of calyculin A (25) were 
reported by the research groups of Evans,42 Masamune43 and Smith.44 
eN 
OH OH OMe 
25 Calyculin A 
12 
Phorboxazoles A (26) and B (27) have been isolated from the Indian Ocean marine 
sponge Phorbas sp. in 1995.45 Their gross structures were shown to encompass an 
unprecedented molecular architecture of four oxane rings, two 2,4-disubstituted 
oxazole rings and a 21-membered macrolactone, incorporating fifteen asymmetric 
centres. They exhibit a broad range of biological activity, showing exciting cytotoxic, 
cytostatic and antifungal properties. A total synthesis of phorboxazole A (26) was 
completed recently by Forsyth et al.46 
Br -;:?' 
OMe 
-;:?' 
26 Rl = H, R2 = OH; Phorboxazole A 
27 R 1 = OH, R2 = H; Phorboxazole B 
Rhizoxin A (28), isolated from Rhizopus chinensis Rh-2 in 1984 as the pathogen of 
rice seedling blight,47 binds to ~ - t u b u l i n n at the same site as maytansine48 causing 
either inhibition of polymerisation or depolymerisation of tubulin. In addition to 
antifungal activity,49 it exhibits remarkable antitumor activity. Rhizoxin A (28) is a 
unique oxazole containing compound because the 2,4-disubstituted oxazole moiety 
resides at the terminus of the side chain. This triene chromophore is fused to a 
16-membered macrolide which contains two epoxides and a 8-lactone ring. A total 
synthesis of rhizoxin A (28) was reported by Ohno et al.50 
13 
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The group A virginiamycin antibiotics also accommodate a 2,4-disubstituted oxazole. 
In conjunction with an acrylamide unit, a polyene segment and an amino acid residue, 
the oxazole ring forms part of a 23-membered macrolactone core. The macrocyclic 
antibiotic virginiamycin M2 (29) was isolated from Streptomyces virginiae in 1966.51 
It has been recognised as a cholecystokinin antagonist for treating panic, anxiety and 
cancer withdrawal. 52 A total synthesis of virginiamycin M2 (29) was reported recently 
by Schlessinger et al. 53 Ten years after the isolation of virginiamycin M2 (29), the 
broad spectrum antibiotic madumycin II (30) was isolated from a culture of 
Streptomyces graminofaciens.54 A total synthesis of madumycin II (30) was reported 
by Meyers et al .55 A synthesis of the related antibiotic 14,15-anhydropristinamycin 
lIB (31) was accomplished by Patten den et ai.56 
29 Virginiamycin M2 
1-+ 
I" 
'. 
~ ~ ... 
I" 
30 Madumycin II 
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3114,15-Anhydropristinamycin lIB 
The 2,4-disubstituted oxazo1e ring is a feature of several cyclic peptide natural 
products. Orbiculamide A (32) and keramamide E (33), isolated from the marine 
sponge Theonella sp. in 199157 and 199558 respectively, are of particular interest. 
These antileukemic metabolites display a conjugated oxazole system within a cyclic 
array of amino acids, subtended by a 2-halo indole unit similar to that found in the 
diazonamides. At present, no total syntheses of these compounds have been reported. 
J J ~ ~ ~ N ~ " " ' ) c ( ) 0 H H
H 0 H NH I I 
(
N 0 0 Br N 0 
" ... ~ o , , : ; ; H 
~ X ; ~ 5 ~ ~
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32 Orbiculamide A 
33 Keramamide E 
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One of the earliest oxazole-containing compounds to be discovered was the 
antiepileptic alkaloid pimprinine (34), which was isolated from the bacterium 
Streptomyces pimprina in 1960.59 Almost twenty years later, two related alkaloids, 
pimprinethine (35) and pimprinaphine (36), were isolated from Streptomyces 
cinnamomeus and Streptomyces oliverticillium respectively.60 These alkaloids differ 
only in the nature of the substituent at the C2 position of the oxazole ring, whilst all 
contain an unusual 2,5-disubstituted oxazole fused to the C3 position of an indole, a 
structural feature also inherent in the diazonamides. Several syntheses of these natural 
products have been reported. 60,61 
~ N N
o 
34 Pimprinine 35 Pimprinethine 36 Pimprinaphine 
More recently, the indolyl oxazole unit has appeared in the marine alkaloid almazole 
C (37). This alkaloid, which bears the amino acid residue L-phenylalanine at the C2 
position of a 2,5-disubstituted oxazole ring, was isolated from a red Senegalese 
delesseriacean seaweed, of the genus Haraldiophyllum, in 1994.62 A biomimetic 
synthesis of almazole C (37) was reported by Pietra et al.62 
37 Almazole C 
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Phorbazoles A-D (38-41) were isolated from the Indo-Pacific sponge Phorbas aff 
clathra in 199463 and they represent further examples of 2,5-disubstituted oxazoles. 
Phorbazole A (38) is a particularly interesting member of this chlorinated 
phenylpyrrolyloxazole family, as it is the only marine natural product other than the 
diazonamides to display chlorination at the C4 position of the oxazole ring. A total 
synthesis of phorbazole A (38) has not yet been reported. 
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In contrast to the large number of natural products that contain isolated oxazole rings, 
significantly fewer compounds with contiguously linked polyoxazoles are known. 
The diazonamides are one of only three types of compounds that contain a 
bis-oxazole system, with the hennoxazoles and muscoride A (42) completing this 
intriguing family of natural products. Hennoxazole A (43) was isolated from the 
marine sponge Polyfibrospongia sp. in 1991 and was shown to be highly active 
against herpes simplex virus.64 This structurally diverse natural product incorporates 
a pyranoid glycoside and a homoconjugated triene terminus in addition to the 
bis-oxazole unit. A total synthesis of hennoxazole A (43) was first reported by Wipf 
and Lim.65 In this original synthesis, the first oxazole ring was constructed by 
cyclodehydration of a hydroxy amide to give an oxazoline ring,66 which was 
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subsequently oxidised to the corresponding oxazole.67 For the preparation of the 
second oxazole ring these steps were reversed and a hydroxy amide was first oxidised 
to the corresponding aldehyde,68 which underwent cyclodehydration to give the 
oxazole.69 An alternative synthesis of hennoxazole A (43) was reported recently by 
Williams et al .70 
QH 
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Muscoride A (42) was isolated from the freshwater cyanobacterium Nostoc muscorum 
in 1995.71 The bis-oxazole core of muscoride A (42) is formally derived from two 
threonine residues. This is a rather remarkable characteristic, since even isolated 
oxazoles derived from threonine are rare. However, it is interesting to note that this 
leads to the trisubstituted oxazole system which is also found in the diazonamides. 
This novel bis-oxazole core, in conjunction with an N-reverse-prenylated amino acid 
and antibacterial activity, has stimulated the interest of several synthetic research 
groups. Wipf and Venkatraman published the first total synthesis of muscoride A 
(42),72 employing the oxidation-cyclodehydration protocol to construct both 
heteroaromatic rings. 68,69 An alternative synthesis of muscoride A (42) was reported 
by Patten den et al,73 in which the cyclodehydration-oxidation sequence was used to 
prepare the bis-oxazole system.74 
42 Muscoride A 
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tris-Oxazole-containing marine natural products are amongst the most fascinating 
family of metabolites to be isolated from marine organisms in recent years. These 
intriguing molecules include the ulapualides,75 kabiramides,76 halichondramides,77 
halishigamides 78 and mycalolides.79 They were first isolated from the egg masses of 
the marine nudibranche Hexabranchus sanguine us in 198675 and exhibit a wide range 
of interesting and unusual biological activity, including antileukemic, antifungal and 
ichthyotoxic properties. 80 The structures of these metabolites are based around three 
contiguous oxazole rings which form part of a 23-membered lactone attached to a 
lipid-like side chain that terminates in an N-methyl-N-alkenylformamide group. It is 
not surprising that these extraordinarily interesting, bioactive macrolides have 
attracted the attention of the synthetic community. Although the stereochemical 
integrity of ulapualide A (44) is in some doubt, Chattopadhyay and Patten den have 
recently completed a total synthesis of the entire ulapualide framework. 81 In this 
approach, the three oxazole rings were constructed by the cyclodehydration-oxidation 
protocol.74c ,82 Extensive work in this area by Panek et al has shown that the 
tris-oxazole system can also be prepared using Hantzsch-type methodology, 83 whilst 
Y 00 has utilised a sequential rhodium(II)-catalysed cycloaddition reaction to furnish 
the tris-oxazole fragment. 84 
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1.4 Biaryl Natural Products 
Although the fascinating structures of the diazonamides present many challenges to 
those embarking on total synthesis studies, perhaps none appears more daunting than 
the construction of the atropisomeric biaryl axis which connects C16 of the 
benzofuran ring to C18 of the halo indole system. 
This complicating issue of atropisomerism is not unique to the diazonamides. The 
biaryl axis is the central building block in a very large number of natural products of 
differing structure, biological activity and biosynthetic origin. These include 
polyketides, terpenes, lignans, quinones, coumarins, flavonoids, tannins, peptides and 
alkaloids. 85 ,86 This section is not intended to be a thorough review of atropisomeric 
biaryl natural products, but rather serves to highlight some of the many biaryl 
compounds that have been isolated in Nature and have captured the interest of 
research groups world-wide because of their fascinating molecular architecture and 
striking biological activity. 
Despite the proliferation of axially chiral biaryl compounds that have been isolated in 
Nature, very few can challenge the diazonamides for structural complexity. One 
notable exception is vancomycin (45), which was isolated from Streptomyces 
orientalis in 195687 and is the prototypical member of a large family of antibiotics 
which include, for example, ristocetin, avovaricin, synmonicin and teicoplanin. The 
intriguing structures of these antibiotics consist of an arylglycine-rich heptapeptide 
aglycon to which are appended an array of sugar residues. Structural diversity within 
this family of natural products is created by variation in the aglycon amino acid 
constituents and in the nature, position and number of incorporated sugar residues. 88 
The biaryl amino acid, actinoidic acid (46), is a common segment in all the antibiotics 
of the vancomycin family. This structural feature shares a similarity with the biaryl 
segment of the diazonamides since it is elegantly incorporated in a 12-membered 
cyclic structure (47). Clinical applications of vancomycin (45) to the treatment of 
Gram-positive bacterial infections and its efficacy against methicillin-resistant 
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Staphylococcus a u ~ e u s s have established vancomycin (45) as the antibiotic of last 
resort against infections of this deadly pathogen.89 Such striking structural diversity 
and biological activity have inspired recently two monumental total syntheses of the 
vancomycin aglycon by Evans et al90 and Nicolaou et al.91 
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Complestatin (48) is a unique glycopeptide antibiotic, isolated from the mycelium of 
Streptomyces lavendulae in 1989.92 Although this polycyclic macropolypeptide is 
related to the vancomycin antibiotics, many structural differences exist. The most 
dominant variations are the absence of any sugar residues and the presence of a 
tryptophan residue instead of a tyrosine ring as one half of the biaryl segment in a 
16-membered macrocycle. Complestatin (48) also differs from vancomycin (45) in its 
biological activity. It is a poor inhibitor of Gram-positive bacteria, but has a potential 
utility in AIDS treatment and is a potent inhibitor with anticomplement activity.93 
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Although a total synthesis of complestatin (48) has not yet been achieved, synthetic 
approaches to the biaryl system have been reported. 94 
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Not all macrocyclic biaryl systems are contained within such complex molecular 
frameworks. Lythranidine (49), isolated from Lythrum anceps in 1970,95 is an 
example of a more structurally simplistic biaryl-containing macrocyclic natural 
product. This cyclophane alkaloid incorporates the biaryl axis into a 17 -membered 
ring that also encompasses a trans-2,6-dialkylpiperidine. Lythranidine (49) was 
synthesised by Fujita et al96 and by Coggins et al,97 but no pharmacological studies 
have yet been reported. 
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The natural products described previously, all display the biaryl segment within a 
complex cyclic framework. This structural feature differs distinctly from the majority 
of biaryl systems in naturally occurring compounds, where the biaryl segment is 
contained in an acyclic array. 
Of all the classes of biaryl acyclic natural products that have been isolated in Nature, 
the alkaloids stand out as providing perhaps the richest source of examples. 
Ancistrocladine (50), an optically active cryptophenolic alkaloid, was isolated from 
the roots of Ancistrocladus heyneanus in 1971.98 Ancistrocladine (50) contains the 
iso-quinoline ring system, a common aromatic partner in biaryl alkaloid natural 
products, in addition to a highly substituted biphenyl system that is configurationally 
stable to above 200°C. No pharmacological investigations have yet been carried out 
with ancistrocladine (50) despite a total synthesis of the alkaloid by Bringmann et 
al.99 
50 Ancistrocladine 
Structurally related to ancistrocladine (50), but less sterically congested around the 
biaryl axis, is the naphthyl iso-quinoline alkaloid dioncophylline A (51). This axially 
chiral biaryl alkaloid was isolated from the West African liana Triphyophylllllll 
peltatum in 1990100 and was found to exhibit fungicidal and antimalarial activity. 101 
A successful total synthesis of dioncophylline A (51) was completed by Bringmann et 
al.102 Relying on the ready availability of this alkaloid on a multi gram scale from 
natural sources, Bringmann et al prepared its dimer, jozimine A (52).103 lozimine A 
(52) was the first non-natural dimer of a naturally occurring, monomeric 
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naphthyliso-quinoline alkaloid to be synthesised. It has aroused much interest since it 
was found to display antimalarial activity twenty times higher than that of its 
monomer. 103 
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Several alkaloids which possess structural characteristics similar to those of jozimine 
A (52) have been isolated in Nature. Michellamine A (53), isolated from A. 
korupensis in 1991,104 is representative of a unique natural class of biologically 
important tetra-aryls with activity against human immunodeficiency virus (HIV).105 
Structurally, michellamine A (53) is characterised by the presence of six free phenolic 
hydroxy groups, two secondary amino functions and by the existence of four 
stereocentres and three axes, two of which are stereo genic due to restricted rotation. 
This C2-symmetric dimer was synthesised using an oxidative phenolic coupling of the 
monomeric naphthyl iso-quinoline alkaloid natural product korupensamine A (54) by 
Bringmann et al,106 then subsequently by Kelly et al l07 and Hoye et al.IOS 
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A more complex biaryl alkaloid system is found in vingramine (55). This cytotoxic 
bis-indole natural product was isolated from the seeds of Catharanthus roseus in 
1998.109 Its structure is exceptional due to the unusual biphenyl linkage and the 
presence of an iso-butyramide group and a tetrahydrofuran ring. No synthetic studies 
towards vingramine (55) have been reported. 
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Although the peptides and alkaloids provide a plethora of biaryl natural products, 
many classes of naturally occurring compounds possessing biaryl systems have been 
reported which are devoid of nitrogen. 
Mastigophorene A (56), a constitutionally symmetric, dimeric sesquiterpene. was 
isolated from the primitive Asiatic liverwort Mastigophora diclados in 1991. 11o Its 
25 
structure is characterised by the presence of two pentasubstituted aromatic rings and 
two chiral cyc10pentyl residues. Mastigophorene A (56) exhibits nerve growth and 
network formation acceleration activityllO and has been synthesised recently by 
Meyers et alII I and by Bringmann et al. 112 
56 Mastigophorene A 
Another dimeric sesquiterpene, gossypol, has received much attention since it was 
first revealed to be active as an antispermatogenic agent. 1l3 Gossypol has also been 
shown to be effective against tumour cells, mv type 1, herpes simplex virus and 
infiuenza,1l4 since it was isolated from cotton seeds in 1886. 115 An asymmetric total 
synthesis of (S)-( + )-gossypol (57) was achieved recently by Meyers and 
Willemson. 116 
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Knipholone (58) was first isolated from the sun dried roots of Kniphofia foliosa in 
1984,117 a perennial herb widely distributed in the mountainous regions of central and 
northern Ethiopia, which is used in traditional Ethiopian medicine for the treatment of 
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abdominal cramps and also displays antimalarial activity. Knipholone (58) represents 
a new type of anthraquinone pigment118 in which the chrysophanol chromophore is 
connected to an acylphloroglucinol unit by a chiral biaryllinkage. A total synthesis of 
knipholone (58) has not yet been reported. 
58 Knipholone 
Pradimicin A (59), from Actinomadura hibisca,119 is yet another biaryl quinone 
natural product, in which the biaryl axis forms part of a 6-membered ring. This 
antifungal antibiotic, isolated in 1989, has a unique structure consisting of a 
5,6-dihydrobenzo[a ]naphthacene chromophore substituted with D-alanine and 
disaccharide residues. A total synthesis of pradimicinone, the pradimicin A (59) 
aglycon, was reported recently by Suzuki et al. 120 
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Steganone (60) is one of four bis-benzocyclooctadiene lignan lactones isolated from 
Steganotac1Jlia araliacea in 1973. 121 This antileukemic, cytotoxic natural product 
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contains three stereochemical elements, two of which are on the lactone ring, whilst 
the third is the asymmetric biaryl bond between the two phenyl rings. Steganone (60) 
has attracted considerable interest within the synthetic community, resulting in eleven 
reported total syntheses,122 five of which have been enantioselective. 123 
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Chaetocromin A (61) was first isolated from Chaetomium virescens in 1980. 124 It is 
one of a closely related family of bis-(naphtho-y-pyrone) metabolites which include, 
for example, cephalochromin, nigerone, ustilaginoidins and aurasperones. 125 
Chaetochromin A (61) is the outstanding member of this class due to its pronounced 
cytotoxic and anti tumour activity, but a successful total synthesis has yet to be 
described. 
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Geraniin (62) is the main tannin of plants of several Geranium species and also 
Euphorbiaceae. This eligatannin was first isolated from Geranium thllllbergii in 
1975 126 in an attempt to obtain the active principle of this medicinal plant, which is 
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one of the most popular folk medicines and also is an official antidiarrheic in 
Japan.127 Geraniin (62) displays an interesting structure in which a cyclohexenetrione 
moiety is attached to a glucose residue, which is further linked to a chiral biphenyl 
system. 
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2. RESULTS AND DISCUSSION 
30 
2.1 General Strategy and Retrosynthesis 
The high degree of complexity associated with the macrocyc1ic aromatic core of 
diazonamide A (1), prompted us to concentrate our initial efforts towards the 
construction of the key C-C a-bonds within this heterocyclic framework. The 
synthetic endeavors of previous workers in Nottingham on the project,128 had 
demonstrated that it was possible to utilise palladium-catalysed sp2-sp2 coupling 
protocols to prepare a benzofuran-oxazole fragment, a benzofuran-indole fragment 
and an indole-oxazole fragment. The completion of a macrocyc1ic system containing 
all four of the aromatic units present in the southern macrocyc1e of diazonamide A 
(63) was the next challenge to be confronted. Hence, at the outset of my research, the 
complex macrocyc1e (64) became our synthetic target. 
63 64 
Although the macrocyc1e (64) represents only the aromatic core of diazonamide A 
(1), its synthesis is still a significant proposition. The benzofuran in 64 is linked via a 
quaternary carbon centre to a trisubstituted oxazole. This forms part of a bis-oxazole 
segment in which the remaining oxazole is fused to an indole. The atropisomeric 
biaryl bond linking the indole to the benzofuran in 64 completes the macrocyclic 
structure. 
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Following our keen interest in macrocyclic sp2-sp2 coupling reactions,56,l29 we 
devised a retrosynthetic strategy in which the macrocycle (64) was first disconnected 
across the biaryl bond to provide the acyclic system (65). The intramolecular union of 
two aryl halide units in the presence of a suitable transition metal, the Ullmann 
reaction,130 would be expected to result in the formation of the desired macrocycle 
(64). The acyclic fragment (65) still represents a significant synthetic challenge, as all 
four of the aromatic units present in the macrocycle remain intact. However, 
retrosynthetic disassembly of the disubstituted oxazole revealed the amide (66). On 
the basis of precedent,65,69,72 it was projected that cyclisation of the keto amide 
function in 66 with triphenylphosphine, iodine or hexachloroethane and a suitable 
base, would lead to the formation of the macrocyclic precursor (65). The amide (66) 
can be dismantled in a convergent fashion by retrosynthetic cleavage of the amide 
bond to provide the acid (67) and the amine (68). It was anticipated that activation of 
the carboxylic acid function in 67 as a mixed anhydride or acid chloride and exposure 
to the amine (68), would result in the formation of the amide (66). 
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2.2 Synthesis of the Benzofuran Oxazole Acid Fragment (69) 
2.2.1 Introduction 
The acid fragment (67) is by far the more structurally complex of the two crucial 
synthetic intermediates derived from the previous retrosynthetic analysis (2.1). It 
incorporates the quaternary carbon centre at the C2 position of the benzofuran ring 
which is linked to a phenyl ring and a trisubstituted oxazole. In addition, the halogen 
substituent at the C7 position of the benzofuran ring is vital for the final 
macrocyclisation reaction. 
2.2.2 Retrosynthetic Analysis 
Following a similar retrosynthetic protocol to that described previously for the 
bis-oxazole (65), we envisaged obtaining the target compound (69) from the amide 
(70) by a cyclodehydration process,69 then hydrolysis of the ester function. It was 
anticipated that the amide function of 70 could be introduced into the ketone (71), 
possibly via an azide, oxime or diazo intermediate. The ketone (71) can be traced 
retrosynthetically to the aldehyde (72) and then to the terminal alkene (73). In the 
forward sense, oxidative cleavage of the terminal alkene (73) would be expected to 
provide the aldehyde (72),132 which could undergo a two carbon homologation with 
ethyl diazoacetate in the presence of a suitable Lewis acid leading to the ketone 
(71).133 The terminal alkene (73) is a crucial intermediate in the synthesis of the acid 
(69), since it can be derived from the iodide (74). In the synthetic direction, subjecting 
the iodide (74) to palladium(O) catalysis could lead to the benzofuran framework via a 
Heck reaction. 134 By utilising this powerful tool, we would unite two sp2-hybridised 
carbon centres, introduce the quaternary carbon centre at the C.:2 position of the 
benzofuran ring and leave a terminal alkene for elaboration to the trisubstituted 
oxazole (69). 
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It was envisaged that the trisubstituted alkene (74) could be obtained by a Wittig 
reaction 135 between the ketone (75) and (ethyl)triphenylphosphonium bromide in the 
presence of a suitable base. We anticipated that the introduction of iodine into the 
ketone (75) could be achieved by an ipso-substitution of the aryl silane (76) with 
silver tetrafluoroborate and iodine. Logical retrosynthetic disassembly across the 
phenolic ether linkage next provided the disubstituted phenol (77) and 
2-bromoacetophenone (78), with the disubstituted phenol (77) ultimately being 
obtainable from phenol (79), via the dibromo derivative (80).136 In the forward sense, 
it was expected that the reaction of bromine and t-butylamine with phenol (79) would 
lead to the ortho-dibromo derivative (80).136 Preparation of the trimethylsilyl phenol 
ether and treatment with n-butyUithium could then give the bromo silyl phenol (77) 
via a silyl group migration 137 in the intermediate aryl lithium species. Deprotonation 
of the acidic phenolic hydrogen with an appropriate base and exposure of the 
resulting phenoxide anion to 2-bromoacetophenone (78) would then be expected to 
provide the desired ketone (76). 
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2.2.3 Synthesis of the Aryl Iodo Alkene Fragment (74) 
Our synthesis of the iodide (74), the precursor for the crucial Heck reaction,134 
followed the retrosynthetic plan outlined previously (2.2.2). The synthesis 
commenced by treatment of phenol (79) with t-butylamine and bromine at -70°C to 
give 2,6-dibromophenol (80) in 63% yield (Scheme 1).136 The phenol (80) was 
transformed to the trimethylsilyl ether (81) using sodium hydride and 
chlorotrimethylsilane. Treatment of the trimethylsilyl ether (81) with n-butyllithium 
at -78°C effected a lithium-bromine exchange reaction, generating the putative aryl 
lithium species (82). This organometallic compound (82) then underwent a 1,3-silyl 
shift,137 to give the aryl silane (77) in an excellent 83% yield for this one pot reaction. 
Alkylation of the phenolic hydroxyl in 77 to give the ketone (76) was achieved in 
95% yield on exposure of the aryl silane (77) to potassium carbonate and 
2-bromoacetophenone (78). The silyl function in the ketone (76) was next converted 
into an iodide via an ipso-substitution reaction, with silver tetrafluoroborate and 
iodine, to give the aryl iodide (75) in 77% yield. This proved an extremely efficient 
method for introducing iodine into the aromatic system, with the aryl silane acting as 
a masked aryl iodide. Wittig olefination l35 of the ketone (75) using ll-butyllithium 
35 
with (ethyl)triphenylphosphonium bromide at DOC, finally gave the desired 
trisubstituted alkene (74), as a 2: 1 ratio of geometrical isomers in 96% yield. 
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Reagents: i, t-BuNH2, Br2, PhMe, CH2C12, 63%; ii, NaH, TMSCl, n-BuLi, THF, 83%; iii, K2C03, 
78, MeCN, 95%; iv, 12, AgBF4, EtOH, 77%; v, n-BuLi, EtPPh3Br, THF, 96%. 
Scheme 1 
At this juncture, we thought it appropriate to consider the possibility of utilising the 
Heck reaction134 in a system which we could extend to the northern macrocycle of 
diazonamide A (1). In order to implement such a strategy, we required the iodide 
(83), as the relevant Heck precursor. The only structural difference between 83 and 
the previous iodide (74) is the incorporation of a suitably protected tyrosine residue in 
place of the phenyl ring. We anticipated that we could follow a very similar 
retrosynthetic pathway for the iodide (83) to that described previously for the iodide 
(74). The task now became the synthesis of the bromide (84), an analog of 
2-bromoacetophenone (78) which incorporates the protected tyrosine residue. 
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Our synthesis of the bromide (84) commenced with a Friedel-Crafts acylation 
reaction of L-tyrosine (85) using acetyl chloride and aluminum chloride at lOO°C,138 
to give the ketone (86) in 67% yield (Scheme 2). With the carbonyl function now 
introduced, we proceeded to protect the three remaining active sites in the ketone 
(86). To this end, esterification of the carboxylic acid function with acetyl chloride 
and methanol 139 at reflux first provided the methyl ester (87) in 95% yield. The amine 
was next converted into the benzyl carbamate (88) under the action of sodium 
carbonate and benzyl chloroformate at O°C in 77% yield. Protection of the phenolic 
hydroxyl function as a benzyl ether proved slightly more difficult due to the low 
reactivity of the phenoxide anion, which can delocalise its negative charge into the 
neighbouring ketone function. However, protection of the hydroxyl was finally 
achieved by treatment of 88 with potassium carbonate, benzyl bromide and three 
equivalents of DMPU140 in DMF141 to give the benzyl ether (89) in a modest 34% 
yield. With all the reactive sites now suitably protected, we could address the question 
of how to introduce the bromine substituent. We found that bromination was best 
performed by in situ formation of the silyl enol ether (90) with lithium 
bis-(trimethylsilyl)amide and chlorotrimethylsilane at -78°C, followed by rapid 
addition of bromine to give the bromide (84) in 78% yield. 
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Scheme 2 
With the bromide (84) now in hand, we could follow the previous synthetic steps 
described in Scheme 1 for the preparation of the iodide (74). Hence, the phenolic 
hydroxyl in the aryl silane (77) underwent alkylation on treatment with potassium 
carbonate and the bromide (84) to give the aryl silane (91) in 85% yield (Scheme 3). 
The aryl iodide required for the Heck reaction 134 was again unmasked by an 
ipso-substitution of the aryl silane (91) with iodine and silver tetrafluoroborate to give 
the ketone (92) in 99% yield. Exposure of the ketone (92) to the Wittig olefination 
conditions used to prepare the trisubstituted alkene (74) (Scheme 1), gave only trace 
amounts of the desired product. Since the remaining starting material could be 
recovered from the reaction, we believed that the phosphonium ylide derived by 
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treatment of (ethyl)triphenylphosphonium bromide with n-butyllithium, was primarily 
involved in abstracting an acidic hydrogen adjacent to the ketone function in 92. This 
problem was overcome by employing sodium bis-(trimethylsilyl)amide as the base at 
-40°C to give the desired trisubstituted alkene (83), the second Heck precursor, in 
62% yield. 
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Reagents: i, K2C03, 84, MeCN, 85%; ii, 12, AgBF4, EtOH, 99%; iii, NaHMDS, EtPPh3Br, 
THF,62%. 
Scheme 3 
2.2.4 The Heck Reaction 
The palladium-catalysed arylation or alkenylation of alkenes is a process known as 
the Heck reaction. 134 First described by R. F. Heck in the late 1960s,142 the reaction 
received little attention in the first decade since its discovery, but has undergone a 
resurgence in the late 1980s and 1990s. The ability of the reaction to bring about 
complex structural changes, construct unprecedented molecular frameworks and form 
quaternary stereogenic centres using only a catalytic amount of palladium(O), has 
established it as one of the true power tools of modern organic synthesis. 
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The Heck reaction 134 can be defined as the palladium(O)-catalysed reaction of an 
alkenyl or aryl halide (93) with an alkene (94) to create a new C-C a-bond in the 
product alkene (95), along with the formation of a hydrogen halide as a by-product. 
~ ' ' ~ ~ Pd(O), base r - - I ~ ~:" 'Il + .. + HX ~ " " X ~ , ,, , 
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The currently accepted mechanism of the reaction is summarised overleaf. The 
catalytic active species is believed to be a coordinatively unsaturated 14-electron 
palladium(O) complex, typically bis-(triphenylphosphine )palladium(O) (96). This is 
formed in situ by the sequential loss of ligands from the saturated 
tetrakis-(triphenylphosphine)palladium(O). The active species (96) initiates the first 
step in the catalytic cycle by taking part in an oxidative addition reaction with an 
alkenyl or aryl halide or triflate (R LX) to give the 16-electron complex (97). 
Complexation of the reacting alkene to 97 is followed by a syn insertion of the alkene 
into the a-alkenyl or a-aryl C-Pd bond, generating the organopalladium species (98). 
The next step in the catalytic cycle involves a simple internal bond rotation to give the 
organopalladium species (99). This event establishes the necessary syn relationship 
between a ~ - h y d r o g e n n atom and the palladium atom. The reaction-terminating syn 
elimination of a ~ - h y d r i d e e can now take place to liberate the product alkene (100) and 
the hydridopalladium complex (101). Finally, a base-assisted reductive elimination of 
HX from the hydridopalladium complex (101) regenerates the catalytically active 
14-electron species (96). 
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The problem of regioselectivity in the alkene insertion step of the catalytic cycle is 
one of the most fundamentally important aspects of the Heck reaction. After oxidative 
addition, the 16-electron complex (102) can follow one of the two paths depicted 
overleaf. The factor determining which path is followed is the nature of the halide, X, 
in the complex (102).134e,143 If the catalytically active 14-electron palladium(O) 
species undergoes oxidative addition into an aryl or alkenyl halide bond when X is a 
halide (usually either bromide or iodide) then the reaction proceeds along Path A. In 
order for the reacting alkene to form a coordinated complex to the palladium (103), 
then, due to the strong nature of the palladium-halide bond, another ligand must 
dissociate. This may be a phosphine or a solvent molecule. If, as depicted, a chelating 
bis-phosphine is present, then one of its phosphorus atoms must dissociate before 
alkene coordination can take place. If X is a triflate then the reaction proceeds along 
Path B. In this instance, the affinity of the triflate for the palladium is considerably 
.+1 
weaker than that of a halide, hence the triflate can readily dissociate to form the 
cationic complex (104) to which the reacting alkene can then coordinate. 
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In a simple reaction such as that of an aryl iodide with the a-substituted alkene (105), 
the reaction follows Path A and the alkene coordinates to gi ve a neutral complex 
similar to 103 shown above. In this case steric considerations dominate and the new 
c-c bond tends to be formed at the least substituted end of the alkene to give the 
disubstituted alkene (106). In the reaction of an aryl triflate with the a-substituted 
alkene (105) the reaction follows Path B to give a cationic complex similar to 104. 
The cationic nature of the palladium species increases the polarisation of the 
coordinated double bond. Electronic factors now govern the alkene insertion step and 
the aryl group is transferred to the end of the alkene with the lowest electron density 
to give the product alkene (107). 
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In the intramolecular Heck reaction conformational constraints also exist, in addition 
to the steric and electronic constraints already discussed. In the alkene insertion step 
the alkene should ideally adopt a coplanar alignment with the palladium and the 
carbon atom of the aryl or alkenyl species. 144 This creates the eclipsed conformation 
depicted in 108 as opposed to the twisted conformation illustrated in 109. 
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Accessing an eclipsed conformation in an intermolecular reaction is not normally a 
problem and hence the reaction is governed by the steric and/or electronic factors 
surrounding the orientation of the reacting alkene in the alkene insertion step. 
However, in an intramolecular reaction the alkene may be constrained to only one 
eclipsed conformation due to the size and/or shape of the substrate. In this case only 
one of the possible regioisomers will be observed. For the synthesis of 5-, 6- and 
7-membered rings, the reaction almost always occurs via the exo mode of cyclisation 
as conformational considerations outweigh any steric or electronic factors in the 
system. 
The well-established intermolecular Heck reaction 134 has proved to be a useful 
method for extending the carbon framework of a molecule. However, by virtue of its 
possible application to essentially every type of alkene and tolerance of a variety of 
functional groups, attention in recent years has centred primarily around the 
intramolecular variant of the Heck reaction. 134f Careful choice of substrates and 
skilful tailoring of reaction conditions has led to a tremendous variety of elegant and 
highly convergent routes to structurally complex molecules. The intramolecular Heck 
reaction 134f is especially suited for the construction of congested polycyclic 
frameworks and quaternary stereogenic centres (110), which are notoriously difficult 
to build by conventional means. In these instances, the reacting alkene involved in the 
cyclisation is geminally substituted. 
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The diverse complexity of molecular architecture that can be constructed utilising the 
intramolecular Heck reaction 134f has been amply demonstrated by the research group 
of Overman. They found that exposure of the aryl iodide (111) to a catalytic amount 
of palladium(O) resulted in the formation of the unsaturated morphinan (112) in 60% 
yield (Scheme 4 ).145 A new carbocyclic ring and a crucial quaternary stereocentre are 
formed in this 6-exo-trig intramolecular process. Further elaboration of 112 gave the 
alkaloid (-)-morphine (113). 
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Scheme 4 
When the substrate was modified to include a second alkene (114) and subjected to 
similar reaction conditions, the pentacycle (115) was produced in 56% yield. 1.+6 In 
this transformation, intramolecular Heck insertion proceeded to form the intermediate 
tetracyclic n-allyl palladium complex (116). Intramolecular nucleophilic attack by the 
free phenolic hydroxyl group on the electrophilic n-allyl palladium complex, then 
gave the pentacyclic opiate core (115), which was also elaborated to (-)-morphine 
(113). 
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Reagents: i, Pd(OCOCF3h(PPh3h, pempidine, PhMe, ~ , , 56%. 
In systems which lack a ~ - h y d r o g e n , , the syn ~ - h y d r i d e e elimination pathway in the 
catalytic cycle is blocked. As a result, the organopalladium species formed after the 
initial alkene insertion step is available to engage a proximal alkene in the system. 
This sets in motion a sequence of successive intramolecular Heck reactions from a 
single substrate which can lead to multiple ring formations and compounds of 
impressive molecular architecture. A most convincing demonstration of the utility of 
the tandem intramolecular Heck cyclisation can be found in the first total synthesis of 
racemic scopadulcic acid A by Overman et al. 1.+7 In this concise synthesis, the action 
of a catalytic amount of palladium(O) on the alkenyl iodide (117) results in the 
formation of the tIicycle (118) in 83% yield. The sequential Heck insertion reactions 
are only possible due to the absence of a ~ - h y d r o g e n n in the organopalladium 
intermediate (119). 
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The area of cascade Heck cyclisations has been extended far beyond the impressive 
tandem examples described previously. Negishi et al have developed a novel cascade 
approach to pentacycles which utilises alkynes in the insertion step of the catalytic 
cycle. 148 In their approach to the pentacycle (120), the alkenyl palladium(II) complex 
formed by oxidative addition of a catalytic amount of palladium(O) into the alkenyl 
iodide (121), undergoes a 6-exo-dig intramolecular Heck reaction with the proximal 
alkyne to form a new alkenyl palladium(II) complex (122). This complex can then 
react with the remaining three alkynes in a similar fashion, with carbonylative 
intramolecular esterification as the terminating step, to give the pentacycle (120) in 
66% yield. 
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All the examples described so far have involved the formation of carbocycles, but it 
has been demonstrated that the Heck reaction 134 is also a powerful tool in the 
synthesis of heterocyclic frameworks. The Heck reaction 134 is particularly prevalent 
in the synthesis of indoles and heterocycles containing the indole skeleton. In 1977 
Mori et al described the first intramolecular Heck cyclisation to form the indole 
system.149 They found that the aryl bromide (123) could be cyclised to the indole 
(124) in 43% yield. Under the reported conditions, the initially formed alkene would 
be exo-cyclic, but this completely isomerises in the reaction mixture to the more 
stable endo-cyclic position. 
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Grigg et al have shown that the Heck reaction can also be employed in the synthesis 
of lactams. 150 They prepared the lactam (125) by a 6-exo-trig cyclisation of the iodide 
.+7 
(126), installing the central 6-membered ring and the chiral quaternary carbon centre 
in 68% yield. This crucial step in the synthesis of the naturally occurring alkaloid 
(R,R)-crinan (127) was initially hampered by a proposed palladium(II)-mediated 
cleavage of the lactam ring. This problem was circumvented by the addition of water 
to the reaction mixture. 
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In a conCIse synthesis of racemIC dehydrotubifoline (128), Rawal et a[l51 
accomplished the catalytic palladium(O)-mediated conversion of the alkenyl iodide 
(129) to the natural product (128) under the conditions developed by Jeffery 152 in 
79% yield. The product of this Heck cyclisation is the en amine (130). This substance 
is a participant in a tautomeric equilibrium with the imine (128), which is shifted 
substantially in favour of the natural product (128) . 
.. 
Reage1lts: i. Pd(OAch, K2C03, n-BuN..t.CI. DMF, ~ , , 79o/c . 
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The tolerance of potentially sensitive functional groups to the conditions required for 
Heck cyclisation is particularly evident in the impressive assembly of the tetracycle 
(131), an advanced intermediate in the synthesis of FR-900482 (132) by Danishefsky 
et al. IS3 In the crucial C-C bond forming reaction, exposure of the aryl iodide (133) to 
a catalytic amount of palladium(O) effected the desired Heck arylation to afford the 
tetracycle (131) in an excellent 93% yield. 
o ------.. 0 
OMe OMe 
133 131 
MeO 
.. 
.. NH 
OHC 
132 
Reagents: i, Pd(PPh3)4, Et3N, MeCN, 11, 93%. 
The intramolecular Heck reaction I34f is often highly diastereoselecti ve. The use of 
chiral auxiliaries in providing stereocontrol has received surprisingly little attention. 
However, Grigg et al have shown that amino ethers may be effective chiral auxiliaries 
for the Heck reaction. 1S4 Thus, when the acyclic alkene (134) bearing the SAMP 
chiral auxiliary was subjected to standard Heck cyclisation conditions, 
diastereoselectivities of 95% were achieved in the product alkene (135). 
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The subtle tailoring of reaction conditions to control the diastereoselectivity of an 
intramolecular Heck reaction has been described by Overman et al155 in their 
synthetic efforts towards the hexacyclic indole alkaloid gelsemine (136). By altering 
the nature of the base, the cyclisation could be tuned to favour one of the possible 
oxindole products, as shown overleaf. Thus, when triethylamine was used as the base 
in the cyclisation of the aryl bromide (137), the reaction gave an 89: 11 ratio of 
stereoisomers in favour of the oxindole (138). However, when silver phosphate was 
employed as the base, a 3:97 ratio of stereoisomers in favour of the oxindole (139) 
was observed. The proposal to account for this reversal in stereoselecti vity was 
founded on the nature of the 16-electron aryl palladium(II) complex formed by 
oxidative addition of palladium(O) to the aryl bromide (137). When triethylamine was 
used as the base, the neutral aryl palladium(II) complex (140) was formed. This 
complex could coordinate the proximal alkene to give the oxindole (138). However, 
when silver phosphate was employed as the base, the ability of the silver salt to 
sequester the bromide away from the palladium led to the formation of a cationic 
palladium intermediate. This cationic species could coordinate both alkenes present in 
the substrate to form the aryl palladium(II) intermediate (141) and ultimately the 
oxindole (139). 
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The area of the asymmetric Heck reaction has been explored mainly by the research 
group of Shibasaki. 134d They have demonstrated that prochiral aryl and alkenyl 
iodides and triflates can be cyclised to products of high optical purity. Given the 
many reports of chiral phosphine ligands dating back to the early 1970s,156 it is 
perhaps a little surprising that the phosphine-mediated asymmetric Heck reaction was 
not attempted until the late 1980s. However, the reaction has since been successfully 
developed to the point where both tertiary and quaternary stereogenic centres can be 
generated with a high degree of enantioselectivity. The bulk of the reported examples 
involve intramolecular ring closure reactions,134f which have the advantage of 
allowing relati vely easy control of alkene regiochemistry and geometry in the 
product, in addition to tolerating less reactive alkene substrates. The chiral 
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his-phosphine BINAP has been found to be the most successful ligand for this 
reaction. The highest degree of influence over the enantioselectivity of the reaction is 
exerted when both phosphorus atoms are bound to the palladium atom. For this to be 
the case when the palladium coordinates to the alkene, the reaction must proceed via a 
cationic 16-electron palladium complex. Hence, the use of silver salts is essential for 
obtaining good enantiocontrol with aryl or alkenyl iodides. 157 With these factors in 
mind, Shibasaki et al have shown that the vinyl iodide (142) can be cyclised to the 
decalin system (143) in 67% yield and 87% ee. 158 
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In an extension of this work, the Shibasaki group have prepared the optically active 
bicyclic diene (144) from the alkenyl triflate (145).159 To rationalise this novel 
transformation, it was proposed that oxidative addition of an asymmetric palladium(O) 
catalyst first generated the cationic 16-electron palladium complex (146). Insertion of 
the coordinated alkene then gave the transitory n-allyl palladium complex (147). This 
complex is captured in a regio and stereocontrolled fashion by an acetate ion to give 
the bicycle (144) in 89% yield and 80% ee. 
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By varying the nature of the base, Overman et al have shown that it is possible to 
access either enantiomer of a cyclic indolone using the same enantiomer of the chiral 
BINAP ligand. 160 Using silver phosphate as the base in the asymmetric Heck reaction 
of the aryl iodide (148), resulted in the formation of the (S)-indolone (149) in 81 % 
yield and 71 % ee. If pempidine is employed as the base, then the (R)-indolone (150) 
is formed in 77% yield and 66% ee. 
... 
148 149 
Reagents: i. Pd2(dba)3, (R)-BINAP, Ag3P04, D M A , ~ . . 81 %.77% ee, ii. Pd2(dba)3, (R)-BINAP, 
pempidine, DMA, ~ , , nr;c. 66%ee. 
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This brief overview of some of the fascinating synthetic accomplishments that ha\e 
incorporated the Heck reaction in key steps, has shown that, in the past few years, the 
Heck reaction has started to reveal its full potential as a powerful tool for the 
synthetic chemist. The broad spectrum of recent achievements, in particular, the 
construction of quaternary carbon centres in sensitive heteronuclear frameworks and 
the advances in diastereo and enantiocontrolled reactions, originally led us to 
investigate this procedure for the formation of the quaternary carbon centre in the 
benzofuran-oxazole acid fragment (69). 
2.2.5 Synthesis of the Benzofuran Amide Fragment (70) 
With multi gram quantities of the iodide (74) in hand, we focused our attention on the 
preparation of the amide fragment (70). Crucial to this phase of the synthesis of the 
benzofuran oxazole acid fragment (69), was the implementation of an intramolecular 
Heck reaction 134f to install the quaternary carbon centre. On construction of this 
centre, the major challenge was to elaborate the resulting terminal alkene to a keto 
amide function for cyclisation to the trisubstituted oxazole. 
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Following an extensive survey of the literature conditions for the Heck reaction and 
previous work by colleagues on the project,128 the iodide (74) was subjected to the 
combined action of palladium(II) acetate, triphenylphosphine and silver carbonate in 
DMF at 80°C to give the terminal alkene (73) in a moderate 53% yield. 
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Unfortunately, when the iodide (83) was subjected to the Heck reaction conditions, no 
cyclised product (150) was obtained. A vast array of reaction conditions were 
employed in an effort to effect the 5-exo-trig ring closure. These included the use of 
different dipolar aprotic solvents, amine and inorganic bases, silver161 and thallium 162 
salts as additives, tetrabutylammonium iodide and chloride as phase-transfer agents 152 
and a variety of temperatures and reaction times. Although, in every reaction, the 
substrate was completely consumed, no identifiable products could be isolated. One 
possible explanation for the failure of this reaction is that the catalytically active 
palladium(O) species is poisoned by coordination of the carbamate function. 
Following oxidative addition this process could compete with alkene insertion, hence 
blocking the catalytic cycle and leading to a variety of unusual by-products. 
Supporting evidence for this theory is provided by recent studies within the Pattenden 
group.163 Exposure of the iodide (151), which lacks the carbamate function, to the 
Heck reaction conditions outlined overleaf, resulted in the formation of the lactone 
(152) in a moderate 52% yield. 
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The success of the Heck reaction with the iodide (74), led us to concentrate our efforts 
solely on the formation of the benzofuran oxazole acid (69) and advancement to the 
macrocyclic core of diazonamide A (64). Following our retrosynthetic plan, the next 
target became the ketone (71). As part of a study towards the total synthesis of 
tetronasin,133 Nomura et al recently described the conversion of hindered aldehydes 
(153) to ketones (154) using methyl (diazoacetoxy)acetate (ISS) and zirconium 
chloride. The keto esters (154) could be cyclised on treatment with TBAF to provide 
the y-unsubstituted a-acyltetronic acids (156). 
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With this precedent in hand, the terminal alkene (73) was treated with a catalytic 
amount of osmium tetroxide and sodium periodate to provide the hindered aldehyde 
(72) in a poor 40% yield (Scheme 5).132b No improvement in yield could be obtained 
by canying out this procedure over two steps, with initial isolation of the intermediate 
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diol, or by treating the terminal alkene (73) with ozone. 132a However, when the 
aldehyde (72) was exposed to ethyl diazoacetate and zirconium chloride at ooe, the 
two carbon homologation 133 proceeded smoothly to give the ketone (71) in 84% 
yield. 
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Reagents: i, OS04, NaI04, THF, H20, 40%; ii, ZrC14, N2CHC02Et, CH2C12, 840(,. 
Scheme 5 
The task now was to introduce an amine function at the position ex to both the ketone 
and ester functions present in the ketone (71), which would ultimately provide the 
nitrogen atom of the trisubstituted oxazole. It was our initial intention to obtain this 
amine by the reduction of an azide, which we anticipated we could prepare by 
nucleophilic displacement of a bromine atom with an azide anion. 164 Hence, the 
ketone (71) was treated with sodium hydride and bromine at ooe to give the bromide 
(157) (Scheme 6). When the bromide (157) was then exposed to sodium azide, some 
nucleophilic substitution was detected to give the azide,164 which existed in its enol 
form (158). However, due to the identical polarity of the three substrates, the azide 
(158) could only be obtained in a mixture which included the ketone (71) and the 
bromide (157). As a result, all attempts to reduce the azide (158) to the amine (159) 
using the Staudinger reaction,165 hydrogenation,166 or trimethylsily I iodide,167 then 
subsequent acylation, gave only complex mixtures of several unidentifiable products. 
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Having failed in our attempts to prepare and reduce the azide (158), we sought an 
alternative nitrogen-containing functional group which we could elaborate to an 
amine function. One of the most common methods for preparing a-amino ketones is 
utilised in the conventional Knorr synthesis of pyrroles. 168 In this classic reaction, 
nitrosation of the active methylene group in the ketone (160) is followed by reduction 
of the oxime (161) to give the amine (162) (Scheme 7). The amine (162) then 
undergoes condensation with a second ketone (163) to give the pyrrole (164). 
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Application of this methodology to our system began by treatment of the ketone (71) 
with sodium nitrite in aqueous acetic acid (Scheme 8).168 The transitory nitronium 
ion was captured by the active methylene group to provide a putative nitro species 
which tautomerised to give the oxime (165) as a 2: 1 mixture of geometrical isomers 
in an excellent 94% yield. Reduction of the oxime (165) by treatment with activated 
zinc dust in acetic acid168 provided the salt (166). Since a-amino ketones are known 
to decompose readily by self-condensation,169 no attempt was made to purify the salt 
(166). Instead, immediate treatment of 166 with triethylamine liberated the reactive 
amine function which underwent acylation on exposure to acetyl chloride to give the 
desired amide (70) in 71 % overall yield. 
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Scheme 8 
Although the synthesis described above provided us with an efficient route to the 
amide (70), we also considered an altemati ve approach, again starting from the ketone 
(71), which avoided the formation of an a-amino ketone intermediate. We were 
aware of the recent investigations conducted by Moody et al into the synthesis of 
functionalised mono- and bis-oxazoles.17o This publication described the 
rhodium(II)-catalysed reaction of diazocarbonyl compounds in the presence of 
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primary amides, which resulted in the regioselecti ve insertion of the carbenoid into 
the amide N-H bond and formation of ~ - c a r b o n y l l amides. 
Insertion reactions of metallocarbenoids are widely used in synthesis, although, with 
the exception of the intramolecular insertion into the N-H bond of a ~ - l a c t a m m
developed by Merck as a route to carbapenems and related compounds,171 the N-H 
insertion reaction has found little use to date. In In a projected synthesis of the natural 
product phenoxan, Moody et al showed that the amide (167) underwent reaction with 
the rhodium carbenoid derived from the diazomalonate (168) to give the N-H 
insertion product (169) in 81 % yield. 
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Reagents: i, Rh2(OAc)4, P h M e , ~ , , 81 %. 
In a bid to effect a rhodium(II)-catalysed N-H insertion reaction to form the amide 
(70), we initially prepared the diazo compound (170) by treatment of the ketone (71) 
with triethylamine and 4-acetamidobenzenesulfonyl azide in 99% yield (Scheme 
9)173 However, the diazo compound (170) failed to undergo regioselective N-H 
insertion on treatment with rhodium(II) acetate and acetamide in refluxing 
chloroform. The only product which could be identified from the complex reaction 
mixture was the benzofuran (171). A possible mechanistic explanation for production 
of the benzofuran (171) involves, after initial formation of the rhodium carbenoid 
(172), a hydride transfer to give the oxonium ion (173), as shown overleaf. 
Decomplexation of the rhodium species would then be expected to provide the 
stabilised carbanion (174) which could attack the electrophilic oxonium ion in an 
intramolecular fashion to give the cyclobutanone (175). A r e t r o - [ ~ + ~ ] ] reaction to 
open the strained cyclobutanone ring would finally provide the benzofuran (171). 
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Despite the failure of the carbenoid N-H insertion approach, a successful strategy for 
the preparation of the amide fragment (70), via the oxime (165), was now in place. 
The next task to be addressed was the cyclisation of the keto amide function in 70 to a 
trisubstituted oxazole. 
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2.2.6 Oxazole Formation 
The name oxazole was introduced by Hantzsch over a century ago,174 but the parent 
ring was not synthesised until some sixty years later. The widespread occurrence, uses 
and synthesis of oxazole derivatives since that time, have been the subject of 
extensi ve reviews. 175 A range of substitution patterns are possible around the oxazole 
ring, but the 2,4-disubstituted oxazole is by far the most common type found in 
natural products and the vast majority of research has been towards those compounds 
possessing a 4-carboxyl substituent. Because of the many roles that these compounds 
play in natural product and synthetic organic chemistry, many methods have been 
developed for their efficient construction. With such a plethora of synthetic methods 
available, only the more relevant examples from the literature will be discussed here. 
Early methods for oxazole formation focused on the combination of imidates with 
amino acids. The procedure of Cornforth,176 with modifications developed by 
Meyers,l77 involves initial condensation between ethyl acetimidate hydrochloride 
(176) and glycine ethyl ester hydrochloride to give the imidate (177) in 50% yield 
(Scheme 10). Formylation of the imidate (177) on treatment with potassium 
t-butoxide and ethyl formate provides the enol ate salt (178), which can be cyclised to 
the oxazole (179) in refluxing acetic acid in 55% overall yield. 
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Reagents: i, glycine.OEt.HCl, K:zC03, Et20, H20 , 50%; ii, Kt-BuO, HC02Et, THF; iii. AcOH, ~ , ,
5Y7r (2 steps). 
Scheme 10 
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Alternatively, the combination of an imidate (180) with senne methyl ester 
hydrochloride (181) under mild basic conditions gives rise to an oxazoline (182), 
which can be subsequently oxidised to an oxazole (183) using conditions developed 
by Meyers et al (Scheme 11).177 
Scheme 11 
a-Diazocarbonyl compounds have also been shown to participate In oxazole 
formation by undergoing 1,3-dipolar cycloaddition reactions with nitriles.178 In this 
method, a-diazocarbonyls (184) are decomposed thermally, photochemically, or by 
metal catalysis. The resulting a-carbonyl carbenes (185) then undergo a cycloaddition 
with the nitrile (R3_CN) to give the oxazole (186). This method can provide oxazoles 
bearing much different, simple functionality, but has not yet been widely applicable 
towards very complex systems. 
.. .. .. 
184 185 
Konopelski et al have demonstrated the utility of this reaction in their studies towards 
diazonamide A (1).173 Treatment of the a - d i a z o - ~ - k e t o o ester (187) under Lewis acidic 
conditions in acetonitrile fUll1ished the desired 2-methyl oxazole (188) in 64S-0 yield. 
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This approach is hampered by the need to employ the nitrile as the sol vent in order to 
obtain the best results, thus limiting the functionality that can be incorporated. 
N ~ ~
~ ~ 0 
CI 
MeCN 
187 188 
isoCyanides have also been shown to be useful intermediates in oxazole synthesis. 
Schollkopf et al have prepared a wide variety of 2-unsubstituted oxazoles (189) in 
good yields by condensing isocyanides (190) with acylating agents (RLCOX).179 The 
reaction proceeds through the intermediacy of the reactive a-isocyano ketones (191). 
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An altemati ve method for oxazole formation is the Hantzsch synthesis,180 which has 
been widely used for the synthesis of thiazoles,83b but less so for oxazoles. This 
method involves condensation of an amide (192) with a halo-keto ester (193), giving 
rise to a 2,4-disubstituted oxazole (194) after acid-mediated dehydration. The utility 
of this method has recently been demonstrated by Panek et al in a synthesis of the 
tris-oxazole unit of ulapualide A (44) (Scheme 12).83a 
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Reagents: i, a) NaHC03, ~ ; ; b) TFAA, THF, 83%; ii, a) 193, NaHC03, ~ ; ; b) TFAA, THE 60%. 
Scheme 12 
A less common method of oxazole formation requires the cyclisation of a vinyl 
bromide. In studies towards the thromboxane receptor antagonist BMS 180,291, Das 
et al reported that treatment of the terminal alkene (195) with bromine and 
triethylamine provided the vinyl bromide (196) in 92% yield (Scheme 13).181 
Cyclisation of the vinyl bromide (196) upon exposure to cesium carbonate in dioxane 
afforded the oxazole (197) in 63% yield. 
H{ C02Me 
N N ~ ~
I H o 
196 Br 
Scheme 13 
Perhaps the most widely used route towards oxazole construction in highly complex 
natural products involves formation of an amide (198) followed by either cyclisation 
to an oxazoline (199) and subsequent oxidation to give the oxazole (200), or 
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oxidation to a 1,3-dicarbonyl species (201) and cyclodehydration. These methods 
allow for the formation of oxazoles with high levels of functionality at each position 
by the union of structurally complex acid (202) and amine (203) fragments. 
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Over recent years many research groups have developed efficient syntheses based on 
these types of reactions and a whole variety of reagents and conditions are now 
available to effect these transformations. Initial formation of the oxazoline can be 
achieved in several ways, but activation of the hydroxy amide function is essential for 
cyclisation to occur. Activation can be promoted by thionyl chloride, followed by 
treatment with silver triflate; 182 methanesulfonyl chloride and triethylamine; 183 
tripheny lphosphine, carbon tetrachloride and DIPEA; 183 under Mitsunobu 
conditions; 184 phosphorus oxychloride; 185 or the more commonly encountered 
Burgess' reagent74c or DAST.74b Careful consideration of substrate reactivity is 
necessary when choosing a suitable reagent for this transformation, as elimination, 
aziridine formation or epimerisation may also occur. 66 
The oxidation of an oxazoline to an oxazole has been developed extensively and in 
general proceeds by either a radical pathway or an addition-elimination sequence. In 
either case, the need for an enolisable group at the C4 position of the oxazoline ring 
seems necessary to effect this transformation in good yield. Nickel peroxide has 
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already been cited as a reliable oxidising agent for this procedure (Scheme 11).177 
Other methods that have been examined and shown to be successful include 
copper(II) bromide and DBU;67 copper(I) bromide and t-butyl peroxybenzoate;186 
formation of 4-seleno-oxazolines, oxidation and elimination; 187 carbon tetrachloride, 
pyridine and DBU in acetonitrile,74a and bromotrichloromethane and DBU.188 Again, 
careful choice of reagent is required for oxidation depending on the substrate. 
An alternative pathway developed by Wipf has also proven to be extremely useful in 
oxazole formation en route to natural products. Wipf, having encountered problems 
with the capricious oxidation of oxazolines to oxazoles, pursued a Robinson-Gabriel 
type cyclisation of a ~ - k e t o o amide to furnish an oxazole.69 Thus, oxidation of a 
~ - h y d r o x y y amide with the Dess-Martin reagent,68 followed by mild cyclodehydration 
of the intermediate ~ - k e t o o amide with triphenylphosphine, iodine and triethylamine 
allowed the rapid synthesis of highly substituted and functionalised oxazoles in good 
overall yield. Amino aldehydes derived from serine residues were found to cyclise to 
the oxazole in a much less facile manner. Wipf overcame this problem by changing 
the reaction conditions, employing the hindered base 2,6-di-t-butyl-4-methylpyridine 
with dibromotetrachloroethane and triphenylphosphine. Under these conditions 
elimination did not occur spontaneously and required treatment with DBU to furnish 
the oxazole.65,189 
The use of both these approaches is described in Wipf's total synthesis of the 
enantiomer of hennoxazole A (204).65,189 Thus, condensation of the acid (205) with 
serine methyl ester hydrochloride (181), via the mixed anhydride, gave the ~ - a m i d o o
alcohol (206) which was cyclised to the oxazoline (207) with Burgess' reagent 
(Scheme 14),74c Oxidation of 207 with copper(II) bromide and DBU then gave the 
desired oxazole (208) in 37% overall yield. 
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Reagents: i, serine.OMe.HCl, i-BuOCOCl, Et3N, CH2Cl2; ii, Burgess' reagent, THF; iii, CuBr, DBU, 
HMTA, CH2Cl2, 37% (3 steps). 
Scheme 14 
Elaboration of the side chain in 208 and hydrolysis of the ester gave the acid (209). 
This was coupled to the amine unit (210) to give the ~ - a m i d o o alcohol (211) in 63% 
yield (Scheme 15). Oxidation of 211 with Dess-Martin periodinane then gave the 
intermediate amido aldehyde,68 which was cyclodehydrated to give the enantiomer of 
hennoxazole A (204) after desilylation with TBAF in 42% overall yield. 65 ,189 
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Reagents: i, PyBoP, DIPEA, CH2CI2, 63%; ii, Dess-Martin periodinane, CH2CI2; iii, BrCI2CCCI2Br. 
PPh3, 2,6-di-t-butyl-4-methylpyridine, CH2CI2; iv, DBU, MeCN; v, TBAF, THF, ...J.27c (4 steps). 
Scheme 15 
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Returning to our own system, we were now in a position to elaborate the 0-amido 
ketone function in the amide (70) to the benzofuran oxazole acid fragment (69) by 
cyclisation to form the trisubstituted oxazole and saponification of the ester. 
In view of all the literature methods towards oxazole formation, we anticipated that 
treatment of the amide (70) with the mild conditions developed by Wipf69 would lead 
to the desired oxazole (212). As anticipated, exposure of the amide (70) to the action 
of triphenylphosphine, iodine and triethylamine,69 rapidly constructed the 
trisubstituted oxazole framework (212) in an excellent 89% yield, as shown below. In 
this cyclisation, it is proposed that the enol form of the ketone (70) is trapped with the 
highly electrophilic diiodotriphenylphosphorane to form the enol phosphonium salt 
(213).69 Subsequently, intramolecular addition of the amide onto the vinyl 
phosphonium species provides the oxazoline (214), which can aromatise to the 
oxazole (212) with the expulsion of triphenylphosphine oxide. 69 An alternative 
mechanism which proceeds via the ring closure of an acylimino carbene (215), 
formed by loss of triphenylphosphine oxide from the enol salt (213), has also been 
proposed.69 
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With the carbon framework of the desired benzofuran oxazole fragment now in place, 
the final saponification step could be addressed. This proceeded uneventfully when 
the ester (212) was subjected to basic hydrolysis with lithium hydroxide to provide 
the acid (69) in quantitative yield. 
LiOH 
Br Br 
212 69 
2.2.7 Conclusions 
We have demonstrated the use of the intramolecular Heck reaction 134f as a competent 
method for the construction of the benzofuran framework via a 5-exo-trig mode of 
cycIisation. In addition to the formation of a new C-C bond and quaternary carbon 
centre, the Heck reaction provided a terminal alkene (73) which could be elaborated 
efficiently to the central trisubstituted oxazole of diazonamide A. In this reaction 
sequence we described a facile entry to B-amido ketone functions by oxime formation 
at an active methylene site, then reduction and acylation. 168 Finally, the application of 
a mild cyclodehydration protocol69 for the formation of a trisubstituted oxazole 
provided us, in excellent yield, with our key synthetic intermediate (69) for 
advancement towards the macrocyclic core of diazonamide A (64). 
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2.3 Synthesis of the Indole Fragment (68) 
2.3.1 Introduction 
Having successfully prepared the benzofuran oxazole acid fragment (69), our 
attention turned to the synthesis of an indole amine fragment (68) which we could 
couple to the acid (69) to provide the amide (66). Although the task of synthesising 
the amine (68) would appear to be less daunting than that posed by the synthesis of 
the acid (69), two interesting structural features had to be carefully addressed. These 
surrounded the introduction of a bromine or iodine atom at the C4 position of the 
indole ring and the incorporation of the ketone functionality in the two carbon side 
chain. Our strategies for circumventing these synthetic problems are outlined below. 
2.3.2 Retrosynthetic Analysis 
Whilst contemplating the problems posed by the necessity for the ketone and halogen 
substituents in the amine (68), it became clear that two alternative pathways for 
retrosynthetic disassembly could be envisaged. In the first approach, introduction of 
the ketone function could be anticipated to occur at a late stage in the synthesis, when 
the halogen substituent on the indole ring was already in place. In the second strategy, 
this sequence could be reversed and the halogen atom could be incorporated with the 
ketone function already in place. 
When we considered the first approach in greater detail we envisaged the carbamate 
(216) as a precursor for the desired amine (217). In the forward sense, benzylic 
oxidation of the indole system would be expected to introduce the required ketone 
function190 and acid-induced removal of the carbamate group191 would provide the 
target compound (217). We anticipated that the carbamate (216) could be prepared 
from the nitro compound (218),128 using a series of functional group manipulations. 
In an unusual retrosynthetic disconnection, we next envisaged cleaving the central 
71 
C-C a-bond of the side chain to provide the tertiary amine (219) and nitromethane. In 
the synthetic direction, treatment of the amine (219) with iodomethane would be 
expected to form a quaternary ammonium salt. Removal of the silyl group on 
exposure of the salt to TBAF could then initiate elimination of trimethylamine to give 
a highly electrophilic ene imine. l92 Trapping of this reactive species with the 
stabilised carbanion of nitromethane would execute a one carbon homologation and 
give the nitro compound (218).193 It was anticipated that the bromine atom could be 
introduced into 219 by a metal-halogen exchange reaction of the amine (220), where 
the nitrogen atom of the tertiary amine function is used to direct the metallation to the 
C4 position of the indole ring. 194 The bulky TIPS protecting group would prevent any 
deprotonation by the alkyl lithium base at the C2 position of the indole ring and could 
be introduced by silylation of commercially available gramine (221).195 
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In our alternative approach, we again considered the carbamate (222)196 as a suitable 
protecting group for the amine (223). However, in this strategy we now envisaged the 
ketone function being present prior to iodination. It was our belief that we could 
utilise the directing power of the ketone (224) to guide thallation to the C4 position of 
the indole ring,197 then effect a thallium-iodine exchange to provide the carbamate 
(222).197a.198 In an effort to devise a short synthetic pathway, we chose to next 
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disconnect across the C-C bond which fused the indole to the side chain at the C3 
position. In the synthetic direction, we anticipated that treatment of indole (225) with 
an alkyl Grignard base would remove the proton from the indole nitrogen, but that the 
electron density would reside at the C3 position of the indole ring. Acylation of this 
reactive carbanion with the acid chloride derived from carbobenzyloxyglycine (226) 
would lead to the ketone (224) in one step. 199 
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2.3.3 Synthetic Approaches to the Bromo Indole Amine (217) 
With our synthetic plans now formulated we began to construct the bromide (217) 
following the first retrosynthetic pathway. Significant quantities of the silylated 
gramine (220) were available from previous studies 128 and this became our starting 
point. When the protected gramine (220) was treated with t-butyllithium at QOC, the 
pendant tertiary amine directed lithiation to the C4 position of the indole ring to form 
the putative aryllithium species (227) (Scheme 16).194 The bulky TIPS protecting 
group was effective at blocking any lithiation at the C2 position.1 9 .t The 
organometallic compound (227) was then trapped by bromine at -78°C to provide the 
bromide (219) in 58% yield. Treatment of the bromide (219) with iodomethane 
uneventfully provided the quaternary ammonium salt (228). Exposure of the salt 
(228) to the action of TBAF facilitated removal of the silyl function and elimination 
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of trimethylamine to give the highly reactive ene imine intermediate (229).192 This 
electrophile was trapped in situ by nucleophilic attack of the carbanion derived from 
nitromethane to effect a one carbon homologation of the side chain and provide the 
desired nitro compound (218) in 80% yield. 193 
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Reagents: i, t-BuLi, Br2, Et20, 58%; ii, Mel, PhH; iii, TBAF, MeN02, THF, 80% (2 steps). 
Scheme 16 
The next task was to convert the nitro function to a t-butyl carbamate which would act 
as an acid labile protecting group for an amine function. To accomplish this, the nitro 
compound (218) was subjected to zinc in aqueous acetic acid at 80°C to provide the 
crude salt (230), which was immediately treated with sodium hydroxide and di-t-butyl 
dicarbonate to give the carbamate (216) in 85% overall yield (Scheme 17). 
NHBoc 
ii 
Reagents: i, Zn, AcOH, H20, ~ ; ; ii, NaOH, (BoC)20, t-BuOH. 857, (2 steps). 
Scheme 17 
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With the carbamate (216) now in hand, we were in a position to attempt the benzylic 
oxidation to introduce the ketone function. Yonemitsu et al had previously 
demonstrated that DDQ was an excellent reagent for the selective oxidation of the 
side chains at the C3 position of indoles. 190 In a synthesis of the antiepileptic alkaloid 
pimprinine (34)59, it was shown that treatment of N-acetyltryptamine (231) with DDQ 
in aqueous THF effected a benzylic oxidation to give the ketone (232) in 73% yield 
(Scheme 18) .190a This underwent cyclodehydration in refluxing phosphorus 
oxychloride 185 to provide pimprinine (34)59 in 82% yield. 
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Reagents: i, DDQ, THF, H20, 73%; ii, POCl3, ~ , , 82%. 
Scheme 18 
Following the protocol developed by Y onemitsu et al,190 we treated the carbamate 
(216) with DDQ in aqueous THF. As expected, the major product was oxidation of 
the benzylic site on the side chain at the C3 position of the indole ring. Unfortunately, 
the oxidation procedure only provided the secondary alcohol (233) in 75% yield and 
not the required ketone (234) (Scheme 19). Extensive investigations into the further 
oxidation of the alcohol (233) to the ketone (234) resulted only in the decomposition 
of the alcohol (233). The failure of the benzylic oxidation is particularly surprising 
based on the precedent set by Y onemitsu et al. 190 In an effort to determine the role of 
the substrate on the reactivity, we prepared the carbamate (235) by treatment of 
tryptamine (236) with sodium hydroxide and di-t-butyl dicarbonate (Scheme 20). The 
carbamate (235) was subjected, without purification, to the action of DDQ in aqueous 
THF 190 to provide the ketone (237) in 39% overall yield, with no evidence that the 
75 
reaction had stopped at the alcohol. This result suggests the bromine atom at the C4 
position of the indole ring is having some bearing on the reactivity of the carbamate 
(216) with DDQ and curtailing the reaction when the alcohol (233) is formed. 
However, the exact influence of this substituent remains unclear. 
NHBoc NHBoc 
oxidation 
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Reagents: i, DDQ, THF, H20, 75%. 
Scheme 19 
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Reagents: i, NaOH, (BochO, dioxane, H20; ii, DDQ, THF, H20, 39% (2 steps). 
Scheme 20 
2.3.4 Synthetic Approaches to the Iodo Indole Amine (223) 
With the failure of the benzylic oxidation, 190 we concentrated our efforts on preparing 
the desired amine (223) following the second retrosynthetic plan. In this approach the 
order of the key steps is reversed and the ketone is present prior to incorporation of 
the halogen substituent. 
It was our desire to establish an efficient synthesis of the amine (223). To this end, we 
planned on incorporating the indole side chain in a single step. Treatment of indole 
(22S) with ethylmagnesium bromide produced the corresponding indolyl anion (238). 
This anion has essentially covalent rather than ionic character and exposure at O°C to 
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the acid chloride derived from the N-protected glycine (226), trapped the anion (238) 
at the C3 position of the indole ring to give the ketone (224) in 13% yield. 199 Our 
efforts to improve the yield of this step by transmetallating the Grignard intermediate 
with zinc chloride,2oo or activating the acid chloride with aluminum chloride,201 
produced no advancement in yield. Although this method provided us with small 
amounts of material with which we could investigate the feasibility of future steps, it 
did not allow us access to large amounts of the ketone (224). To obtain multi gram 
quantities of material, we employed the two step approach outlined previously. 
Hence, tryptamine (236) was treated with sodium hydroxide and benzoyl chloride to 
provide the benzyl carbamate (239), which was next treated with DDQl90 to give the 
desired ketone (224) in 72% overall yield (Scheme 21). 
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Scheme 21 
McKillop et al gave impetus to the study of thallium in organic synthesis when they 
reported that the electrophilic aromatic metallation of benzenoid compounds (240) 
with thallium trifluoroacetate (TTFA) provided the arylthallium compounds 
(241).198b Perhaps more interestingly, they observed that treatment of the arylthallium 
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compounds (241) with aqueous potassium iodide solution resulted in instantaneous 
precipitation of thallium iodide and formation of the corresponding aromatic iodides 
(242). 198b 
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Hollins and Colnago extended this two step thallation-iodination procedure when they 
investigated its application with heteroaromatic substrates. 198a They found that 
exposure of pyrrole aldehyde (243) to thallium trifluoroacetate provided the aryl 
thallium intermediate (244), which then gave the diiodide (245) upon exposure to 
aqueous potassium iodide. More importantly however, they showed that treatment of 
the indole aldehyde (246) under identical reaction conditions provided the iodide 
(247) via the thallium intermediate (248). Preferential thallation at the C4 position of 
the indole ring was rationalized by assuming that thallium coordinates with the 
carbonyl group of the side chain and also that the C4 position is less deactivated than 
the C2 position. 198a 
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In recent years the most significant developments in this procedure have been 
attributable to the work of Somei. Following investigations into the regioselective 
synthesis of 4-substituted indoles,197 Somei et al developed a one pot synthetic 
method for conversion of the aldehyde (246) to the iodide (247). 197a This procedure 
avoided isolation of the toxic thallium intermediate (248) and used a combination of 
molecular iodine and copper(I) iodide in DMF to effect the thallium-iodine exchange 
with an improved yield. 
With considerable amounts of our indole carbonyl substrate (224) now available, we 
turned to the improved conditions of Somei 197a for incorporation of the iodine 
substituent. Treatment of the ketone (224) with thallium trifluoroacetate at 30°C 
effected regioselective electrophilic metallation at the C4 position of the indole ring 
to give the organothallium intermediate (249) (Scheme 22). Removal of the solvent 
and exposure of the crude reaction mixture to molecular iodine, copper(l) iodide and 
DMF prompted a thallium-iodine exchange reaction to give the carbamate (222)196 in 
58% overall yield. Initial attempts to liberate the reactive amine function by 
hydrogenolysis were unsuccessful and no reaction was observed. However, the benzyl 
carbamate protecting group could be removed by treatment of the carbamate (222) 
with hydrogen bromide in acetic acid191 ,196 to finally provide our desired indole 
fragment as the salt (250) in 99% yield. 
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Reagents: i, a) TTFA, TFA; b) CuI, 12, DMF, 58%; ii, HEr, AcOH, 99%. 
Scheme 22 
2.3.5 Conclusions 
Although we were unsuccessful in utilising a benzylic oxidation 190 to form the 
desired ketone function in the bromide (216), this approach demonstrated the 
efficiency of the amine-directed metallation-halogenation strategy for the synthesis of 
a 4-substituted bromo indole (219).194 
Despite earlier failings, we were successful in accessing the salt (250). In constructing 
this fragment we employed a one step procedure for acylation at the C3 position of an 
indole ring using ethylmagnesium bromide as the base. 199 However, due to the 
unacceptably low yield of this process, we returned to a two step procedure involving 
a benzylic oxidation 190 to gain access to multi gram quantities of material. This 
material could be transformed to the salt (250) using a carbonyl-directed 
thallation-iodination protoco}l 97a for the regioselective introduction of an iodine 
substituent at the C4 position of the indole ring and subsequent deprotection. 191 
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2.4 Studies towards the Macrocyclic Core of Diazonamide A 
2.4.1 Introduction 
Having successfully completed the synthesis of the acid (69) and the salt (250) we 
were now in a position to consider the union of these two fragments. Once achieved, 
the entire carbon framework for the macrocyc1ic core of diazonamide A (1) would be 
in place. In elaborating this framework to the macrocycle (64) we faced the 
considerable synthetic challenges of cyclising another keto amide function, this time 
to prepare the more complex bis-oxazole unit,64,71 then effecting an intramolecular 
Ullmann reaction. 130 
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2.4.2 The Ullmann Reaction 
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The coupling of two aromatic sp2-hybridised centres to give biaryl compounds is a 
transformation that has a long history. Like many organic reactions, it has been 
developed considerably over the past decades to encompass the subtleties of modem 
chemistry. Before turning our attention to one of the oldest biaryl forming processes, 
the Ullmann reaction,130 we will begin by highlighting the main alternative synthetic 
methods for the construction of biaryl bonds. 
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The palladium(O)-catalysed Suzuki reaction is perhaps the most favoured method for 
the formation of biaryl systems.202 In this process, an arylboronic acid, borate ester or 
borane (ArLBY 2) is coupled to an aryl halide or triflate (Ar-X) in the presence of an 
inorganic base (e.g. NaOH) and a catalytic amount of palladium(O). 
Pd(O) 
1 Ar-Ar + HO-BY2 + NaX 
Snieckus has combined the Suzuki reaction with his work on artha-metallation to 
form a powerful method of converting simple arenes into more complex biaryl 
systems.203 One example is in the synthesis of the fluorenone dengibsinin (251),203a 
where the amide and isopropoxy groups in the arene (252) directed lithiation to the 
artha-position (Scheme 23). The aryllithium species was trapped with tributyl borate 
to give the borate ester (253), which underwent a Suzuki coupling reaction with the 
iodide (254) to provide the biaryl compound (255). 
0 . ~ ~ 11 i-PrO CONEt2 .. MeO i-PrO ~ ~ CONEt2 i-PrO ~ ~ CON Et2 
B(OBu)2 i-PrO 
MeO 
252 253 255 
HO I 
.. 0 
... MeO M e o ~ ~
HO i-PrO ~ ~ I 
OMe MeO 
251 254 
Scheme 23 
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A closely related coupling process is the Stille reaction,204 in which the organoboron 
species in the Suzuki reaction202 is replaced by an organotin compound. This 
stannane (ArLSnR3) can be coupled to an aryl halide (Ar-X) in the presence of an 
inorganic base (e.g. K2C03) to provide the biaryl product. 
Ar-Arl + X-SnR3 
A macrocyclic biaryl Stille reaction has been used by Kilburn et al to prepare the 
possible dipeptide host (256).205 Despite exchanging the tin and bromine substituents 
in the precursor (257) to try and increase the reactivity, the macrocycle could never be 
obtained in greater than 15% yield. 
257 256 
A tandem palladium-catalysed stannylation-biaryl coupling reaction has been 
developed by the research group of Kelly.206 The two step process couples two aryl 
halides and starts with the palladium-catalysed transfer of a trialkyltin unit from 
hexabutyl or hexamethylditin to one of the aromatic rings to provide an intermediate 
organostannane. The reactive tin species then undergoes an intramolecular Stille 
reaction204 to provide the desired biaryl compound. This tandem process was used by 
Kelly et al in their synthesis of the chiral B-ring unit of pradimicine A (59).119 In this 
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efficient synthetic sequence, the diiodide (258) was converted into the stannane (259) 
and then the biaryl (260) in a single step and 87% yield. 206 
OH 
258 
dioxane 
.. 
OH 
259 
OH 
260 
A class of biaryl reactions developed by Somei,207 has found particular application in 
the construction of aryl substituted indoles. The reactions involve the 
palladium(O)-catalysed coupling of organothallium compounds (261) with either 
stannanes (e.g. 262) or boronic acids. They can be interpreted as variations of the 
Stille and Suzuki couplings,202,204 with the arylthallium species replacing the aryl 
halide. 
< ) TI(OCOCF312 + Ph,Sn Pd(OAch .. 
DMF < ) < ) 
261 262 
Indole 4-carboxaldehyde derivatives are readily and regiospecifically thallated, so the 
Somei method is especially suited to the formation of aryl indoles. Konopelski et al 
applied this methodology to form a biaryl bond in their model studies towards 
diazonamide A.173 They described the preparation of the organothallium species 
(263), which on treatment with the stannane (264), in the presence of a catalytic 
amount of palladium(O), afforded the coupled product (265). 
8.+ 
TI(OCOCF3)2 MeO 
HO ~ ~ Pd(PPh3)4 CI + MeO 0 • CI 
SnBu3 dioxane 
263 264 265 
The classical Ullmann synthesis of biaryls comprises the reaction in which two aryl 
halides are condensed in the presence of finely divided copper to form a new biaryl 
bond with the elimination of copper halide. 130a,c Temperatures as high as 250°C are 
often employed to effect the coupling, but despite these harsh conditions the reaction 
is often high yielding and tolerates a range of functionality including nitro, aldehyde, 
ester and alkoxy groups. However, the reaction is greatly inhibited by the presence of 
substituents which can provide an alternative path for reaction of the aryl halide, such 
as amino, hydroxy, or free carboxy groups. Bulky groups in the artha position may 
inhibit the reaction by steric hindrance. However, for simple systems, such as the aryl 
chloride (266),208 with little steric crowding, it remains the method of choice. 
eu 
• 
266 
In recent years the Ullmann reaction has been developed extensively by the work of 
Meyers,130a who has shown the potential of the reaction in contemporary synthesis. 
An example is the asymmetric construction of the biaryl bond in the total synthesis of 
the natural product mastigophorene A (56) 110 in which a chiral oxazoline auxiliary on 
the aryl bromide (267) controls the atropisomerism in the coupling reaction to provide 
the biaryl compound (268) in 85% yield. 1 11 
85 
MeO OMe MeO 
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The use of the Ullmann reaction for intramolecular couplings has also been 
demonstrated. Newman and Logue described the closure of a 7-membered diphenic 
anhydride ring on refluxing the benzoic anhydride (269) with copper bronze in DMF 
to provide the biaryl anhydride (270) in an excellent 90% yield. 209 
Cll 
DMF 
269 
Et Et 
270 
Several modifications to the classical Ullmann coupling conditions have been 
reported. These have tended to emphasise the use of lower reaction temperatures in an 
effort to make the reaction applicable to more sensitive substrates. Liebeskind 
reported that copper(I) thiophene-2-carboxylate promotes efficient reductive coupling 
of a range of aromatic compounds, incorporating a wide variety of functionality, at 
ambient temperature in NMP.210 In one particularly interesting example, it was 
reported that the diiodide (271) underwent an intramolecular Ullmann coupling at 
ambient temperature to form the biaryl compound (272) in 88% yield. 
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271 
CuTC 
NMP 
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Semmelhack has also developed a lower temperature variant of the classical Ullmann 
reaction which, instead of copper, uses a zero valent nickel complex.2II Originally, 
these were bis-(1 ,5-cyclooctadiene )nickel or tetrakis-(triphenylphosphine )nickel, but 
it has since been demonstrated that reduction of bis-(triphenylphosphine)nickel(II) 
chloride with zinc and then complexation of triphenylphosphine provides an in situ 
method for formation of a highly active nickel(O) reagent.212 In general, the reactions 
can be carried out at 50-80°C in dipolar aprotic solvents such as DMF or NMP. 
This methodology was employed by Percec et al in an intermolecular nickel-catalysed 
homocoupling of the aryl mesylate (273) to give the biphenyl (274) in 65% yield.213 
Jutand and Mosleh also described the nickel-catalysed synthesis of a range of 
symmetrical biaryls (275), this time using aryl triflates (276) as the starting 
materials.214 
0 0 
Ph 
C12Ni(PPh3h, Zn, PPh3, Et4N1 
• MeO OMe MeO OMs 
THF 
0 
273 274 
DMF {> <1R R C1 2Ni(dppe), Zn, KI • 
276 275 
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Despite these accomplishments it is the area of intramolecular coupling reactions 
which have witnessed the greatest applications of this modified Ullmann protocol. 
Semmelhack et al were the first to describe the nickel-promoted intramolecular 
coupling of two aryl iodides in a total synthesis of the natural product alnusone.211 
They showed that treatment of the diiodide (277) with 
tetrakis-(triphenylphosphine)nickel(O) in DMF at 50°C gave the biaryl species (278) 
in 46% yield. 
.. 
DMF MOMO 
MOMO 
277 278 
Carruthers et al have used this methodology in the key step of a total synthesis of the 
lythranidine alkaloid (49).95 They utilised the in situ reduction of a nickel(II) complex 
with zinc to provide the active nickel(O) species, which reacted with the diiodide 
(279) to form the 17-membered macrocycle (280) in 55% yield. 97 
.. 
DMF 
I MeO OMe I MeO OMe 
279 280 
Renewed interest in the biaryl portion of the vancomycin antibiotics has sparked a 
resurgence in the Ullmann cyclisation,130 with the recent synthetic studies 
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concentrating on a nickel-mediated coupling approach. 130b,2II,2I2 If it is assumed that 
the mechanism of the Ullmann reaction involves the formation of an organonickel 
intermediate,130b then the lower polarisation of the C-Ni bond, in comparison to other 
organometallic species, allows for greater compatibility of the reaction with common 
polar functional groups such as alcohols, amines and carbonyl functions. Nicolaou et 
al have demonstrated the tolerance of sensitive functionality to these reaction 
conditions in their approach to the rigid 12-membered biaryl ring system of the 
vancomycin antibiotics.2IS It was reported that treatment of the diiodide (281), which 
contains amide, carbamate and ketone functions, with in situ generated nickel(O), 
resulted in the formation of the biaryl system (282) in 26% yield. Less sterically 
encumbered substrates which contained the same functionality could be cyclised in 
greater yield. 
0 ,\NHBoc 0 ,\NHBoc 
N ", ", 
H 
CI2Ni(PPh3h, Zn, PPh3 
.. 
I I DMF 
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281 282 
Lipshutz et al have applied very similar methodology to prepare the nonracemic 
biaryl portion of vancomycin (45).216 In this strategy, the diiodide (283) is treated 
with a nickel(II) complex and n-butyllithium as the reducing agent to effect the 
closure of an 8-membered ring and give the model biaryl species (284) in 50% yield. 
A tartrate-derived tether was used to induce the chirality and allow preferential access 
to only one atropisomer (284). 
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The research group of Roussi has demonstrated the utility of the nickel(O)-based 
coupling reaction for the formation of a new C-C 0' -bond between an indole and a 
conventional phenyl ring.217 As well as the application of this protocol to 
intramolecular cross-couplings which involve heteroaromatic units, it should be noted 
that this reaction proceeds by the union of two, less reactive, aromatic bromides. 
Hence, the dibromide (285) is cyclised under the standard conditions to give the 
17-membered ring macrocycle (286) in 17% yield, which is a model compound of the 
eastern substructure of the natural products kistamycin and chloropeptin II. 
o 
Br 
DMF 
285 286 
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The advent of the nickel(O)-mediated Ullmann coupling reaction97,21 1,213-7 meant that 
the harsh conditions required for the copper-mediated couplings were no longer 
necessary. However, this effective process suffers because of the need for 
stoichiometric amounts of the nickel reagent.212 Thus, the search has continued over 
recent years for a catalytically active varient to the nickel complexes which also 
avoids the demanding conditions of the classical copper-promoted 
coupling. 111 ,130a,208,209 
Rawal et al described recently a novel palladium-catalysed Ullmann coupling 
reaction. 218 These authors reported the homocoupling of substituted aryl iodides and 
bromides (287) using a catalytic equimolar ratio of palladium acetate and tri-o-
tolylarsine under basic conditions in the presence of hydroquinone, as a homogenous 
reductant, in DMA at 75°C. Excellent yields of the coupled products (288), generally 
in excess of 80%, have been achieved. 
287 288 
Even more impressive is the extension of this methodology to the formation of 
7 -membered heterocyclic and carbocyclic rings.218 Although this intramolecular 
process has only been applied to the formation of symmetrical macrocyclic systems, it 
should not be long before this novel transformation is used for the construction of 
challenging biaryl frameworks in natural products synthesis. 
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Reagent: i, Pd(OAch, As(o-tol)3, hydroquinone, CS2C03, DMA, ~ . .
This section of the thesis has provided a brief overview of the principle methods 
available for the formation of biaryl bonds. Particular attention has been paid to the 
Ullmann coupling reaction 130 and several examples of successful intramolecular 
variants have been highlighted. 97,209-11,215-18 The succeeding pages will report how 
these methodologies have been applied to our strategy for construction of the 
macrocyclic core of diazonamide A (1). 
2.4.3 A First Generation Approach to the Macrocycle (64) 
As mentioned previously, our first task was to unite the benzofuran oxazole acid 
fragment (69) and the salt (250) to provide the amide (289) which contained the 
relevant keto amide function for preparation of the bis-oxazole unit. Our initial 
attempts to construct the amide bond used the standard peptide coupling conditions of 
EDC and HOBt in basic media,!31 which gave the amide (289) in a poor 407( yield. 
In an effort to increase the yield, we turned our attention to the formation of an acid 
chloride as the reactive electrophilic species. Thus. the acid (69) was treated with 
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oxalyl chloride to provide the acid chloride (290) (Scheme 24). Exposure of the salt 
(250) to triethylamine at oDe liberated the nucleophilic amine which was trapped with 
the acid chloride (290) to give the amide (289) in 60% yield. The amide (289) proved 
to be exceptionally sensitive to the conditions developed by Wipf for oxazole 
formation. 69 However, after considerable experimentation, we found that careful 
addition of triethylamine, triphenylphosphine and hexachloroethane to the amide 
(289) induced cyc1isation to provide the bis-oxazole (291) in 81 % yield. With the 
bis-oxazole unit now installed we had successfully prepared a system which 
incorporated all the aromatic units of the southern macrocyc1e of diazonamide A (1). 
In conjunction, we had the necessary substitution on the aromatic rings for the 
implementation of our macrocyc1isation strategy. 
.. GOGI 
Br Br 
69 290 
11 111 
... 
250 289 291 
Reagents: i, (COClh; ii, Et3N, 290, CH2Ch, 60% (2 steps); iii, Et3N, PPh3, Cl3 CCCI3, 
CH2Ch, 81 %. 
Scheme 24 
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In light of the successful examples of nickel-mediated intramolecular Ullmann 
couplings described previously,97,211,213-7 we first focussed our attention on these 
conditions for carrying out the macrocyclisation in our system. Unfortunately, all 
attempts to cyclise the bis-oxazole (291) using nickel reagents, or subsequent 
reactions under the classical copper-mediated conditions,111,130a,208,209 failed to 
provide any of the desired biaryl product (64). The major products to be recovered 
and identified from the reaction mixtures were unreacted starting material (291) and 
the bromide (292). Formation of the bromide (292) suggested that the aryl iodide unit 
was obviously reactive, since it presumably underwent oxidative addition of a 
nickel(O) species to give an organonickel intermediate which was quenched on a 
proton source. 130b However, the aryl bromide unit, which remained intact, was either 
an unreactive site or too far away from the indole ring to engage the organonickel 
intermediate. 
.. 
291 292 
Reagents: i, C12Ni(PPh3h, Zn, PPh3, DMF, ~ ; ; or Cu, Py, ~ . .
In an alternative to the Ullmann coupling,130 the one pot palladium(O)-catalysed 
stannylation-intramolecular Stille coupling was attempted USIng 
tetrakis-(triphenylphosphine)palladium(O) and hexabutylditin.206 It was hoped that 
this method would form an intermediate stannane in which the tributyltin group 
resided on the indole ring. Surprisingly, the iodide (291) proved unreactive under 
these conditions. In a final attempt to unite the two aromatic halides we decided to 
remove any internal proton source by protecting the indole nitrogen with a TIPS 
group. We hoped that this would extend the lifetime of the intermediate organonickel 
species and that cross coupling would then occur, but, again, no biaryl product could 
be isolated using the nickel(O)-mediated conditions.212 
2.4.4 A Second Generation Approach to the Macrocycle (64) 
Having considered a variety of conditions to effect ring closure in the acyclic 
precursor (291) without success, we began to analyse the substrate structure and 
considered subtle changes in a bid to increase the reactivity. From our experiences we 
had learnt that the ideal substrate for an intramolecular Ullmann coupling using the 
modified nickel(O) conditions would contain two aryl iodides at the reacting 
sites.97,211,213-6 Therefore, we decided to construct the analog of the bis-oxazole 
(291), in which the bromine atom was replaced with an iodine atom. 
Following analysis of the intermediates en route to the macrocyclic precursor (291), 
we believed that the alkene (73) represented the most efficient point at which to 
exchange the bromine atom for an iodine atom. Considerable quantities of the 
bromide (73) were still available and, in the absence of any sensitive functionality, we 
anticipated that treatment of the bromide (73) with an alkyllithium base, then 
exposure of the resulting organolithium species to iodine would provide the desired 
iodide (293). After extensive experimentation, we found that reaction of 
n-butyllithium with the bromide (73) at -78°C gave the putative aryllithium species 
(294). Rapid addition of a concentrated solution of iodine in THF trapped the 
organolithium species (294) and gave the desired iodide (293) in 86% yield. 
n-BuLi 
... 
.. 
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l:.i Br 294 I 293 
95 
With the iodine substituent on the benzofuran ring now in place, we were in a 
position to follow the previous synthetic sequence and prepare a modified 
macrocyclic precursor. Towards this end, the terminal alkene (293) was oxidatively 
cleaved with osmium tetroxide and sodium periodate to give the aldehyde (295) in 
84% yield (Scheme 25).I 32b A two carbon homologation was successfully performed 
by exposure of the aldehyde (295) to ethyl diazoacetate in the presence of zirconium 
chloride133 at O°C to next provide the ketone (296) in 50% yield. Treatment of the 
ketone (296) with sodium nitrite in aqueous acetic acid then gave the oxime (297) as a 
2: 1 mixture of geometrical isomers in 89% yield. 
CHO 
11 
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Scheme 25 
With the oxime (297) in hand, we were in a position to prepare the oxazole (298) 
using our established reduction, acylation and cyclisation protocol. Treatment of the 
oxime (297) with zinc in aqueous acetic acid effected a smooth reduction of the 
oxime function to provide the salt (299). However, partial reduction of the iodide was 
also observed, presumably by zinc insertion into the C-I bond and trapping of the 
organozinc species with a proton from the solvent. This gave the desired salt (299) in 
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a 6: 1 ratio with the de-iodinated salt (300). All attempts to remove the de-iodinated 
material (300) by chromatography were unsuccessful, both at this stage and in all 
future synthetic steps. Partial reduction of the C-I bond is not surprising since it has 
been demonstrated that zinc insertion into aryl halide bonds is more facile for iodides 
than for bromides.219 This has led to the use of o-bromophenyl iodide (301) as the 
synthetic equivalent of o-phenylene-l-anion-2-cation. Takagi et al illustrated the 
synthetic utility of this process in their synthesis of the aromatic compound (302).220 
In this example, treatment of o-bromophenyl iodide (301) with zinc in TMU at 70°C 
provided the organozinc intermediate (303), by preferential zinc insertion into the C-I 
bond (Scheme 26). A Negishi coupling of 303 with 3-iodo-benzoic acid methyl ester, 
in the presence of tetrakis-(triphenylphosphine)palladium(O), next gave the biaryl 
compound (304).221 A second Negishi coupling using the organozinc species derived 
from o-chlorophenyl iodide and the bromide (304) constructed another biaryl bond 
and the aromatic compound (302).221 
Zn 
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The mixture of the salts (299 and 300) underwent acylation when treated with acetic 
anhydride in pyridine to give the amide (305) (for clarity, only the iodinated product 
is now shown) in 53% yield (Scheme 27). Exposure of the amide (305) to 
triethylamine, triphenylphosphine and iodine provided the trisubstituted oxazole (298) 
in 89% yield. 69 Finally, basic hydrolysis of the ester (298) with lithium hydroxide 
gave the modified benzofuran oxazole acid fragment (306) in quantitative yield . 
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Scheme 27 
Finally, we could consider the union of the two iodide fragments (306 and 250). Thus, 
the acid fragment (306) was first converted into the corresponding acid chloride (307) 
by treatment with oxalyl chloride (Scheme 28). The salt (250) was again treated with 
triethylamine to liberate the free amine function which was trapped by the acid 
chloride (307) to give the amide (308) in a poor 25% yield. Attempts to form the 
amide bond using standard peptide coupling conditions 131 led to only a 5% recovery 
of the desired product (308). At this juncture we decided to investigate the 
nickel(O)-mediated Ullmann coupling of the amide (308).97.211.213-7 It was our belief 
that allowing the disubstituted oxazole to exist in its open keto amide form would 
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convey greater confonnational freedom on the system and possibly bring together the 
reacting centres. We were very disappointed therefore, when treatment of the amide 
(308) with an active nickel(O) complex212 gave the reduced compound (309) as the 
only new product in 40% yield. 
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Scheme 28 
Following this setback we next treated the amide (308) with triethylamine, 
triphenylphosphine and hexachloroethane to provide the bis-oxazole (310) in 56% 
yield (Scheme 29).69 In our final macrocyclisation attempt we treated the bis-oxazole 
(310) with an in situ generated nickel(O) complex.212 The reaction was far more 
complex than that of the amide (308), but from the HRMS of the crude reaction 
mixture it was impossible to detect any of the cyclised product, although it was 
possible to identify some unreacted starting material and products in which either one 
or both of the iodine atoms had been removed. 
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2.4.5 An Alternative Approach to the Macrocycle (64) 
In light of the problems we encountered in constructing the biaryl bond between the 
benzofuran ring and the indole ring in the final macrocyclisation step of our synthesis, 
we began to consider alternative approaches to the macrocyclic aromatic core of 
diazonamide A (1). In planning an alternative strategy, we wanted to make use of the 
extensive research we had already conducted, whilst simplifying the problem of biaryl 
bond construction. Our answer to this dilemma is outlined in the retrosynthetic 
analysis shown overleaf. 
In this approach, initial retrosynthetic disassembly now cleaved the disubstituted 
oxazole of the macrocycle (64) to the carbamate (311). In the forward sense, we 
anticipated that removal of the benzyl carbamate protecting group191 would liberate 
an amine which could be condensed with a carboxylic acid, exposed following 
saponification of the ester group, to give an amide. 131 Completion of the macrocyclic 
core (64) would then take place via a cyclodehydration reaction to form the 
bis-oxazole unit. Dissection of the remaining oxazole next gave the trisubstituted 
alkene (312).69 We envisaged utilising the unusual cyclisation of an amide function 
onto an internal vinyl bromide (2.2.6), prepared by treatment of the alkene (312) with 
bromine and triethylamine, to construct the trisubstituted oxazole f r a m e w o r k . l ~ ~ I The 
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alkene (312) incorporates the quaternary carbon centre on the benzofuran ring with a 
pendant vinyl group. This familiar arrangement could be derived from the iodide 
(313) by an intramolecular 5-exo-trig Heck reaction. 134f This retrosynthetic 
maneouver greatly simplified the task of disconnecting the alkene (312), since the 
iodide (313) can now be cleaved across the phenolic ether linkage to provide the 
phenol (314) and the mesylate (315). In the synthetic direction, exposure of the 
phenol (314) to the action of a suitable base was expected to result in the formation of 
a reactive phenoxide anion which could be trapped by the mesylate (315) to provide 
the Heck precursor (313) after exchange of the TMS group for an iodine atom. 
Construction of the simplified biaryl substrate (314) could now take place in an 
intermolecular fashion by uniting the boronic acid or stannane (316) with the iodide 
(317) using a Suzuki or Stille reaction respectively.202,204 
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Our initial task on this approach was to prepare a suitable mesylate for coupling with 
a phenol derivative. We envisaged constructing the trisubstituted alkene using a 
Wadsworth-Emmons olefination222 of a phosphonate with Garner aldehyde (318).223 
To prepare the required phosphonate we utilised the copper(I) salt-mediated arylation 
of phosphinyl stabilised carbanions developed by Minami et al.224 Hence, triethyl 
phosphonoacetate (319) was treated with sodium hydride and iodobenzene in the 
presence of copper(I) iodide at 100 0 e to provide the phosphonate (320) in 71 % yield 
(Scheme 30). The phosphonate (320) then participated in a Wadsworth-Emmons 
olefination reaction222 with Garner aldehyde (318),223 using sodium hydride as the 
base, to provide the trisubstituted alkene (321) in 58% yield. The ester function in 321 
was reduced by treatment with DIBAL-H at -78°e to give the alcohol (322) in 75% 
yield. Finally, exposure of the alcohol (322) to methanesulfonyl chloride and 
triethylamine at ooe gave the crude mesylate (323). 
In order to determine if this approach offered a viable route for formation of the 
benzofuran and oxazole rings we chose to first use 2-iodophenol (324) instead of a 
more complex biaryl phenol derivative. Thus, treatment of 2-iodophenol (324) with 
potassium carbonate and the mesylate (323) resulted in the formation of the phenolic 
ether (325) (Scheme 31). Acid-induced removal of the t-butyl carbamate and 
acetonide protecting groups in 325, followed by acylation of the crude salt (326) with 
acetic anhydride and DMAP in pyridine, next gave the amide (327) in 81 % overall 
yield. Protection of the primary hydroxyl group in 327, by treatment with 
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t-butyldimethylsilyl chloride, DMAP and triethylamine, finally provided the silyl 
ether (328), another precursor for the Heck reaction, 134 in 69% yield. 
ii 
( E t O ) 2 " ~ C O O Et 
II 2 II 
o o 
319 320 
111 IV 
HO MsO 
322 323 
Reagents: i, NaH, CuI, PhI, DMF, ~ , , 71 %; ii, NaH, 318, THF, 58%; iii, DIBAL-H, PhMe, 75'k; iv, 
ceOH ceO 10 • 10 
I I 
324 
o 
iii .. c e ~ ~
0 1 
O ~ N H H
327 
Scheme 30 
ii ceO • 10 
I 
325 326 
O ~ N H H
IV .. 1 ~ ~. ceo 
o I 
328 
Reagents: i, K2C03, 323, DMPU, MeCN, 75%; ii, HCl, dioxane; iii, AC20, DMAP, Py, 81';( (2 steps); 
Scheme 31 
103 
We were now in a position to investigate the intramolecular Heck reaction 13.+f of the 
iodide (328). Hence, 328 was treated with tris-(dibenzylideneacetone)dipalladium, a 
bidentate phopshine ligand, a silver salt and a phase-transfer agent in DMF at 80 a C, 
as outlined below. This cocktail provided a complex crude reaction mixture which. 
after exposure to TBAF in THF, gave one major product. It was not possible to 
conclusively prove that this product was the alcohol (329) as there was insufficient 
material for l3C NMR studies. However, early indications suggest that this approach 
might offer an alternative to that described previously and this strategy is currently 
being pursued within the group. One possible modification of the substrate which 
could lead to a more favourable Heck reaction involves conversion of the silyl ether 
(328) to the ester (330). This alteration should facilitate ~ - h y d r i d e e elimination, since 
the ~ - h y d r o g e n n would be more acidic and the product alkene would exist in 
conjugation with the carbonyl group. The synthesis of this substrate is also under 
investigation. 
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C02Me 
I,ll ~ ~0:0 .. 0:0 I ~ ~ OH I ~ ~
I I 
328 329 330 
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2.4.6 Conclusions 
Ultimately, we were unsuccessful in uniting two aryl halides by an intramolecular 
Ullmann cyclisation reaction97,209-11,215-8 to form the biaryl bond and the macrocyclic 
aromatic core of diazonamide A (1). However. we have described an efficient route to 
suitably substituted precursors for the macrocyclisation reaction which could lead to 
the desired product (64) when treated under modified reaction c o n d i t i o n s . 2 1 ~ ~ Our 
10..+ 
approach to these precursors utilised the convergent union of the acids (69 and 306) 
with the amine derived from the salt (250) to provide the amides (289 and 308).131 
The keto amide function inherent in the amides (289 and 308) was then cyclised to 
construct the intriguing bis-oxazole unit.69 
Our initial investigations into an alternative approach for the synthesis of the 
macrocyde (64), involving another intramolecular Heck reaction134f and allowing for 
intermolecular biaryl bond formation,202,204 has also been reported. 
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2.5 Research Summary 
The main emphasis throughout this period of research has been towards the efficient 
construction of the macrocyclic aromatic core of diazonamide A (1). Our 
disconnection strategy simplified this problem to the synthesis of two subunits (67 
and 68). We applied Heck methodology 134 to form the benzofuran ring in the more 
complex acid fragment (67) via an intramolecular 5-exo-trig reaction of the iodide 
(74). Our success with this substrate led us to prepare the analog (83) which 
incorporated a protected tyrosine residue for elaboration into the northern substructure 
of diazonamide A (1). However, all attempts to effect ring closure with this substrate 
met with failure and our synthetic efforts were then concentrated solely towards a 
model compound of the southern macrocycle. The product alkene (73) was next 
manipulated so that oxazole formation could be investigated. An efficient five step 
procedure provided the amide (70), which encompassed a keto amide function that 
could be cyclodehydrated under conditions described recently by Wipf69 to construct 
the desired trisubstituted oxazole framework in an excellent yield. 
The indole fragment (68) provided the next challenge en route to the macrocycle (64). 
Our initial strategy for the synthesis of this fragment was based on the early inclusion 
of a bromine substituent and the late introduction of the ketone function. An 
amine-directed metallation-bromination sequence successfully provided the bromine 
derivative (219).194 The side chain was elaborated to the carbamate (216), but 
exposure of this compound to the action of DDQ190 gave only the secondary alcohol 
(233) and none of the desired ketone (234). It was possible to introduce the ketone 
function either in a single step, by acylation of indole (225),199 or in a two step 
sequence involving the protection and benzylic oxidation of tryptamine (236).190 The 
carbonyl function in the ketone (224) then directed thallation to the C4 position of the 
indole ring and a thallium-iodine exchange reaction 197a, 198 finally provided a suitably 
substituted indole fragment (250). 
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The two subunits could be combined to give the amide (289) by prior activation of the 
carboxylic acid (69) as the acid chloride (290). The amide (289) included a keto 
amide function which was again cyclodehydrated under the conditions developed by 
Wipf69 to provide the unusual bis-oxazole ring system (291). This reaction gave our 
first precursor for an intramolecular Ullmann coupling reaction97,210,211,215-8 which 
we hoped would unite the two aromatic halides and form the crucial biaryl bond. 
However, exposure of the bis-oxazole (291) to an in situ generated nickel(O) 
complex212 resulted principally in reduction of the C-I bond. In an effort to increase 
the reactivity of the benzofuran portion, we decided to synthesise the diiodide 
precursors (309 and 310). To achieve this, we first effected a bromine-iodine 
exchange reaction of the bromide (73), via the aryl lithium intermediate (294), to 
provide the iodide (293). With the iodide (293) now in hand, we next utilised the 
previous synthetic pathway to prepare two more precursors for the Ullmann 
reaction. 130 We were hugely disappointed when treatment of the amide (309), under 
Ullmann coupling conditions,212 again resulted solely in deiodination of the indole 
portion. The bis-oxazole (310) also failed to provide any of the desired macrocycle 
(64) under analogous reaction conditions,212 but there was evidence in this reaction 
for insertion of the nickel(O) complex into the C-I bond on the benzofuran ring. 
Finally, we have described an alternative approach to the macrocycle (64) which we 
hope will simplify the problem of biaryl bond formation. In this strategy we 
anticipated forming the biaryl bond at an early stage in the synthesis by an 
intermolecular coupling process.202,204 Our initial synthetic efforts have focused on 
preparing a model Heck precursor (328). Early indications have shown that this 
substrate may well participate in the desired 5-exo-trig intramolecular coupling 
process 134f and this work is ongoing in our laboratories. 
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3. EXPERIMENTAL 
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3.0 General Details 
All melting points were determined on a Kofler hot-stage apparatus and are 
uncorrected. Optical rotations were recorded in spectroscopic grade chloroform or 
methanol on a Jasco DIP-370 polarimeter, [aJD values are recorded in units of 10-1 
deg cm2 g-l. Ultraviolet spectra were recorded on a Philips PU 8700 
spectrophotometer as solutions in either deionised water, or spectroscopic grade 
methanol or ethanol, £ values are recorded in units of dm3 mol- 1 cm- I . Infrared spectra 
were obtained using a Perkin-Elmer 1600 series FT-IR instrument or a Nicolet Magna 
550 instrument either in a KBr disc, as a nujol mull, or dilute solutions in 
spectroscopic grade chloroform. Proton nmr spectra were recorded on either a Bruker 
DPX 360 (360MHz), or a Varian Unity 300 (300MHz) spectrometer as dilute 
solutions in deuterochloroform at ambient temperature, unless otherwise stated. The 
chemical shifts are quoted in parts per million (ppm) relative to residual chloroform 
as internal standard (8 7.27) and the multiplicity of each signal is designated by the 
following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; sep., septet; br, 
broad; m, multiplet; app., apparent. All coupling constants are quoted in Hertz. 
Carbon-13 nmr spectra were recorded on either a Bruker DPX 360 (at 90.6MHz), a 
Varian Unity 300 (at 75MHz), or a Jeol EX-270 (at 67.8MHz) instrument as dilute 
solutions in deuterochloroform, unless otherwise stated. Chemical shifts are reported 
relative to internal chloroform standard (8 77.0) on a broad band decoupled mode, 
and the multiplicities determined using a DEPT sequence. Where required, H-H 
COSY, H-C COSY and NOE spectra were recorded on a Bruker DPX 360 (360MHz) 
instrument using standard Bruker software with no modifications. Mass spectra were 
recorded on a VO Autospec, a MM-701CF, a VO Micromass 7070E or a Micromass 
LCT spectrometer using electron ionisation (EI), electrospray (ES), or fast atom 
bombardment (FAB) techniques. Microanalytical data were obtained on a 
Perkin-Elmer 240B elemental analyser. 
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Flash chromatography225 was performed on Merck silica gel 60 as the stationary 
phase and the solvents employed were either of analytical grade or were distilled 
before use. All reactions were monitored by tlc using Merck silica gel 60 F254 
precoated aluminium backed plates which were visualised with ultraviolet light and 
then with either acidic alcoholic vanillin solution, basic potassium permanganate 
solution, or acidic anisaldehyde solution. 
Routinely, dry organic solvents were stored under nitrogen and/or over sodium wire. 
Other organic solvents were dried by distillation from the following: THF and 
benzene (potassium benzophenone ketyl), dichloromethane (calcium hydride) and 
methanol (magnesium methoxide). Other organic solvents and reagents were purified 
by the accepted literature procedures.226 All organic extracts were dried with 
magnesium sulfate unless otherwise stated. Solvent was removed on a Blichi rotary 
evaporator. Where necessary, reactions requiring anhydrous conditions were 
performed in a flame or oven dried apparatus under a nitrogen or argon atmosphere as 
stated. 
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3.1 Synthetic Studies towards the Benzofuran Oxazole Unit (69) 
2-Bromo-6-(trimethylsilanyl)-phenol (77) 
OH 
T M S ~ B r r
V 
Sodium hydride (3.34g, 60% dispersion in mineral oil, 83.6mmol) was added to a 
stirred solution of the dibromide (80) (l0.5g, 41.8mmol) in THF (150ml) at ambient 
temperature, under an atmosphere of nitrogen. The solution was stirred at ambient 
temperature for 1 h, then chlorotrimethylsilane (5.3ml, 41.8mmol) was added 
dropwise over 2 min. The solution was stirred at ambient temperature for 3 h, then 
cooled to -78°C and n-butyllithium (26.1ml, 1.6M solution in hexanes, 41.8mmol) 
was added dropwise over 8 min. The mixture was warmed to ambient temperature 
and a saturated aqueous solution of ammonium chloride (l50ml) was added. The 
mixture was concentrated in vacuo to leave an aqueous residue which was extracted 
with diethyl ether (3 x 150ml). The combined organic extracts were dried (MgS04 ) 
and concentrated in vacuo to leave a residue which was purified by chromatography 
on silica, eluting with petroleum ether (b.p. 40-60°C), to give the aryl silane (8.53g, 
83%) as a yellow liquid; Umax (soln., CHCI3) 3517, 2954,1324,1244,1080, 841cm-1; 
bH (360MHz) 7.50 (lH, dd, J 7.9 and 1.5, phenol H3), 7.35 (lH, dd, J 7.3 and 1.5, 
phenol H5), 6.83 (lH, app. t, J 7.5, phenol H4), 5.76 (lH, s, OH), 0.37 (9H, s, 
SiC(CH3)3); be (67.8MHz) 157.2 (s), 135.7 (d), 134.1 (d), 128.2 (s), 122.7 (d), 11l.6 
(s), 0.00 (q); m/z (El) Found: 243.9910 (M+ C9H\3BrOSi requires 243.9919). 
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2-[2-Bromo-6-(trimethylsilanyl)-phenoxy]-1-phenylethanone (76) 
I ~ ~ I Q(T;PS -?' o ~ ~
Br 0 
Potassium carbonate (14.0g, 102mmol) and then 2-bromoacetophenone (78) (8.89g, 
44.7mmol) were added portionwise to a stirred solution of the aryl silane (77) (lO.Og, 
40.6mmol) in acetonitrile (400ml) at ambient temperature, under an atmosphere of 
nitrogen. The solution was stirred at ambient temperature for 3 h, then filtered and 
concentrated in vacuo. The residue was diluted with ethyl acetate (200ml) and washed 
with water (200ml), then dried (MgS04 ) and concentrated in vacuo to leave a residue 
which was purified by chromatography on silica, eluting with 5% ethyl acetate in 
petroleum ether (b.p. 40-60°C), to give the aryl ether (14.0g, 95%) as a pale yellow 
oil; Dmax (soln., CHCI3) 2956, 2901, 1705, 1598, 1579, 1450, 1404, 1091cm- 1; DH 
(300MHz) 7.91 (2H, app. dd, J 7.9 and 1.5, phenyl H2 and phenyl H6), 7.51 (lB, app. 
tt, J 7.0 and 1.5, phenyl H4), 7.49 (lH, dd, J 7.5 and 1.5, phenoxy H3), 7.40 (2H, app. 
t, J 7.9, phenyl H3 and phenyl H5), 7.31 (lH, dd, J 7.5 and 1.7, phenoxy H5), 6.95 
(lH, t, J 7.5, phenoxy H4), 5.27 (2H, s, CH2), 0.22 (9H, s, SiC(CH3)3); Dc (75MHz) 
193.8 (s), 160.0 (s), 136.2 (s), 135.7 (d), 135.0 (d), 134.1 (s), 129.2 (d), 128.3 (d), 
126.3 (d x 2), 116.7 (s), 75.6 (t), 0.00 (q); m/z (El) Found: 362.0338 (M+ 
C17H19Br02Si requires 362.0336); Found: C, 56.4; H, 5.2; Br, 22.2%, C17H19Br02Si 
requires C, 56.2; H, 5.3; Br, 22.0%. 
2_(2_Bromo-6-iodophenoxy)-1-phenylethanone (75) 
Y ~ r P P
Br 0 
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Silver tetrafluoroborate (0.29g, I.Slmmol) was added in a single portion to a stirred 
solution of the aryl ether (76) (O.SOg, l.37mmol) in methanol (l4ml) at ambient 
temperature, under an atmosphere of nitrogen. The solution was cooled to ocC and 
iodine (0.38g, l.SI mmol) was added portionwise. The mixture was warmed to 
ambient temperature and stirred at ambient temperature for 1.S h, then diluted with 
diethyl ether (20ml) and filtered. The filtrate was washed with a 20% aqueous 
solution of sodium thiosulfate (2 x 40ml), then dried (MgS04) and concentrated in 
vacuo to leave a residue which was purified by chromatography on silica, eluting with 
S% ethyl acetate in petroleum ether (b.p. 40-60 C C), to give the iodide (0.44g, 77%) as 
a pale yellow solid; m.p. 97-99°C, [Lit. m.p. 96-9TCJ227; u max (soln., CHCI3 ) 2902, 
1706cm- 1; DR (300MHz) 7.91 (2H, app. d, 1 7.S, phenyl H2 and phenyl H6), 7.7S 
(IH, dd, 17.9 and l.1, Ar), 7.62 (lH, t, 17.S, phenyl H4), 7.S6 (IH, dd, 17.9 and l.1, 
Ar), 7.S0 (2H, app. t, 1 7.S, phenyl H3 and phenyl HS), 6.77 (IH, t, 17.9, phenoxy 
H4), S.27 (2H, s, CH2) , 0.22 (9H, s, SiC(CH3)3); Dc (7SMHz) 193.0 (s), lSS.2 (s), 
139.3 (d), 134.8 (s), 134.3 (d), 134.2 (d), 129.2 (d), 128.S (d), 128.2 (d), 92.7 (s), 89.9 
(s), 74.8 (t); m/z (EI) Found: 41S.8909 (M+ C14H lOBrI02 requires 41S.8920); Found: 
C, 40.1; H, 2.4; 1,30.6%, C14H lOBrI02 requires C, 40.3; H, 2.4; I, 30.4%. 
(EIZ)-l- (2-Bromo-6-iodophenoxy)-2-pheny Ibnt-2-ene (74) 
QC I I ~ ~ o 
Br 
n-Butyllithium (lS.Sml, l.6M in hexanes, 24.8mmol) was added dropwise over 5 min 
to a stirred solution of (ethyl)triphenylphosphonium bromide (9.19g, 24.8mmol) in 
THF (l2Sml) at O°C, under an atmosphere of nitrogen. The solution was stirred at O°C 
for 20 min, then a solution of the iodide (75) (7.37g. 17.7mmol) in THF (90ml) was 
added dropwise over 10 min. The solution was warmed to ambient temperature and 
113 
stirred at ambient temperature for 3 h, then a saturated aqueous solution of 
ammonium chloride (lOOml) was added. The mixture was extracted with diethyl ether 
(3 x 250ml), then the combined organic extracts were dried ( M g S O ~ ) ) and 
concentrated in vacuo. The residue was diluted with diethyl ether (40ml) and cooled 
to O°C, then pentane (40ml) was added to the rapidly stirred solution and the mixture 
was stirred at O°C for 30min. The mixture was filtered and the filtrate was 
concentrated in vacuo to leave a residue which was purified by chromatography on 
silica, eluting with 5% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the 
alkene (7.34g, 96%), in a 2:1 ratio of Z:E geometrical isomers, as a yellow oiL Umax 
(soln., CHCI3) 2961, 1434, 1368cm-1; ~ ~ (300MHz, Z isomer) 7.78 (lH, dd, 17.9 and 
1.5, Ar), 7.58 (lH, dd, 17.9 and 1.5, Ar), 7.52-7.36 (5H, m, phenyl), 6.73 (lH, app. 1, 
17.5, phenoxy H4), 6.32 (lH, q, 17.2, CHCH3), 4.77 (2H, s, CH2), 1.86 (3H, d, 17.2, 
CH3); Dc (75MHz) 155.9 (s), 139.3 (d), 138.7 (s), 137.2 (s), 134.4 (d), 134.3 (d), 
129.7 (d), 128.6 (d), 127.6 (d), 127.5 (d), 117.8 (s), 93.5 (s), 77.7 (t), 15.3 (q); 111/;' 
(El) Found: 427.9273 (M+ C I6H I4BrIO requires 427.9274). 
(S)-2-(3-Acetyl-4-hydroxyphenyl)-1-carhoxyethylammonium chloride (86) 
HO 
Aluminium chloride (29.0g, 215mmol) was added portionwise to a stirred suspension 
of L-tyrosine (85) (lO.Og, 55.2mmol) in nitrobenzene (l50ml) at ambient 
temperature. Acetyl chloride (4.7ml, 66.2mmol) was added dropwise over 3 min and 
the mixture was heated at 100°C for 16 h, then cooled to ambient temperature and 
poured onto a mixture of ice (300g) and concentrated hydrochloric acid (5Sml). The 
aqueous solution was washed with ethyl acetate (2 x 300ml), then concentrated ill 
vacuo to leave a residue which was stored at O°C overnight. The precipitate \\as 
11.+ 
removed by filtration to leave the ketone (9.0g, 67%) as a white solid; m.p. 
227-229°C dec. (5M HCI), [Lit. m.p. 221-225°C]228; DR (D20, 360MHz) 7.53 OH, d, 
J 2.0, phenol H2), 7.23 OH, dd, J 8.1 and 2.0, phenol H6), 6.70 OH, d, J 8.1, phenol 
H5), 4.14 (lH, t, J 6.6, CHCH2), 3.08 (lH, dd, J 14.5 and 6.0, CHCH2), 2.99 (lH, dd, 
J 14.5 and 7.1, CHCH2 ), 2.40 (3H, s, CH3); Dc (D20, 67.8MHz) 207.7 (s), 172.2 (s), 
160.4 (s), 138.5 (d), 133.2 (d), 125.9 (s), 120.3 (s), 119.1 (d), 54.8 (d), 35.3 (t), 27.2 
(q); mlz (FAB) Found: 224.0936 ([M-HCI]+ CllH 13N04 requires 224.0925). 
(S)-2-(3-Acetyl-4-hydroxyphenyl)-l-methoxycarbonylethylammonium chloride 
(87) 
Acetyl chloride (0.9ml, 12.9mmol) was added dropwise over 5 min to methanol 
(20ml) at O°C with stirring. The solution was stirred at O°C for 10 min, then the 
ketone (86) (1.12g, 4.30mmol) was added portionwise at O°C and the mixture was 
warmed to ambient temperature. The mixture was heated at reflux for 3 h, then cooled 
to ambient temperature and concentrated in vacuo to leave the ester (1.12g, 95%) as a 
white solid, m.p. 187-189°C (MeOHlEt20), [Lit. m.p. 180-183°CJ229; [a]o = +7.2 (c 
= 1.0, MeOH), [Lit. [a]D = -3.3 (c = 1.0, MeOH)]229; VIDax (KBr) 3410, 1752, 1637, 
1490, 1446, 1362, 1252, 1232, 1060cm-1; DR (CD30D, 360MHz) 7.84 (lH, s, phenol 
H2), 7.44 OH, dd, J 8.6 and 2.3, phenol H6), 6.99 (lH, d, J 8.6, phenol H5), 4.40 
(lH, t, J 6.6, CHCH2), 3.88 (3H, s, OCH3)' 3.29 (lH, dd, J 14.6 and 6.0, CHCH:J. 
3.21 (lH, dd, J 14.6 and 7.3, CHCH2 ), 2.70 (3H, s, COCH3); Dc (CD 30D. 67.8MHz) 
206.2 (s), 170.3 (s), 162.8 (s), 138.4 (d), 133.4 (d), 125.8 (s), 121.1 (s), 119.7 (d), 55.1 
(d), 53.7 (q), 36.3 (t), 27.2 (q); 1 7 I / ~ ~ (El) Found: 238.1074 ([M-HCI]+ C I2H 1,:'\O.) 
requires 238.1079). 
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(S)-Methyl-3-(3-acetyl-4-hydroxyphenyl)-2-benzyloxycarbonylaminopropionate 
(88) 
HO 
Sodium carbonate (8.97g, 84.6mmol) was added in a single portion to a stirred 
solution of the ester (87) (l1.0g, 40.3mmol) in THF (l35ml) and water (l35ml) at 
O°C. Benzyl chloroformate (6.3ml, 44.3mmol) was added dropwise over 1 min at O°C 
and the solution was warmed to ambient temperature and stirred at ambient 
temperature for 2 h. The solution was concentrated in vacuo to leave a residue which 
was diluted with ethyl acetate (30ml). The aqueous layer was separated, then washed 
with ethyl acetate (30ml). The combined organic extracts were dried (MgS04 ) and 
concentrated in vacuo to leave a residue which was purified by chromatography on 
silica, eluting with 35% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the 
carbamate (l1.6g, 77%) as a clear oil which solidified on standing; m.p. 91-93°C, 
[Lit. m.p. 94-96°C]229; [cx]o = -9.0 (c = 1.0, MeOH), [Lit. [cx]o = -4.9 (c = 1.0, 
MeOH)]229; 'U max (soln., CHCI3) 3429, 1714, 1644, 1620, 1353cm- 1; DH (360MHz) 
7.45 (lH, s, phenol H2), 7.33 (5H, m, Ar), 7.21 (lH, dd, J 8.5 and 2.2, phenol H6), 
6.87 (lH, d, J 8.5, phenol H5), 5.45 (lH, d, J 8.1, NH), 5.14 (lH, d, J 12.2, CH20), 
5.05 (lH, d, J 12.2, CH20), 4.68-4.63 (lH, m, CHCH2 ), 3.73 (3H, s, OCH3), 3.14 (lH, 
dd, J 14.1 and 5.6, CHCH2 ) , 3.01 (lH, dd, J 14.1 and 6.4, CHCH2) , 2.52 (3H, s, 
COCH3); Dc (67.8MHz) 204.2 (s), 171.7 (s), 161.3 (s), 155.5 (s), 137.3 (d), 136.0 (s), 
131.1 (d), 128.4 (d), 128.2 (d), 128.0 (d), 127.4 (d), 126.8 (d), 126.1 (s), 119.4 (s). 
118.5 (d), 66.9 (t), 54.6 (d), 52.3 (q), 37.3 (t), 26.5 (q); miz (El) Found: 371.1359 (M+ 
C2oH 21N06 requires 371.1369). 
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(S)-Methyl-3-(3-acetyl-4-benzyloxyphenyl)-2-benzyloxycarbonylamino 
propionate(89) 
BnO 
Potassium carbonate (6.70g, 48.5mmol), benzyl bromide (2.1ml, 17.8mmol) and then 
DMPU (5.9ml, 48.5mmol) were added to a stirred solution of the carbamate (88) 
(6.00g, 16.2mmol) in DMF (80ml) at ambient temperature, under an atmosphere of 
nitrogen. The solution was stirred at ambient temperature for 22 h, then poured onto 
water (100mI) and acidified with hydrochloric acid (2M). The aqueous solution was 
extracted with ethyl acetate (3 x 150mI), then the combined organic extracts were 
washed with water (300ml) and dried (MgS04), then concentrated in vacuo to leave a 
residue which was purified by chromatography on silica, eluting with 35% ethyl 
acetate in petroleum ether (b.p. 40-60°C), to give the benzyl ether (2.46g, 34%) as a 
colourless oil which solidified on standing; m.p. 80-82°C, [Lit. m.p. 83-85°C]229; [a]o 
= -6.6 (c = 1.0, MeOH), [Lit. [a]o = -3.1 (c = 1.0, MeOH)]229; U max (soln., CHCI3) 
3429,1714,1672, 1353cm-1; bH(360MHz) 7.56 (lH, d, J 2.3, phenyl H2), 7.45-7.30 
(10H, m, Ar), 7.21 (lH, dd, J 8.4 and 2.3, phenyl H6), 6.94 (lH, d, J 8.4, phenyl H5), 
5.46 (lH, d, J 7.8, NH), 5.13 (2H, s, ArCH20Ar), 5.10 (2H, s, C0 2CH2Ar), 4.69-4.62 
(lH, m, CHCH2 ) , 3.75 (3H, s, OCH3 ), 3.12 (lH, dd, J 13.9 and 5.3, CHCH2 ), 3.04 
(lH, dd, J 13.9 and 6.2, CHCH2) , 2.59 (3H, s, COCH3); bc (67.8MHz) 199.2 (s), 
171.7 (s), 157.1 (s), 155.5 (s), 136.1 (s), 135.9 (s), 134.2 (d), 131.1 (d), 128.5 (d), 
128.3 (d), 128.2 (s), 128.1 (d), 128.0 (d), 127.9 (d), 127.8 (s), 127.4 (d), 112.9 (d). 
70.5 (t), 66.8 (t), 54.7 (d), 52.3 (q), 36.9 (t), 32.0 (q); m / ~ ~ (FAB) Found: .+62.1925 
([MH]+ C27H28N06 requires 462.1917). 
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(S)-Methyl-3-( 4-benzyloxy -3-bromoacetylphenyl)-2-benzyloxycarbonylamino 
propionate (84) 
BnO 
Br 
Lithium bis-(trimethylsilyl)amide (9.8ml, 1.0M in THF, 9.75mmol) was added 
dropwise to a stirred solution of the benzyl ether (89) (1.50g, 3.25mmol) in THF 
(35ml) at -78°C, under an atmosphere of nitrogen. The solution was stirred at -78°C 
for 15 min, then chlorotrimethylsilane (l.4ml, 11.4mmol) was added dropwise over 1 
min at -78°C. The solution was warmed to O°C for 10 min, then cooled to -78°C. A 
solution of bromine (6.5ml, 3.25mmol) in dichloromethane (20ml) was added 
dropwise at -78°C and the solution was stirred at -78 °C for 1 min, then poured onto a 
saturated aqueous solution of sodium hydrogencarbonate (10ml). The aqueous phase 
was separated and extracted with dichloromethane (2 x 10ml). The combined organic 
extracts were dried (MgS04), then concentrated in vacuo to leave a residue which was 
purified by chromatography on silica, eluting with 35% ethyl acetate in petroleum 
ether (b.p. 40-60°C), to give the bromide (1.38g, 78%) as a white solid; m.p. 98-99°C; 
[a]D = +49.8 (c = 2.9, CHCI3); 'Omax (soln., CHCI3) 3429, 1714, 1351cm- 1; bH 
(360MHz) 7.59 (lH, d, J 2.0, phenyl H2), 7.44-7.30 (10H, m, Ar), 7.25 (lH, dd, J 8.4 
and 2.0, phenyl H6), 6.95 (lH, d, J 8.4, phenyl H5), 5.40 (lH, d, J 8.0, NH), 5.14 
(2H, s, ArCH20Ar), 5.09 (2H, s, C02CH2Ar), 4.66-4.61 (lH, m, CHCH2 ), 4.50 (2H, s, 
CH
2
Br), 3.74 (3H, s, CH 3 ), 3.09 (lH, dd, J 13.9 and 5.3, CHCH2 ), 3.04 (lH, dd, J 
13.9 and 6.0, CHCH2); be (67.8MHz) 192.2 (s), 171.6 (s), 156.9 (s), 155.5 (s), 136.1 
(s), 135.4 (s), 135.4 (d), 132.1 (d), 128.7 (s), 128.7 (d), 128.4 (d x 2),128.2 (d), 128.0 
(d), 127.9 (d), 124.9 (s), 112.9 (d), 71.0 (t), 66.8 (t), 54.7 (d), 52.4 (q), 37.4 (t), 36.9 
(t); mlz (FAB) Found: 540.0986 ([MH]+ C27H27BrN06 requires 540.1022). 
118 
(S)-Methyl-3-(4-benzyloxy-3-{[2-bromo-6-(trimethylsilanyl)-phenoxy]-acetyl}-
phenyl)-2-benzyloxycarbonylaminopropionate (91) 
BnO Br 
O ~ ~
T M S ~ ~
Potassium carbonate (0.77g, 5.55mmol) and then the bromide (84) (0.60g, l.11mmol) 
were added to a stirred solution of the aryl silane (77) (l.09g, 4.44mmol) in 
acetonitrile (lOml) at ambient temperature, under an atmosphere of nitrogen. The 
solution was stirred at ambient temperature for 19 h, then filtered and concentrated ill 
vacuo. The residue was diluted with ethyl acetate (lOml), then washed with water 
(lOml) and dried (MgS04), then concentrated in vacuo to leave a residue which was 
purified by chromatography on silica, eluting with 35% ethyl acetate in petroleum 
ether (b.p. 40-60°C), to give the aryl ether (0.67g, 85%) as a yellow oil; [a]D = +38.2 
(c = l.8, CHCI 3); Dmax (soln., CHCI3) 3622, 3429, 1718, 1352, 1061, 841cm- i ; bH 
(360MHz) 7.82 (lH, d, J 2.1, phenyl H2), 7.53 (lH, dd, J 8.5 and 2.1, phenyl H6), 
7.37-7.22 (l2H, m, Ar), 7.02 (lH, t, J 7.4, phenoxy H4), 6.95 (lH, d, J 8.5, phenyl 
H5), 5.33 (lH, d, J 7.9, NH), 5.26 (lH, d, J 18.0, COCH20Ar), 5.20 (lH, d, J 18.0, 
COCH20Ar) , 5.12 (2H, s, ArCH20Ar), 5.10 (2H, s, C02CH2Ar), 4.70-4.64 OH, m, 
CHCH2) , 3.78 (3H, s, OCH3 ), 3.18 (lH, dd, J 13.9 and 5.3, CHCH2), 3.11 OH, dd, J 
13.9 and 5.8, CHCH2), 0.24 (9H, s, SiC(CH3)3); be (67.8MHz) 193.8 (s), 172.2 (s), 
160.3 (s), 158.0 (s), 156.0 (s), 136.6 (s), 136.0 (s), 135.8 (s), 135.7 (d), 135.5 (d), 
134.8 (d), 132.1 (d), 129.1 (d), 129.0 (d), 128.8 (d), 128.6 (d), 128.5 (d), 128.2 (s), 
128.1 (d), 125.8 (d), 125.4 (s), 116.8 (s), 113.4 (d), 79.6 (t), 71.4 (t), 67.5 (t), 55.2 (d), 
53.0 (q), 37.6 (t), 0.00 (q); 17I/z (FAB) Found: 704.1671 ([MH]+ C36H39BrN07Si 
requires 704.1679). 
119 
(8)-Methyl-3-(4-benzyloxy -3-{ [2-bromo-6-iodophenoxy ] -acetyl }-pheny 1)-2-
benzyloxycarbonylaminopropionate (92) 
BnO O ) ) B ~ ~
I ~ ~
I 
Silver tetrafluoroborate (0.15g, 0.79mmol) was added to a stirred solution of the aryl 
ether (91) (0.40g, 0.56mmol) in ethanol (6ml) at ambient temperature, under an 
atmosphere of nitrogen. The solution was cooled to ODC and iodine (0.21g, 0.84mmol) 
was added in a single portion. The solution was warmed to ambient temperature and 
stirred at ambient temperature for 19 h, then diluted with diethyl ether (lOml) and 
filtered. The filtrate was concentrated in vacuo to leave a residue which was diluted 
with water (lOml), then extracted with ethyl acetate (3 x 10ml). The combined 
organic extracts were washed with hydrochloric acid (30ml, 2M) and brine (30ml), 
then dried (MgS04 ) and concentrated in vacuo to leave a residue which was purified 
by chromatography on silica, eluting with 35% ethyl acetate in petroleum ether (b.p. 
40-60DC), to give the iodide (0.46g, 99%) as a yellow oil; [CX]D = +36.2 (c = 2.8, 
CHCI3); umax (soln., CHCI3) 3429,1714, 1609cm-1; bH(360MHz) 7.83 (lH, d, 12.2, 
phenyl H2), 7.68 (lH, dd, 1 7.5 and 0.9, Ar), 7.47 (lH, dd, 1 7.5 and 0.9, Ar), 
7.33-7.23 (llH, m, Ar), 6.94 (lH, d, 1 8.5, Ar), 6.70 (lH, t, 17.9, phenoxy H4), 5.40 
(lH, d, J 8.0, NH), 5.14-5.13 (2H, m, COCH20Ar) , 5.09 (4H, s, ArCH20Ar and 
C0
2
CH
2
Ar), 4.68-4.62 (lH, m, CHCH2 ), 3.76 (3H, s, CH3 ), 3.17 (lH, dd, 1 13.8 and 
5.1, CHCHz), 3.08 (lH, dd, 1 13.8 and 6.0, CHCH2); be (67.8MHz) 192.5 (s), 171.7 
(s), 157.6 (s), 155.0 (s), 154.7 (s), 138.6 (d), 135.7 (s), 135.4 (s), 135.-+ (d), 133.7 (d), 
131.7 (d), 128.7 (s), 128.6 (d), 128.5 (d), 128.3 (d), 128.1 (d x 2),127.7 (d), 127.2 (d), 
124.7 (s), 116.5 (s), 113.0 (d), 92.4 (s), 78.2 (t), 71.1 (t), 67.0 (t), 5-+.8 (d), 52.5 (q), 
37.1 (t); 11//z. (FAB) Found: 758.0247 ([MH]+ C-,-,H30BrIN07 requires 758.0250). 
120 
(Z)-(S)-Methyl-3-{4-benzyloxy-3-[1-(2-bromo-6-iodophenoxymethyl)-propenyl]-
phenyl}-2-benzyloxycarbonylaminopropionate (83) 
BnO 
NHCbz 
Br 
o ~ ~
IN 
Sodium bis-(trimethylsilyl)amide (0.56ml, 1.0M in THF, 0.56mmol) was added 
dropwise over 1 min to a stirred solution of (ethyl)triphenylphosphonium bromide 
(0.22g, 0.60mmol) in THF (2ml) at -40°C, under an atmosphere of nitrogen. The 
solution was stirred at -40°C for 20 min, then a solution of the iodide (92) (0.14g, 
0.18mmol) in THF (2ml) was added dropwise over 1 min. The solution was stirred at 
-40°C for 1 h, then poured onto a saturated aqueous solution of ammonium chloride 
(lOml). The mixture was extracted with diethyl ether (3 x 15ml), then the combined 
organic extracts were dried (MgS04) and concentrated in vacuo to leave a residue 
which was purified by chromatography on silica, eluting with 25% ethyl acetate in 
petroleum ether (b.p. 40-60°C), to give the alkene (86mg, 62%) as a colourless oil; 
[a]D = +16.7 (c = 3.8, CRCI3); 1)max (soln., CRCI3) 3430, 1714, 1606, 1349cm-1; bH 
(360MRz) 7.67 (lR, dd, 17.9 and 1.3, Ar), 7.47 (lR, dd, 17.9 and 1.3, Ar), 7.41-7.27 
(lOR, m, Ar), 7.05-6.97 (2R, m, Ar), 6.87 (lR, d, 1 8.3, Ar), 6.66 (lR, t, 1 7.9, 
phenoxy R4), 6.22 (lR, q, 1 6.8, CHCR3), 5.31 (lR, d, 1 2.6, NH), 5.07 (4R, s, 
ArCH
2
0Ar and C02CH2Ar), 4.66 (2R, s, ArCCH20Ar), 4.19-4.15 (lR, m, CHCR2 ) , 
3.72 (3R, s, OCH3), 3.10 (2R, d, 1 5.4, CRCH2) , 1.62 (3R, d, 1 6.8, CRCH3): be 
(67.8MRz) 172.0 (s), 155.6 (s), 155.5 (s), 155.3 (s), 138.6 (d), 137.2 (s), 136.2 (s), 
134.2 (s), 133.7 (d), 132.9 (d), 129.2 (s), 129.2 (d), 128.4 (d), 128.1 (d), 128.0 (d), 
127.9 (d), 127.6 (d), 127.3 (s), 127.1 (d), 126.8 (d), 117.2 (s). 112.5 (d), 92.9 (s). 76.2 
(t), 70.2 (t), 66.8 (t), 61.4 (d), 54.8 (t), 52.3 (q), 37.2 (t), 1.+.7 (q): 1 1 I / ~ ~ (ES) Found: 
792.0493 ([MNa]+ C35R33BrIN06Na requires 792.0434). 
121 
7-Bromo-3-phenyl-3-vinyl-2,3-dihydrobenzofllran (73) 
Br 
A solution of the alkene (74) (2.50g, 5.S3mmol) in DMF (20ml) was added dropwise 
over 3 min to a stirred solution of silver carbonate (3.54g, 12.Smmol) and 
triphenylphosphine (0.15g, 0.5Smmol) in DMF (40ml) at ambient temperature, under 
an atmosphere of nitrogen. PaUadium(II) acetate (65mg, 0.29mmol) was added in a 
single portion and the solution was heated at SO°C for 92 h, then cooled to ambient 
temperature and filtered through cellite. The filtrate was diluted with water (500ml) 
and extracted with diethyl ether (3 x 500ml). The combined organic extracts were 
dried (MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 25% dichloromethane in petroleum ether (b.p. 
40-60°C), to give the dihydrobenzofuran (0.92g, 53%) as a colourless oil; U max (soln., 
CRCI3 ) 1636, 990cm- 1; ~ ~ (300MHz) 7.36 (lR, dd, J S.l and 1.1, Ar), 7.33-7.22 (5R, 
m, Ar), 7.00 (lR, dd, J 7.5 and 1.1, Ar), 6.S2 (lR, t, J 7.5, dihydrobenzofuran H5), 
6.27 (lR, dd, J 17.4 and 10.6, CHCR2 ), 5.32 (lR, d, J 10.6, CRCH:J, 5.0S (lR, d, J 
17.4, CRCH2 ), 4.S0 (lR, d, J 9.1, CH 20Ar), 4.73 (lR, d, J 9.1, CH 20Ar); be 
(75MRz) 157.4 (s), 143.S (s), 141.1 (d), 133.9 (s), 132.2 (d), 129.0 (d), 127.8 (d), 
127.6 (d), 125.0 (d), 122.7 (d), 116.0 (t), 103.8 (s), 83.7 (t), 58.9 (s); m/z (El) Found: 
300.0162 (M+ C16RJ3BrO requires 300.0150). 
122 
7-Bromo-3-phenyl-2,3-dihydrobenzofuran-3-carbaldehyde (72) 
CHO 
Br 
Osmium tetroxide (O.llg, 2.5wt. % solution in 2-methyl-2-propanol, llllmol) and 
then sodium periodate (0.54g, 2.50mmol) were added to a stirred solution of the 
dihydrobenzofuran (73) (0.30g, 1.00mmol) in THF (5ml) and water (5ml) at ooe. 
under an atmosphere of nitrogen. The solution was warmed to ambient temperature 
and stirred at ambient temperature for 16 h. A saturated aqueous solution of 
ammonium chloride (lOml) was then added and the mixture was extracted with ethyl 
acetate (3 x 20ml). The combined organic extracts were dried (MgS04) and 
concentrated in vacuo to leave a residue which was purified by chromatography on 
silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the 
aldehyde (0.12g, 40%) as a colourless oil; umax (soln., CHCI3) 2821, 1726cm-1; bH 
(360MHz) 9.68 (lH, d, J 1.2, CHO), 7.49 (IH, dd, J 8.0 and 1.1, Ar), 7.45-7.36 (3R, 
m, Ar), 7.25 (lH, dd, J 7.5 and 1.1, Ar), 7.17-7.13 (2H, m, Ar), 6.93 (IR, t, J 7.7, 
dihydrobenzofuran H5), 5.57 (lR, d, J 9.2, CH2) , 4.41 (lR, dd, J 9.2 and 1.2, CH:J; 
be (90.6MHz) 192.7 (d), 158.1 (s), 137.2 (s), 133.4 (d), 129.5 (d), 128.5 (d), 127.4 
(d), 125.5 (s), 124.7 (d), 122.4 (d), 103.9 (s), 77.1 (t), 67.2 (s); mlz (El) Found: 
301.9944 (M+ C 15H llBr02 requires 301.9942). 
123 
Ethyl-3-(7-bromo-3-phenyl-2,3-dihydrobenzofuran-3-yl)-3-oxopropionate (71) 
Br 
Solutions of ethyl diazoacetate (1.2ml, 10.9mmol) in dichloromethane (8ml) and then 
the aldehyde (72) (1.11g, 3.64mmol) in dichloromethane (8ml) were added dropwise 
to a stirred solution of zirconium chloride (0.8Sg, 3.64mmol) in dichloromethane 
(I5ml) at -10°C, under an atmosphere of nitrogen. The solution was warmed to O°C 
and stirred at O°C for 2 h, then warmed to ambient temperature and poured onto brine 
(30ml). The organic layer was separated and the aqueous layer was extracted with 
dichloromethane (2 x 30ml). The combined organic extracts were dried (NaZS04), 
then concentrated in vacuo to leave a residue which was purified by chromatography 
on silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the 
ketone (1.19g, 84%) as a pale red oil; 'Umax (soln., CHCI3) 2983, 2940,1744,1716, 
1464, 1448, 1369, 1314, 1120cm-1; bH (360MHz) 7.46 (IH, d, J 8.0, Ar), 7.42-7.32 
(4H, m, Ar), 7.22-7.20 (2H, m, Ar), 6.91 (IH, t, J 7.8, dihydrobenzofuran H5), 5.64 
(IH, d, J 9.1, CH20Ar), 4.28 (IH, d, J 9.1, CH20Ar), 4.05 (2H, qd, J 7.1 and l.9, 
CH2CH3), 3.54 (2H, d, J 2.6, CH2CO), 1.17 (3H, t, J 7.1, CH3 ); be (90.6MHz) 197.1 
(s), 166.3 (s), 158.3 (s), 137.8 (s), 133.2 (d), 129.4 (d), 128.3 (d), 126.7 (d), 126.1 (s), 
125.2 (d), 122.2 (d), 104.0 (s), 79.0 (t), 69.3 (s), 61.2 (t), 44.6 (t), 13.8 (q); Ill/:: (El) 
Found: 388.0323 ([MH]+ C19H 1SBrO .. requires 388.0310). 
12.+ 
Ethyl-3-(7 -bromo-3-phenyl-2,3-dihydrobenzofuran-3-yl)-2-diazo -3-oxo 
propionate (170) 
Br 
Triethylamine (80/-!1, 0.66mmol) was added dropwise to a stirred solution of the 
ketone (71) (0.20g, 0.52mmol) in acetonitrile (5ml) at ambient temperature, under an 
atmosphere of nitrogen. The solution was cooled to O°C and 
4-acetamidobenzenesulfonyl azide (0.15g, 0.62mmol) was added in a single portion. 
The solution was warmed to ambient temperature and stirred at ambient temperature 
for 5.5 h, then concentrated in vacuo to leave a residue which was diluted with water 
(20ml). The aqueous solution was extracted with ethyl acetate (3 x 20ml) and the 
combined organic extracts were dried (Na2S04), then concentrated in vacuo to leave a 
residue which was purified by chromatography on silica, eluting with 20% ethyl 
acetate in petroleum ether (b.p. 40-60°C), to give the diazoketone (0.22g, 99%) as a 
pale yellow oil; Umax (soln., CHCI3) 2148, 1722, 1644, 1314cm- 1; bH (360MHz) 
7.38-7.34 (3R, m, Ar), 7.29-7.25 (3H, m, Ar), 7.19 (lH, dd, J 7.6 and 1.2, Ar), 6.78 
(lH, t, J 7.8, dihydrobenzofuran H5), 5.23 (lH, d, J 10.5, CH20Ar), 5.17 (lH, d, J 
10.5, CH20Ar) , 4.09 (2H, qd, J 7.1 and 1.2, CH2CH3 ), 1.15 (3H, t, J 7.1, CH3 ); be 
(90.6MHz) 188.9 (s), 159.6 (s), 156.4 (s), 140.5 (s), 133.2 (d), 129.5 (s), 129.0 (d), 
127.3 (d), 126.7 (d), 125.1 (d), 122.0 (d), 103.2 (s), 79.3 (t), 77.2 (s), 67.3 (s), 61.9 (t), 
13.9 (q); m/z (EI) Found: 386.0145 ([M-N2]+ C 1 9 H 1 5 B r O ~ ~ requires 386.0154). 
(EIZ)-Ethyl-3-(7-bromo-3-phenyl-2,3-dihydrobenzofuran_3-yl)-2-hydroxyimino-
3-oxo-propionate (165) 
Br 
A solution of sodium nitrite (1.69g, 23.8mmol) in water (5ml) was added dropwise 
over 3 min to a stirred solution of the ketone (71) (1.16g, 2.97mmol) in acetic acid 
(5ml) at ambient temperature. The mixture was stirred at ambient temperature for :2 h, 
then diluted with water (20ml) and extracted with ethyl acetate (3 x 30ml). The 
combined organic extracts were washed with water (70mI) , a saturated aqueous 
solution of sodium hydrogencarbonate (70ml) and finally water (70mI) , then dried 
(MgS04) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 30% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the oxime (1.17g, 94%), in a 2:1 ratio of geometrical isomers, as a 
yellow oil; Dmax (soln., CHCI3 , major isomer) 3536, 1630cm-1; ~ ~ (360MHz) 9.24 
OH, s, OH), 7.41 OH, dd, J 6.9 and 1.1, Ar), 7.39 (lH, dd, J 7.2 and 1.1, Ar), 
7.35-7.30 (2H, m, Ar), 7.25 (lH, tt, J 7.1 and 2.2, phenyl H4), 7.19-7.16 (2H, m, Ar), 
6.84 OH, t, J 7.7, dihydrobenzofuran H5), 5.37 OH, d, J 9.7, CH20Ar), 4.77 (lB, d, J 
9.7, CH20Ar) , 4.34 (2H, q, J 7.1, CH2CH3 ), 1.33 (3H, t, J 7.1, CH3 ); be (90.6MHz) 
190.8 (s), 160.8 (s), 157.3 (s), 148.3 (s), 140.8 (s), 132.8 (d), 129.2 (d), 127.6 (d), 
127.5 (s), 127.2 (d), 125.6 (d), 122.4 (d), 103.4 (s), 79.4 (t), 67.1 (s), 60.8 (t), 13.9 (q); 
m/z (EI) Found: 399.0114 ([M-H20]+ C19H14BrN04 requires 399.0106). 
126 
Ethyl-2-acetylamino-3-(7-bromo-3-phenyl-2,3-dihydrobenzofuran-3-yl)-3-
oxopropionate (70) 
Br 
Zinc dust (21mg, 0.32mmol) was added in a single portion to a stirred solution of the 
oxime (165) (68mg, 0.16mmol) in 80% aqueous acetic acid (2ml) at ambient 
temperature. The solution was stirred at ambient temperature for 3.5 h, with more zinc 
dust (21mg, 0.32mmol) added after 2.5 h. The precipitate was removed by filtration 
and washed with acetic acid, then the filtrate was concentrated ill vacuo to leave the 
crude salt (74mg, 100%) as a pale yellow solid, which was used immediately without 
characterisation. A solution of acetyl chloride ( 4 0 ~ 1 , , 0.48mmol) in dichloromethane 
(2ml) was added dropwise over 1 min to a stirred solution of the salt (166) (74mg, 
0.16mmol) and triethylamine ( 7 0 ~ 1 , , 0.48mmol) in dichloromethane (3ml) at O°C, 
under an atmosphere of nitrogen. The solution was warmed to ambient temperature 
over 1 h and stirred at ambient temperature for 9.5 h, then diluted with 
dichloromethane (l5ml) and washed with water (20ml). The organic phase was dried 
(MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the amide (51mg, 71%), in a 2:1 ratio of diastereoisomers, as a pale 
yellow oil; u max (soln., CRCI3) 3427, 1749, 1717, 1682, 1314, 1114cm- 1; 8H 
(360MHz) 7.79 (lR, dd, J 7.6 and 1.1, Ar), 7.58 (lR, dd, J 7.6 and 1.1. Ar), 7.49-7.44 
(2R, m, Ar), 7.40-7.30 (6R, m, Ar), 7.23-7.19 (4R, m, Ar), 6.97 (lH, t, J 7.8. 
dihydrobenzofuran R5), 6.92 (lR, t, J 7.8, dihydrobenzofuran R5). 6.68 (lH, d, ] 7.2. 
NH), 6.55 (lR, d, J 8.8, NH), 5.81 (lR, d, J 8.8, CRN), 5.64 (lH, d, ] 9.2, CH20Arl. 
5.61 (lR, d, J 7.2, CRN), 5.54 (lR, d, ] 9.4, CH20Ar), -1-.5-1- (1H, d. ] 9.-1-. C H ~ O A r L L
127 
4.29 OR, d, J 9.2, CH20Ar), 3.93-3.78 (2H, m, CH2CR3), 3.44 (2H, dq, J 10.7 and 
7.2, CH2CR3), 1.92 (3R, s, CH 3CO), 1.89 (3H, s, CH 3CO), 1.03 (3H, t, J 7.2, 
CH2CH3), 1.03 (3R, t, J 7.2, CR2CH3); be (90.6MRz) 199.4 (s), 197.0 (s), 169.5 (s), 
169.0 (s), 166.3 (s), 166.1 (s), 158.4 (s), 158.2 (s), 137.2 (s), 137.1 (s), 133.5 (d), 
133.2 (d), 129.2 (d), 129.1 (d), 128.4 (d), 128.3 (d), 126.7 (d), 126.6 (d), 126.4 (d), 
126.3 (d), 125.6 (s), 122.7 (d), 122.5 (d), 104.1 (s), 103.7 (s), 79.9 (t), 79.2 (t), 69.0 
(s), 68.8 (s), 62.4 (t), 62.3 (t), 57.7 (d), 56.6 (d), 22.5 (q), 13.5 (q x 2); m/:: (ES) 
Found: 446.0599 ([MR]+ C21R21BrNOs requires 446.0603). 
Ethyl-5-(7-bromo-3-phenyl-2,3-dihydrobenzofuran-3_yl)_2-methyloxazole-4-
carboxylate (212) 
Br 
Triethylamine (0.17ml, 1.20mmol) and then a solution of the amide (70) (0.13g, 
0.30mmol) in dichloromethane (3ml) were added dropwise to a stirred solution of 
triphenylphosphine (0.16g, 0.60mmol) and iodine (0.15g, 0.60mmol) in 
dichloromethane (6ml) at ambient temperature, under an atmosphere of nitrogen. The 
solution was stirred at ambient temperature for 12 h, then concentrated ill vacuo to 
leave a residue which was purified by chromatography on silica, eluting with 50% 
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the oxazole (O.llg, 86%) as a 
pale yellow oil; umax (soln., CRCI3) 1722,1123, 1091cm- 1; bH (360MHz) 7.40 (lH, 
dd, J 8.0 and 1.1, Ar), 7.38 (lR, dd, J 7.6 and 1.1, Ar), 7.31-7.24 (3H, m, Ar), 
7.14-7.11 (2R, m, Ar), 6.83 (lR, t, J 7.7, dihydrobenzofuran R5), 5.29 (lH, d, J 9.9, 
CH20Ar), 5.19 (lR, d, J 9.9, CH20Ar), 4.24 (lH, dq, J 10.9 and 7.2, C H 2 C H ~ ) , , 4.17 
(lH, dq, J 10.9 and 7.2, CH2CH.,), 2.50 (3H, s, ArCH), 1.20 (3H. t. J 7.2, CH2Cl(;); 
128 
DC (90.6MHz) 16l.2 (s), 159.9 (s), 158.5 (s), 156.8 (s), 143.0 (S), 132.5 (d). 13l.2 (s). 
128.7 (d), 128.2 (s), 127,4 (d), 126.2 (d), 125.7 (d), 122.5 (d), 103,4 (s), 83.7 (t). 6l.3 
(t), 56.5 (s), 14.0 (q), 13.9 (q); mlz (EI) Found: 428.0493 ([MH]+ C 2 1 H I 9 B r N O ~ ~
requires 428.0497). 
S-(7-Bromo-3-phenyl-2,3-dihydrobenzofuran-3-yl)-2-methyloxazole-4-carboxylic 
acid (69) 
Br 
Lithium hydroxide (29mg, 0.70mmol) was added in a single portion to a stirred 
solution of the oxazole (212) (30mg, 70l-lmol) in methanol (l.5ml) and water (0.5ml) 
at ambient temperature. The solution was stirred at ambient temperature for 8 h, then 
acidified with a 10% aqueous solution of citric acid (2ml) and extracted with ethyl 
acetate (3 x 5ml). The combined organic extracts were dried (MgS04 ) and 
concentrated in vacuo to leave the acid (28mg, 100%) as a white solid; m.p. 
194-196°C (hexane), [Lit. m.p. 192-193°C]227; Amax (EtOH) 291 (l.85 x 1()4), 284 
(l.80 x 104), 211nm (l.08 x 105); umax (soln., CHCI3) 3494, 3241 (br), 1762, 1702, 
1077cm- 1; DR (360MHz) 7,44-7,41 (2H, m, Ar), 7.31-7.24 (3H, m, Ar), 7.13-7.10 
(2H, m, Ar), 6.86 (lH, t, J 7.8, dihydrobenzofuran H5), 5,41 (lH, d, J 10.0, CHz). 
5.14 (lH, d, J 10.0, CH2), 2.53 (3H, s, CH3); Dc (90.6MHz) 162.9 (s), 160.3 (s), 159.3 
(s), 157.0 (s), 142.3 (s), 132.7 (d), 130.7 (s), 128.8 (d), 127.6 (d), 126.3 (d), 125.9 (d). 
122.5 (d), 103.5 (s), 83.3 (t), 56.5 (s), 13.7 (q); mlz (ES) Found: 463.0269 
([MNaMeCN]+ C 2 1 H 1 7 B r N 2 0 ~ N a a requires 463.0309). 
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3.2 Synthetic Studies towards the Indole Unit (68) 
[4-Bromo-l-(tri-iso-propylsiianyl)-lH-indol-3-ylmethyl]-dimethylamine (219) 
Br 
CQNMe2 I ~ ~ ~ ~~ ~ N 
\ 
TIPS 
t-Butyllithium (9.4ml, 1.7M solution in pentane, 16.0mmol) was added dropwise over 
6min to a stirred solution of dimethyl-[1-(tri-iso-propylsilanyl)-lH-indol-3-ylmethyl]-
amine (220) (2.50g, 7.61mrnol) in diethyl ether (38ml) at O°C, under an atmosphere of 
nitrogen. The solution was stirred at O°C for 1 h, then cooled to -78°C and bromine 
(0.5lml, 9.89mmol) was added dropwise over 1 min. The solution was warmed to 
O°C over 4 h, then poured onto a 20% aqueous solution of sodium thiosulfate (40ml). 
The organic phase was separated and the aqueous phase was extracted with diethyl 
ether (3 x 40ml). The combined organic extracts were washed with a 20% aqueous 
solution of sodium thiosulfate (l50ml) and brine (l50ml), then dried (MgS04) and 
concentrated in vacuo to leave a residue which was purified by chromatography on 
silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-60°C), increasing to 
ethyl acetate, to give the bromide (l.80g, 58%) as a brown oil; 'U max (soln., CHCI 3) 
2947,2869,2814,2774, 1600, 1546, 1456cm-1; ~ ~ (360MHz) 7.45 (lH, d, J 8.3, Ar), 
7.31 (lH, d, J 7.6, Ar), 7.22 (lH, s, indole H2), 6.97 (lH, app. t, J 7.9, indole H6), 
3.87 (2H, s, CH2), 2.36 (6H, s, N(CH3)2), 1.71 (3H, sep., J 7.6, Si(CH(CH3hh), l.16 
(l8H, d, J 7.6, Si(CH(CH3)2)3); be (90.6MHz) 142.7 (s), 132.2 (d), 128.7 (s), 124.3 
(d), 121.9 (d), 115.9 (s), 113.9 (s), 112.9 (d), 55.0 (t), 45.1 (d), 17.9 (q), 12.6 (q); 111/; 
(El) Found: 408.1602 (M+ C2oH33BrN2Si requires 408.1600). 
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4-Bromo-3-(2-nitroethyl)-IH-indole (218) 
Iodomethane (3.8ml, 61.1mmol) was added dropwise over 3 min to a stirred solution 
of the bromide (219) (2.50g, 6.11mmol) in benzene (25ml) at ambient temperature. 
under an atmosphere of nitrogen. The solution was stirred at ambient temperature for 
16 h, then concentrated in vacuo to leave the crude salt (3.20g, 100%) as an off-white 
solid, which was used immediately without characterisation. Tetrabutylammonium 
fluoride hydrate (2.89g, 9. 16mmol) was added in a single portion to a stirred solution 
of the salt (228) (3.20g, 6.11mmol) and nitromethane (3.3ml, 61.1mmol) in THF 
(30ml) at ambient temperature, under an atmosphere of nitrogen. The solution was 
stirred at ambient temperature for 2 h, then concentrated in vacuo. The residue was 
diluted with water (40ml), then extracted with diethyl ether (3 x 40ml). The combined 
organic extracts were dried (MgS04) and concentrated in vacuo to leave a residue 
which was purified by chromatography on silica, eluting with 20% ethyl acetate in 
petroleum ether (b.p. 40-60°C), to give the nitroindole (2.36g, 80%) as a pale yellow 
oil; Dmax (soln., CHCI3 ) 3473, 2939, 1557, 1379cm-1; bH (360MHz) 8.26 (lR, br s, 
NH), 7.32-7.30 (2H, m, Ar), 7.07-7.02 (2H, m, Ar), 4.78 (2H, t, J 6.9, CH2N), 3.71 
(2H, t, J 6.9, CH2Ar); be (90.6MHz) 137.5 (s), 125.0 (d), 124.7 (s), 124.1 (d), 123.2 
(d), 113.6 (s), 110.9 (d), 110.5 (s), 77.2 (t), 24.3 (t); mlz (EI) Found: 267.9859 (M+ 
ClOH9BrN202requires 267.9847). 
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tert-Butyl-[2-(4-bromo-1H-indol-3-yl)-ethyl]-carbamate (216) 
Br NHBoc 
Zinc dust (0.30g, 4.64mmol) was added in a single portion to a stirred solution of the 
nitroindole (218) (O.llg, 0.39mmol) in 80% aqueous acetic acid (14ml) at 75°C. The 
mixture was heated at 80°C for 4.5 h, then cooled to ambient temperature and filtered. 
The precipitate was washed with 80% aqueous acetic acid, then dried in vacuo 
(lmmHg) to give the crude salt (0.10g, 100%) as a pale yellow solid, which was used 
immediately without characterisation. Di-tert-butyl dicarbonate (0.33g, 1.44mmol) 
was added in a single portion to a stirred solution of the salt (230) (0.10g, 0.39mmol) 
and an aqueous solution of sodium hydroxide (4ml, 2M) in 2-methyl-2-propanol 
(10ml) at ambient temperature. The mixture was stirred at ambient temperature for 
16 h, then concentrated in vacuo. The residue was diluted with brine (20ml) and 
extracted with dichloromethane (3 x 20ml). The combined organic extracts were dried 
(MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 35% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the carbamate (O.llg, 85%) as an off-white solid; U max (soln., 
CHCl3 ) 3475, 3306, 2978, 2930, 1703, 1456, 1392, 1367cm-1; DR (360MHz) 8.73 
(lH, s, indole NH), 7.31 (lH, d, 18.1, Ar), 7.27 (lH, d, 17.5, Ar), 7.02 (lH, s, indole 
H2), 7.00 (lH, app. t, 17.8, indole H6), 4.77 (lH, s, NHCO), 3.51 (2H, app. q, 16.5, 
CH2N), 3.20 (2H, t, 16.5, CH2Ar) , 1.47 (9H, s, C(CH3)3); Dc (90.6MHz) 156.2 (s), 
137.8 (s), 125.3 (s), 124.1 (d), 123.8 (d), 122.7 (d), 114.1 (s), 113.6 (s), 110.7 (d), 
79.2 (s), 42.1 (t), 28.4 (q), 26.6 (t); mlz (El) Found: 338.0641 (M+ Cl5Hl9BrN202 
requires 338.0630). 
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tert -Butyl-[2-( 4-bromo-IH -indol-3-yl)-2-hydroxyethyl]-carbamate (233) 
NHBoc 
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (0.33g, 1.47mmol) was added in a single 
portion to a stirred solution of the carbamate (216) (0.25g, 0.74mmol) in THF (8ml) 
and water (0.9ml) at O°C, under an atmosphere of nitrogen. The solution was warmed 
to ambient temperature over 2 h, then stirred at ambient temperature for 2 h. The 
solution was diluted with diethyl ether (20ml) and washed with an aqueous solution 
of sodium hydroxide (20ml, O.lM), then dried (MgS04) and concentrated ill vacuo to 
leave a residue which was purified by chromatography on silica, eluting with 50% 
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the alcohol (0.20g, 75%) as a 
red oil; Vrnax (soln., CRCI3) 3598,3471, 1698, 1103cm- 1; 8tI (360MRz) 8.86 (lH, s, 
indole NH), 7.31 (lR, dd, J 8.1 and 0.8, Ar), 7.29-7.25 (2R, m, Ar and indole H2), 
7.01 (lR, app. t, J 7.9, indole R6), 5.70 (lR, br d, J 5.9, OH), 5.15 (lR, br s, NHCO), 
3.75-3.74 (lR, m, CH2), 3.55-3.48 (2R, m, CH2, CHOR), 1.48 (9R, s, C(CH3)3); be 
(90.6MRz) 157.4 (s), 137.7 (s), 124.5 (s), 124.1 (d), 123.4 (d), 122.9 (d), 117.7 (s), 
113.3 (s), 110.8 (d), 79.9 (s), 67.4 (d), 47.5 (t), 28.4 (q); mlz (ES) Found: 377.0487 
([MNa]+ ClsR19BrN203Na requires 377.0477). 
tert_Butyl_[2_(IH_indol-3-yl)-2-oxoethyl]-carbamate (237) 
o 
NHBoc 
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A solution of sodium hydroxide (0.26g, 6.SSmmol) in water (3ml) was added 
dropwise over 1 min to a stirred solution of tryptamine (236) (O.SOg, 3.12mmol) in 
dioxane (ISml) at O°C, under an atmosphere of nitrogen. The solution was stirred at 
O°C for 10 min, then di-tert-butyl dicarbonate (0.72g, 3.28mmol) was added and the 
solution was warmed to ambient temperature. The solution was stirred at ambient 
temperature for 1 h, then concentrated in vacuo. The residue was diluted with diethyl 
ether (20ml) and washed with water (20ml), hydrochloric acid (20ml, O.lM) and brine 
(20ml), then dried (MgS04 ) and concentrated in vacuo to leave the crude carbamate 
(0.81g, 99%) as a pale red oil, which was used immediately without characterisation. 
2,3-Dichloro-S,6-dicyano-1,4-benzoquinone (0.3Sg, l.S4mmol) was added in a single 
portion to a stirred solution of the carbamate (235) (0.20g, 0.77mmol) in THF (4ml) 
and water (O.Sml) at O°C, under an atmosphere of nitrogen. The solution was warmed 
to ambient temperature and stirred at ambient temperature for l.S h, then concentrated 
in vacuo to leave a residue which was diluted with dichloromethane (Sml). The 
precipitate was removed by filtration and washed with dichloromethane (S x 10m]) 
and diethyl ether (S x 10ml), then dried in vacuo (1mmHg) to give the ketone (82mg, 
39%) as a white solid; m.p. 230-231°C (EtOH); Amax (MeOH) 296 (l.10 x 1()4), 240 
(l.11 x 104), 210nm (2.S7 x 104); u max (soln., CHCI3) 34S9, 170S, 1660, 1492, 14S6, 
1368, 10SScm- I ; DR ( ( C ~ ) 2 S 0 , , 360MHz) 8.42 (1H, d, 13.0, indole H2), 8.17 (lH, d, 
17.1, Ar), 7.49 (IH, d, 1 7.0, Ar), 7.26-7.18 (2H, m, indole HS and indole H6), 7.02 
(lH, t, 1 S.9, NHCO), 4.32 (2H, d, 1 S.9, CH2), 1.43 (9H, s, C(CH3)3); be ((CD3hSO, 
90.6MHz) 19l.7 (s), lS6.9 (s), 137.3 (s), 134.3 (d), 126.3 (s), 123.8 (d), 122.7 (d), 
122.1 (d), 114.9 (s), 113.1 (d), 78.8 (s), 47.8 (t), 29.2 (q); mlz (FAB) Found: 27S.1392 
([MH]+ C15H19N203 requires 27S.1396); Found: C, 6S.4; H, 6.6; N, 10.0%, 
C15H18N203 requires C, 6S.7; H, 6.6; N, 10.2%. 
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Benzyl-[2-(lH-indol-3-yl)-2-oxoethyl]-carbamate (224) 
o 
NHCbz 
Oxalyl chloride (l0.3ml, 50.3mmol) was added dropwise over 5 min to a stirred 
suspension of benzyloxycarbonylglycine (226) (lO.Og, 47.8mmol) in diethyl ether 
(lOOml) at ambient temperature, under an atmosphere of nitrogen. The solution was 
stirred at ambient temperature for 18 h, then filtered and diluted with benzene, then 
concentrated in vacuo to leave the crude acid chloride (10.9g, 100%) as a pale yellow 
oil, which was used immediately without characterisation. A solution of indole (225) 
(5.90g, 50.3mmol) in diethyl ether (200ml) was added dropwise over 15 min to a 
stirred solution of ethylmagnesium bromide (l6.8ml, 3M in diethyl ether, 50.4mmol) 
in diethyl ether (500ml) at ambient temperature, under an atmosphere of nitrogen. The 
solution was stirred at ambient temperature for 10 min, then cooled to OcC and a 
solution of the acid chloride (l0.9g, 47.8mmol) in diethyl ether (200ml) was added 
rapidly. The mixture was stirred at OcC for 30 min, then a saturated aqueous solution 
of ammonium chloride (300ml) was added and the mixture was warmed to ambient 
temperature over 2 h. The precipitate was removed by filtration and washed with 
water (l50ml) and diethyl ether (l50ml), to leave the ketone (1.90g, 13%) as a pale 
brown solid; m.p. 214-216cC (EtOH), [Lit. m.p. 215-220cC]199; "'max (EtOH) 298 
(1.23 x 104),241 (1.42 x 104), 209nm (3.65 x 104); Umax (soln., CHCI3) 3457, 1714, 
1661, 1455cm-1; DR «CD3)2S0, 360MHz) 8.45 (lH, d, J 2.6, indole NH), 8.19-8.16 
(lH, m, Ar), 7.54-7.49 (2H, m, Ar), 7.41-7.33 (4H, m, Ar), 7.26-7.21 (3H, m, Ar), 
5.09 (2H, s, CH2Ar), 4.41 (2H, d, J 6.1, CH2N); Dc «CD3)2S0, 90.6MHz) 191.4 (s), 
157.6 (s), 138.1 (s), 137.3 (s), 134.4 (d), 129.3 (d), 128.7 (d x 2), 126.3 (s), 123.8 (d), 
122.8 (d), 122.1 (d), 114.8 (s), 113.1 (d), 66.3 (t), 48.0 (t); 111/:: (ES) Found: 331.1069 
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([MNa]+ C18H16N203Na requires 331.1059); Found: C, 70.0; H, 5 . ~ : : ~ . . 9.10(. 
C18H16N203 requires C, 70.1; H, 5.2; N, 9.1 %. 
Benzyl-[2-(4-iodo-lH-indol-3-yl)-2-oxoethyl]-carbamate (222) 
o 
NHCbz 
The carbamate (224) (20mg, 6 0 ~ m o l ) ) was added in a single portion to a stirred 
solution of thallium trifluoroacetate (44mg, 8 0 ~ m o l ) ) in trifluoroacetic acid (O.lml) at 
ambient temperature, under an atmosphere of nitrogen. The solution was heated at 
30°C for 2 h, then cooled to ambient temperature and concentrated in vacuo. Iodine 
(48mg, 0.19mmol), copper iodide (50mg, 0.26mmol) and then DMF (0.44ml) were 
added to the residue at ambient temperature, under an atmosphere of nitrogen. The 
solution was heated at 25°C for 2 h, then cooled to ambient temperature and diluted 
with a solution of methanol (2ml) in dichloromethane (40ml). The mixture was 
filtered through celite® and the filtrate was washed with brine (40ml) and water 
(40ml), then dried (MgS04) and concentrated in vacuo to leave a residue which was 
purified by chromatography on silica, eluting with 65% ethyl acetate in petroleum 
ether (b.p. 40-60°C), to give the iodide (15mg, 58%) as a yellow oil which solidified 
on standing; m.p. 170-172°C; Amax (MeOH) 257 (1.46 x 104), 217 (3.88 x 104 ). 
194nm (3.99 x 104); u max (soln., CHCI3) 3454,1716,1673, 1048cm-1; bH (360MHz) 
9.25 (1H, br s, indole NH), 7.83 (lH, d, ] 7.6, Ar), 7.80 (1H, m, Ar), 7.42-7.32 (6H, 
m, Ar), 6.96 (1H, app. t, ] 7.9, indole H6), 5.93 (lH, s, NHCO), 5.17 (2H, s. CH2Ar), 
4.52 (2H, d, ] 4.7, CH2N); be (CD 30D, 90.6MHz) 193.0 (s), 160.0 (s), 140.3 (s). 
139.1 (s), 136.9 (d), 135.5 (d), 130.7 (s), 130.3 (d), 129.8 (d), 1 ~ 9 . 7 7 (d), 126.-+ (d). 
118.0 (s), 114.0 (d), 86.4 (s), 68.6 (t), 5l.2 (t); 111/:: (ES) Found: -+57.0055 ( [ ~ l ) ! a ] + +
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Cl8H15IN203Na requires 457.0025); Found: C, 49.7; H, 3.4; N, 6.1; I, 29.10(-, 
C18HI5IN203 requires C, 49.8; H, 3.5; N, 6.5; I, 29.2%. 
2-( 4-Iodo-lH -indol-3-yl)-2-oxoethylammonium bromide (250) 
The iodide (222) (l9mg, 40/-lmol) was added in a single portion to a stirred solution 
of hydrogen bromide in acetic acid (1.2ml, 30wt. %) at ambient temperature, under an 
atmosphere of nitrogen. The solution was stirred at ambient temperature for 1.5 h, 
then diluted with diethyl ether (5ml). The precipitate was removed by filtration and 
dried in vacuo (lmmHg) to leave the salt (l7mg, 99%) as a pale brown solid; m.p. 
210-212°C (MeOH); Amax (H20) 305 (6.3 x 103),253 (9.2 x 103), 216nm (2.09 x 104); 
'Omax (KEr) 3407,3103,2924, 1654, 1498, 1406, 1096cm-1; bH (D20, 360MHz) 7.94 
(lH, s, indole H2), 7.61 (lH, d, J 7.4, Ar), 7.30 (lH, d, J 8.1, Ar), 6.80 (lH, app. t, ] 
7.7, indole H6), 4.25 (2H, s, CH2 ); be (D20, 90.6MHz) 186.5 (s), 137.7 (s), 136.0 (d), 
135.4 (d), 127.4 (s), 125.1 (d), 113.2 (s), 112.6 (d), 83.5 (s), 45.6 (t); m/z (ES) Found: 
342.0106 ([MHMeCN-HBr]+ C11H 13IN30 requires 342.0103). 
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3.3 Synthetic Studies towards the Macrocycle (64) 
5-(7-Bromo-3-phenyl-2,3-dihydrobenzofuran_3_yl)_2_methyloxazole-4-carboxylic 
acid [2-( 4-iodo-IH -indol-3-yl)-2-oxoethyl]-amide (289) 
-{ 
N 
NH 
Br 
A solution of the acid (69) (0.13g, 0.32mmol) in oxalyl chloride (4ml) was stirred at 
ambient temperature for 3 h. The solution was concentrated in vacuo to leave the 
crude acid chloride (0.13g, 100%) as a yellow oil, which was used immediately 
without characterisation. Triethylamine (0.45ml, 3.20mmol) was added dropwise over 
1 min to a stirred suspension of the salt (250) (0.46g, 1.22mmol) in dichloromethane 
(6ml) at O°C, under an atmosphere of nitrogen. The solution was stirred at O°C for 
15 min, then a solution of the acid chloride (290) (0.13g, 0.32mmol) in 
dichloromethane (3ml) was added dropwise over 1 min. The solution was warmed to 
ambient temperature and stirred at ambient temperature for 16 h, then diluted with 
dichloromethane (lOml) and washed with water (lOml). The aqueous phase was 
extracted with dichloromethane (2 x 10ml), then the combined organic extracts were 
dried (MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 65% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the amide (0.13g, 60%) as a yellow solid; m.p. 139-142°C; "-max 
(EtOH) 290 (l.55 x 104), 203nm (6.35 x 104); Vmax (soln., CHCI3) 3454,3391. :29:26, 
2855, 1659, 1610, 1459, 1105cm-1; DR (360MHz) 9.59 (lH, br s, indole NH). 8.1-+ 
(lH, t, J 4.9, NHCO), 7.78 (lH, d, J 7.0, Ar), 7.73 (lH, d, J 3.0, indole H:2). 7.-+-+ (lH, 
138 
dd, J 7.6 and 1.1, Ar), 7.41 (lR, dd, J 8.0 and 1.1, Ar), 7.28-7.14 (6R, m. Ar). 6.89 
(lR, app. t, J 7.8, Ar), 6.85 (lR, app. t, J 7.8, Ar), 5.56 (lR, d, J 10.0, CH
2
0Ar), 5.22 
(lR, d, J 10.0, CH20Ar), 4.61 (2R, d, J 4.9 CH2N), 2.47 (3R, s, CH3 ); Dc (90.6\IHz) 
187.7 (s), 161.2 (s), 159.2 (s), 157.0 (s), 155.5 (s), 143.3 (s), 137.6 (s), 135.5 (d), 
132.5 (d), 132.3 (d), 131.4 (s), 129.9 (s), 128.7 (d), 128.2 (s), 127.4 (d), 126.5 (d), 
126.0 (d), 124.9 (d), 122.4 (d), 115.9 (s), 112.1 (d), 103.3 (s), 84.3 (s), 84.1 (t). 56.3 
(s), 47.7 (t), 13.8 (q); m/z (ES) Found: 703.9727 ([MNa]+ C29H21BrIN304Na requires 
703.9658). 
3-[S'-(7-Bromo-3-phenyl-2,3-dihydrobenzofuran_3_yl)_2'-methyl-[2,4']-
bioxazolyl-S-yl]-4-iodo-IH -indole (291) 
Triethylamine (30IlI, 0.23mmol) and then a solution of the amide (289) (40mg, 
60llmol) in dichloromethane (lml) were added dropwise to a stirred solution of 
triphenylphosphine (31mg, 0.12mmol) and hexachloroethane (28mg, 0.12mmol) in 
dichloromethane (lml) at OcC, under an atmosphere of nitrogen. The solution was 
warmed to ambient temperature and stirred at ambient temperature for 5 h, with more 
triphenylphosphine (31mg, 0.12mmol), hexachloroethane (28mg, 0.12mmol) and 
triethylamine (30IlI, 0.23mmol) added after 3 h. The solution was diluted with 
dichloromethane (lOml), then washed with water (lOml). The aqueous phase \\JS 
extracted with dichloromethane (2 x 10ml), then the combined organic extracts were 
dried (MgS04 ) and concentrated in l'([CllO to leave a residue which was purified by 
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chromatography on silica, eluting with 65% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the bis-oxazole (32mg, 81 %) as a yellow oil; Amax (EtOH) 2 8 ~ ~ (2.51 
x 104), 202nm (7.71 x 104); Dmax (soln., CHCI3) 3467,1640,1595,1115, 1064cm-1: 
bH (360MHz) 9.18 (lH, br s, indole NH), 7.58 (lH, d, J 7.5, Ar), 7.53 (lH, dd, J 7.6 
and 1.1, Ar), 7.41 OH, dd, J 6.7 and 1.1, Ar), 7.39 (IH, dd, J 6.0 and 1.1, Ar), 7.28-
7.20 (6H, m, Ar), 7.14 (lH, s, oxazole H4), 6.90 (IH, app. t, J 7.9, Ar), 6.87 (lH, app. 
t, J 7.9, Ar), 5.69 (IH, d, J 9.9, CH2 ), 5.12 (lH, d, J 9.9, CH2 ), 2.53 (3H, s, CH1,); be 
(90.6MHz) 160.7 (s), 157.1 (s), 154.3 (s), 151.8 (s), 144.1 (s), 142.6 (s), 135.7 (s), 
132.7 (d), 132.0 (d), 131.4 (s), 129.2 (d), 128.7 (d), 128.5 (s), 127.9 (d), 127.4 (d), 
126.6 (d), 126.4 (d), 126.3 (s), 123.9 (d), 122.5 (d), 111.6 (d), 105.0 (s), 103.4 (s), 
84.9 (s), 83.3 (t), 56.4 (s), 13.9 (q); m/z (ES) Found: 663.9786 ([MH]+ C29H2oBrIN]03 
requires 663.9734). 
7-Iodo-3-phenyl-3-vinyl-2,3-dihydrobenzofuran (293) 
I 
n-Butyllithium (0.16ml, 2.5M solution in hexanes, 0.40mmol) was added dropwise 
over 1 min to a stirred solution of the aryl bromide (73) (55mg, 0.18mmol) in THF 
(0.7ml) at -78°C, under an atmosphere of nitrogen. The solution was stirred at -78°C 
for 1 h, then a solution of iodine (0.37g, 1.46mmol) in THF (O.4ml) was added 
rapidly and the solution was warmed to ambient temperature over 2 h. The solution 
was stirred at ambient temperature for 14 h, then poured onto a saturated aqueous 
solution of sodium thiosulfate (5ml) and stirred at ambient temperature for 30 min. 
The aqueous solution was extracted with diethyl ether (3 x 10ml), then the combined 
organic extracts were dried (MgS04) and concentrated in "({CliO to leave a residue 
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which was purified by chromatography on silica, eluting with 2% ethyl acetate in 
petroleum ether (b.p. 40-60°C), to give the aryl iodide (54mg, 86%) as a brown oil; 
Umax (soln., CHCI 3) 1636, 1493, 990cm- 1; bH (360MHz) 7.62 (lH, dd, 17.8 and 1.1, 
Ar), 7.41-7.27 (5H, m, Ar), 7.09 (lH, dd, J 7.4 and l.1, Ar), 6.76 (lR, app. t, 17.6, 
dihydrobenzofuran H5), 6.32 (lH, dd, 1 17.3 and 10.5, CHCH2 ), 5.38 (lR, d, 1 10.5, 
CHCH2) , 5.14 (lH, d, 1 17.3, CRCH2), 4.91 (lR, d, 19.1, CH20Ar), 4.77 OR, d, 1 
9.1, CH20Ar); be (90.6MHz) 160.0 (s), 143.4 (s), 140.7 (d), 137.3 (d), 132.0 (s), 
128.4 (d), 127.2 (d), 127.0 (d), 125.4 (d), 122.7 (d), 115.4 (t), 82.7 (t), 74.6 (s), 58.6 
(s); mlz (EI) Found: 348.0008 (M+ C16H 1310 requires 348.0011); Found: C, 55.4; R, 
3.6%, C16H 1310 requires C, 55.4; H, 3.5%. 
7 -Iodo-3-phenyl-2,3-dihydrobenzofuran-3-carbaldehyde (295) 
I 
Osmium tetroxide (O.llg, 2.5wt. % solution in 2-methyl-2-propanol, 1 1 ~ m o l ) ) and 
then sodium periodate (51mg, 0.24mmol) were added to a stirred solution of the aryl 
iodide (293) (33mg, 0.10mmol) in THF (lml) and water (lml) at O°C, under an 
atmosphere of nitrogen. The solution was warmed to ambient temperature and stirred 
at ambient temperature for 18 h, then poured onto a saturated aqueous solution of 
sodium thiosulfate (5ml) and stirred at ambient temperature for 30 min. The mixture 
was extracted with ethyl acetate (3 x 10ml), then the combined organic extracts were 
dried (MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 15% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the aldehyde (28mg, 84%) as a colourless oil: U max (soln .. CHCl}) 
2821,2710, 1729cm-1; bH (360MHz) 9.68 (lR, d, 1 1.2. CHO), 7.68 (lH. dd, J 8.0 
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and 1.1, Ar), 7.45-7.35 (3R, m, Ar), 7.27 (IR, dd, 17.5 and 1.1, Ar), 7.17-7.14 (2H, 
m, Ar), 6.80 OR, app. t, 17.8, dihydrobenzofuran H5), 5.55 (IH, d, 19.2, CH
2
). -t-..+O 
(IR, dd, 19.2 and 1.2, CH2 ); Dc (90.6MHz) 192.8 (d), 161.2 (s), 139.1 (d), 137.4 (s). 
129.5 (d), 128.5 (d), 127.4 (d), 125.7 (d), 124.1 (s), 122.9 (d), 76.5 (t), 75.0 (s). 67.5 
(s); m/z (EI) Found: 349.9799 (M+ C1sH l1l02 requires 349.9804). 
Ethyl-3-(7-iodo-3-phenyl-2,3-dihydrobenzofuran-3-yl)_3-oxopropionate (296) 
I 
Solutions of the aldehyde (295) (1.03g, 2.94mmol) in dichloromethane (8ml) and 
ethyl diazoacetate (0.93ml, 8.82mmol) in dichloromethane (8ml) were added 
dropwise to a stirred solution of zirconium chloride (0.75g, 3.23mmol) in 
dichloromethane (I5ml) at -10°C, under an atmosphere of nitrogen. The solution was 
warmed to O°C and stirred at O°C for 2 h, then warmed to ambient temperature and 
diluted with water (30ml). The organic layer was separated and the aqueous layer was 
extracted with dichloromethane (2 x 30ml). The combined organic extracts were dried 
(MgS04 ), then concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 15% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the ketone (0.64g, 50%) as a pale yellow oil; vmax (soln., CHC13) 
1744,1716,1369,1312, 1114cm-1; DR (360MHz) 7.63 (lH, dd, 17.9 and 1.0, Ar). 
7.40-7.19 (6R, m, Ar), 6.77 (IH, app. t, 1 7.7, dihydrobenzofuran H5), 5.61 (lH, d, 1 
9.1, CH20Ar), 4.25 (lH, d, 19.1, CH20Ar), 4.04 (2H, qd, 17.2 and 2.1, CH2CH 3 ), 
3.53 (2H, d, 13.6, CH2CO), 1.15 (3H, t, 17.2, CH3); Dc (90.6MHz) 197.1 (s), 166.2 
(s), 161.2 (s), 138.9 (d), 137.8 (s), 129.3 (d), 128.1 (d), 126.7 (d), 126.0 (d), 12-t-.6 (s). 
I-t-2 
122.6 (d), 78.3 (t), 75.3 (s), 69.3 (s), 61.1 (t), 44.5 (t), 13.8 (q); 111/:: (El) Found: 
436.0170 (M+ C19R 17l04 requires 436.0172). 
(EIZ)-Ethyl-3-(7-iodo-3-phenyl-2,3-dihydrobenzofuran_3-yl)-2-hydroxyimino-3-
oxopropionate (297) 
I 
A solution of sodium nitrite (0.26g, 3.67mmol) in water (0.6ml) was added dropwise 
over 1 min to a stirred solution of the ketone (296) (0.20g, 0.46mmol) in acetic acid 
(5ml) at ambient temperature. The mixture was stirred at ambient temperature for 3 h, 
then diluted with water (l5ml) and extracted with ethyl acetate (3 x 30ml). The 
combined organic extracts were washed with water (80ml), a saturated aqueous 
solution of sodium hydrogencarbonate (80ml) and finally water (80ml), then dried 
(MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 25% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the oxime (0.19g, 89%), in a 2:1 ratio of geometrical isomers, as a 
pale yellow oil; vmax (soln., CRCI3 , major isomer) 3534, 3269, 1632cm- 1; OH 
(360MRz) 9.72 (lR, s, OH), 7.57 (lR, dd, J 7.9 and 1.1, Ar), 7.44 OR, dd, J 7.6 and 
l.1, Ar), 7.33-7.21 (3R, m, Ar), 7.18-7.16 (2R, m, Ar), 6.70 OR, app. t, J 7.7, 
dihydrobenzofuran R5), 5.33 OR, d, J 9.7, CH20Ar), 4.75 OR, d, J 9.7, CH 20Ar), 
4.32 (2R, q, J 7.1, CH2CR3 ), l.32 (3R, t, J 7.1, CH3 ); Oc (90.6MRz) 191.0 (s), 161.0 
(s), 160.1 (s), 148.2 (s), 14l.0 (s), 138.4 (d), 129.1 (d), 128.2 (d), 127.5 (d), 126.2 (s). 
125.5 (d), 122.9 (d), 78.7 (t), 74.6 (s), 67.3 (s), 62.6 (t), 13.9 (q); mlz (El) Found: 
465.0086 (M+ C19R16lNOs requires 465.0073). 
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Ethyl-2-acetylamino-3-(7-iodo-3-phenyl-2,3_dihydrobenzofuran-3-yl)-3-
oxopropionate (305) 
I 
Zinc dust (23mg, 0.3Smmol) was added in a single portion to a stirred solution of the 
oxime (297) (0.31g, 0.70mmol) in 80% aqueous acetic acid (7ml) at ambient 
temperature. The solution was stirred at ambient temperature for 8 h, with more zinc 
dust (69mg, 1.0Smmol) added portionwise over 6 h. The precipitate was removed by 
filtration and washed with acetic acid, then the filtrate was concentrated in vacuo to 
leave the crude salt (0.36g, 100%) as a pale yellow solid, which was used 
immediately without characterisation. Acetic anhydride (90J,!1, 0.98mmol) was added 
dropwise over 1 min to a stirred solution of the salt (299) (0.36g, 0.70mmol) in 
pyridine (7ml) at O°C, under an atmosphere of nitrogen. The solution was stirred at 
O°C for 1 h, then 4-dimethylaminopyridine (36mg, 0.29mmol) was added in a single 
portion and the solution was warmed to ambient temperature. The solution was stirred 
at ambient temperature for 9 h, then diluted with ethyl acetate (SOml) and washed 
with hydrochloric acid (SOml, 2M), water (SOml) and brine (SOml), then dried 
(MgS04) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with SO% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the amide (0.18g, S3%), in a 2:1 ratio of diastereoisomers, as a pale 
yellow oil; Dmax (soln., CRCI3) 3427, 1748, 1716, 1682, 1313, 1111cm- 1 : 6H 
(360MRz) 7.79 (lR, dd, 17.6 and 1.1, Ar), 7.6S OR, dd, 17.2 and 1.1, Ar). 7.63 (lH, 
dd,1 6.S and 1.1, Ar), 7.S9 (1R, dd, 1 7.6 and 1.1, Ar), 7.3S-7.29 (6H. m. Ar). 
7.24-7.19 (4R, m, Ar), 6.84 (IR, app. t, 17.7, dihydrobenzofuran HS). 6.79 (lH, app. 
t, 17.7, dihydrobenzofuran RS), 6.72 OR, d, 17.4, Nfl), 6.63 (lH, d, 18.9, Nfl), 5.81 
(lH, d, 1 8.9, CRN), 5.62 (lH, d, 19.3, CH20Ar), 5.61 (lH, d, 17.4, CJr:\). 5.51 (lH, 
d, 19.4, CH20Ar), 4.52 OH, d, 19.4, CH20Ar), 4.27 (IH, d, 19.3, CH20Ar), 3 . 9 ~ ~
3.78 (2H, m, CH2CH3 ), 3.45 (2H, dq, 17.5 and 7.2, CH2CH3), 1.91 (3H, s, CH3CO). 
1.87 (3H, s, CH3CO), 1.03 (3H, t, 17.2, CH2CH3), 1.02 (3H, t, 17.2, CH2CH3 ): be 
(90.6MHz) 199.4 (s), 197.0 (s), 169.5 (s), 169.0 (s), 166.3 (s), 166.1 (s), 161.3 (s). 
161.1 (s), 139.2 (d), 138.9 (d), 137.3 (s), 137.2 (s), 129.1 (d), 129.0 (d), 128.3 (d), 
128.2 (d), 127.3 (d), 127.2 (d), 126.7 (d), 126.6 (d), 125.1 (s), 124.2 (s), 123.2 (d), 
122.9 (d), 79.2 (t), 79.0 (t), 75.3 (s), 74.8 (s), 69.3 (s), 69.1 (s), 62.3 (t), 57.7 (d), 56.6 
(d), 22.4 (q), 13.6 (q), 13.5 (q); mlz (FAB) Found: 494.0477 ([MH]+ C
2
1H21INO
s 
requires 494.0465). 
Ethyl-5-(7-iodo-3-phenyl-2,3-dihydrobenzofuran_3_yl)_2_methyloxazole-4-
carboxylate (298) 
I 
Triethylamine (0.67ml, 4.80mmol) and then a solution of the amide (305) (0.59g, 
1.20mmol) in dichloromethane (8ml) were added dropwise to a stirred solution of 
triphenylphosphine (0.63g, 2.40mmol) and iodine (0.61g, 2.40mmol) in 
dichloromethane (4ml) at ambient temperature, under an atmosphere of nitrogen. The 
solution was stirred at ambient temperature for 8 h, then concentrated in vacuo to 
leave a residue which was purified by chromatography on silica, eluting with 50S{ 
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the oxazole (0.51g, 89%) as a 
colourless oil; umax (soln., CHCI3) 1722, 1117, 1088cm-1; 8rr (360MHz) 7.57 (lH, dd, 
17.8 and 1.0, Ar), 7.38 (lH, dd, 17.7 and 1.0, Ar), 7.28-7.19 (3H, m. Ar), 7.13-7.l0 
(2H, m, Ar), 6.69 OH, app. t, 1 7.7, dihydrobenzofuran H5). 5.26 (lH, d, 1 9.9. 
145 
CH20Ar), 5.16 (lR, d, J 9.9, CH20Ar), 4.22 (lR, dq, J 10.8 and 7.1, C H ~ C R 3 ) ' ' 4.15 
(lR, dq, J 10.8 and 7.1, CH2CR3 ), 2.48 (3R, s, ArCH3 ), 1.18 (3R, t, J 7.1, CR7CHd: 
Dc (90.6MHz) 16l.1 (s), 159.8 (s), 159.6 (s), 158.5 (s), 143.0 (s), 138.1 (d), 129.7 (s). 
128.6 (d), 127.3 (d), 127.0 (d), 125.6 (s), 126.5 (d), 122.9 (d), 83.0 (t), 74.-+ (s), 61.2 
(t), 56.7 (s), 13.9 (q), 13.7 (q); mlz (El) Found: 475.0293 (M+ C:nR I81N04 requires 
475.0281). 
5-(7-Iodo-3-phenyl-2,3-dihydrobenzofuran-3-yl)-2_methyloxazole-4-carboxylic 
acid (306) 
I 
Lithium hydroxide (0.23g, 5.47mmol) was added in a single portion to a stirred 
solution of the oxazole (298) (0.26g, 0.55mmol) in methanol (6ml) and water (2ml) at 
ambient temperature. The solution was stirred at ambient temperature for 90 min, then 
acidified with a 10% aqueous solution of citric acid (15ml) and extracted with ethyl 
acetate (3 x 25ml). The combined organic extracts were dried (MgS04) and 
concentrated in vacuo to leave the acid (0.25g, 100%) as a colourless oil; v max (soln., 
CRCl3 ) 3466 (br), 3200 (br), 1738, 1015cm- 1; DR (360MHz) 7.62 (lR, dd, J 7.9 and 
1.2, Ar), 7.46 (lR, dd, J 7.6 and 1.2, Ar), 7.31-7.25 (3R, m, Ar), 7.14-7.10 (2R, m, 
Ar), 6.74 (lR, app. t, J 7.7, dihydrobenzofuran R5), 5.42 (lR, d, J 10.0, CH-J, 5.11 
(lR, d, J 10.0, CH2), 2.50 (3R, s, CH3); Dc (CD30D, 90.6MHz) 164.5 (s), 162.8 (s), 
16l.7 (s), 160.9 (s), 145.4 (s), 140.2 (d), 13l.9 (s), 130.5 (d), 129.8 (s), 129.1 (d), 
127.4 (d), 127.3 (d), 124.8 (d), 84.6 (t), 75.7 (s), 58.6 (s), 14.3 (q); m/: (ES) Found: 
446.9976 (M+ C19R141N04 requires 446.9968). 
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5-(7-Iodo-3-phenyl-2,3-dihydrobenzofuran_3_yl)_2_methyloxazole-4-carboxylic 
acid [2-( 4-iodo-1H -indol-3-yl)-2-oxoethYI]-amide (308) 
-{ 
N 
I 
A solution of the acid (306) (0.12g, 0.28mmol) in oxalyl chloride (3ml) was heated at 
reflux for 90 min. The solution was cooled to ambient temperature and concentrated 
in vacuo to leave the crude acid chloride (0.13g, 100%) as a yellow oil, which was 
used immediately without characterisation. Triethylamine (0.31ml, 2.24mmol) was 
added dropwise over 1 min to a stirred suspension of the salt (250) (0.32g, 0.84mmol) 
in dichloromethane (3ml) at O°C, under an atmosphere of nitrogen. The solution was 
stirred at O°C for 15 min, then a solution of the acid chloride (307) (0.13g, 0.28mmol) 
in dichloromethane (3ml) was added dropwise over 3 min. The solution was warmed 
to ambient temperature and stirred at ambient temperature for 16 h, then diluted with 
dichloromethane (20ml) and washed with water (20ml). The aqueous phase was 
extracted with dichloromethane (2 x 20ml), then the combined organic extracts were 
dried (MgS04 ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 65% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the amide (50mg, 25%) as a yellow solid; m.p. 139-142°C; U max (soln., 
CRC}3) 3454, 2927, 1659, 1609, 1456, 1104cm- 1; bH (360MRz) 10.09 (lB, br s. 
indole NH), 8.15 (lR, br t, J 4.8, NHCO), 7.73 (lR, d, J 7.6, Ar). 7.65 (lB, d, J 3.2. 
Ar), 7.59 OR, dd, J 7.9 and l.2, Ar), 7.45 (lR, dd, J 7.6 and 1.2, Ar), 7.24-7.12 (6H, 
m, Ar), 6.82 OR, app. t, J 7.8, Ar), 6.72 OR, app. t, J 7.8, Ar), 5.55 (lH. d. ) 10.0, 
CH
2
0Ar), 5.18 OR, d, J 10.0, CH20Ar), 4.56 (2R, d, J 4.8 CH:;N), 2,45 (3B, s, CH}l: 
1.+7 
be (90.6MHz) 187.8 (s), 160.9 (s), 159.7 (s), 159.1 (s), 155.5 (s), 143.1 (s). 138.0 (s). 
137.9 (d), 135.0 (d), 133.3 (s), 129.7 (s), 129.6 (s), 128.4 (d), 118.3 (d). 117.3 (d), 
127.0 (d), 125.7 (d), 124.4 (d), 122.6 (d), 115.3 (s), 111.9 (d), 84.5 (s), 83.1 (t). 74.0 
(s), 56.4 (s), 47.3 (t), 13.3 (q); m/z (FAB) Found: 729.9740 ([MH]+ C29H2)2N30-l 
requires 729.9700). 
5-(7-Iodo-3-phenyl-2,3-dihydrobenzofuran-3-yl)_2_methyloxazole-4-carboxylic 
acid [2-(lH-indol-3-yl)-2-oxoethyl]-amide (309) 
-( 
N 
I 
DMF (lml) was added to his-(triphenylphosphine)nickel(II) chloride (48mg, 
70llmol), zinc dust (5mg, 70llmol) and triphenylphosphine (39mg, 0.15mmol) at 
ambient temperature, under an atmosphere of argon and the solution was heated at 
50°C for 1 h. A solution of the amide (308) (30mg, 40llmol) in DMF (7ml) was added 
dropwise over 5 min to the stirred solution at 50°C and the solution was heated at 
50°C for 1 h, then cooled to ambient temperature. The solution was concentrated in 
vacuo to leave a residue which was diluted with ethyl acetate (30ml) and washed with 
water (30ml). The organic phase was dried (MgS04 ) and concentrated in 1'(ICI/O to 
leave a residue which was purified by chromatography on silica, eluting with 60% 
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the amide (lOmg, 40(,0) as a 
yellow oil; Vrnax (soln., CHCI3) 3458, 3391, 2928,1651,1609,1495,1456, 11 19cm- 1: 
bH (360MHz) 9.32 (lH, br s, indole NH), 8.34-8.31 (lH, m, Ar), 8.18 OH, br t. J 4.8. 
NHCO), 7.83 (lH, d, J 3.2, Ar), 7.61 (lH, dd, J 7.9 and 1.2. Ar). 7.43 (lH. dd, J 7.9 
148 
and 1.2, Ar), 7.32-7 15 (8H mAr) 673 (lH J 77 d'h 
. "" , app. t, " 1 ydrobenzofuran H5). 
5.56 (lR, d, J 10.1, CH20Ar), 5.21 (lH, d, J 10.1, CH20Ar), 4.68 (2H, dd, J 4.8 and 
1.1, CH2N), 2.47 (3R, s, CH3); be (90.6MHz) 188.5 (s), 161.0 (s), 160.1 (s), 159.1 (s), 
155.5 (s), 143.4 (s), 138.2 (d), 136.1 (s), 131.0 (d), 130.0 (s), 128.7 (d), 117.6 (d), 
127.3 (d), 126.1 (d), 125.2 (s), 124.0 (d), 123.0 (d), 122.8 (d), 122.0 (d), 115.2 (s), 
111.7 (d), 83.5 (t), 74.5 (s), 56.7 (s), 46.0 (t), 29.7 (s), 13.8 (q); mlz (FAB) Found: 
604.0738 ([MH]+ C29H23IN304 requires 604.0733). 
3-[5'-(7-Iodo-3-phenyl-2,3-dihydrobenzofuran_3_yl)_2'_methyl-[2,4']-bioxazolyl-
5-yl]-4-iodo-IH -indole (310) 
Triethylamine (30/-ll, 0.18mmol) and then a solution of the amide (308) (33mg, 
50/-lmol) in dichloromethane (lml) were added dropwise to a stirred solution of 
triphenylphosphine (24mg, 90/-lmol) and hexachloroethane (21mg, 90/-lmol) in 
dichloromethane (lml) at O°C, under an atmosphere of nitrogen. The solution was 
warmed to ambient temperature and stirred at ambiemt temperature for 18 h, with 
more triphenylphosphine (24mg, 90/-lmol), hexachloroethane (21mg, 90/-lmol) and 
triethylamine (15/-ll, 90/-lmol) added after 4 hand 15 h. The solution was diluted with 
dichloromethane (lOml), then washed with water (lOml). The aqueous phase was 
extracted with dichloromethane (2 x 10ml), then the combined organic extracts were 
dried (MgSO .. ) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 65% ethyl acetate in petroleum ether (b.p. 
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40-60°C), to give the bis-oxazole (l8mg, 56%) as a yellow oil; v
max 
(soln., CHCLl 
3467, 1640, 1594, 1114, 1049cm-1; bH (360MHz) 9.48 (lH, br s, indole NH), 7.61 
(lH, dd, J 7.9 and 1.0, Ar), 7.57 (lH, d, J 7.4, Ar), 7.38 (lH, d, J 8.1, Ar), 7 . 2 6 - 7 . ~ 1 1
(7H, m, Ar), 7.12 (lH, s, oxazole H4), 6.88 (lH, app. t, J 7.8, Ar), 6.75 (lH, app. t, J 
7.7, Ar), 5.69 (1H, d, J 9.9, CH2), 5.12 (lH, d, J 9.9, CHz), 2.54 (3H, s, CH3): be 
(90.6MHz) 160.7 (s), 160.1 (s), 154.2 (s), 151.9 (s), 144.2 (s), 142.7 (s), 1 3 8 . ~ ~ (d), 
135.7 (s), 131.9 (d), 130.0 (s), 129.2 (d), 128.7 (d), 128.5 (s), 128.0 (d), 127.4 (d), 
127.3 (d), 126.6 (d), 123.8 (d), 123.0 (d), 111.7 (d), 104.8 (s), 84.8 (s), 82.6 (t), 74.6 
(s), 56.8 (s), 29.7 (s), 13.9 (q); m/z (FAB) Found: 711.9585 ([MH]+ CZ9H2oIzN303 
requires 711.9594). 
3.4 An Alternative Approach to the Macrocycle (64) 
Ethyl-( diethoxyphosphoryl)-phenylacetate (320) 
A solution of triethyl phosphonoacetate (319) (8.0ml, 40.0mmol) in DMF (6ml) was 
added dropwise over 10 min to a stirred suspension of sodium hydride (1.60g, 
40.0mmol) in DMF (8ml) at ambient temperature under an atmosphere of nitrogen. 
The solution was stirred at ambient temperature for 10 min, then iodobenzene (2.2ml, 
20.0mmol) and copper iodide (3.80g, 20.0mmol) were added in single portions. The 
solution was heated at 100°C for 7 h, then cooled to ambient temperature and diluted 
with hydrochloric acid (l5ml, 2M). The mixture was filtered through celite S and 
diluted with water (50 ml), then the filtrate was extracted with ethyl acetate (3 x 
100ml). The combined organic extracts were dried (MgSO .. ). then concentrated ill 
\'([ClIO to leave a residue which was purified by chromatography on silica. eluting \\lth 
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65% ethyl acetate in chloroform, to give the phosphonate (4.24g, 71 %) as a pale 
yellow oil; umax (soln., CRCI3) 1731, 1601, 1496, 1054cm-1; bH (360MHz) 7.52-7.48 
(2R, m, Ar), 7.41-7.26 (3R, m, Ar), 4.31-3.92 (7R, m, CH2, PCH), l.33-l.14 (9H, m, 
CH3 ); be (90.6MHz) 167.5 (s), 130.9 (s), 129.5 (d), 128.4 (d), 127.8 (d), 63.3 (t), 63.0 
(t), 6l.7 (t), 52.9 (d), 16.2 (q x 2), 13.9 (q); m/z (ES) Found: 623.2101 ([M2Na]+ 
C28R42P20lONa requires 623.2151). 
(E)-(S)-tert-Butyl-4-(2-ethoxycarbonyl-2-phenylvinyl)_2,2-dimethyloxazolidine-3-
carboxylate (321) 
A solution of the phosphonate (320) (80mg, 0.27mmol) in THF (lml) was added 
dropwise over 1 min to a stirred suspension of sodium hydride (llmg, 60% 
dispersion in mineral oil, 0.27mmol) in THF (lml) at ambient temperature, under an 
atmosphere of nitrogen. The solution was stirred at ambient temperature for 10 min, 
then a solution of the aldehyde (318) (0.12g, 0.53mmol) in THF (lml) was added 
dropwise over 1 min. The solution was stirred at ambient temperature for 5 h, then 
poured onto a saturated aqueous solution of ammonium chloride (5ml). The mixture 
was extracted with ethyl acetate (3 x 10ml), then the combined organic extracts were 
dried (MgS04) and concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the alkene (59mg, 58%) as a colourless oil; [a]o = -4l.9 (c = l.1, 
CRCI3); umax (soln., CRCI3 ) 1694, 1389 1090cm- 1; bH (C6D6' 360MHz, T 340K) 
7.45-7.42 (2R, m, Ar), 7.24-7.13 (3H, m, Ar), 6.37 (lH, d, J 8.2, CHCHCH:), 5.29 
(lR, br s, CRN), 4.31-4.24 (lR, m, CH20), 4.13-4.05 (2H, m, CH:O), 3.9)-3.91 (lH. 
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m, CH20), l.77 (3H, br s, CCH3 ), l.65 (3H, br s, CCH3), l.50 (9H, s, C(CH3h), l.0'+-
0.99 (3H, m, CH2CH3 ); be (C6D 6 , 90.6MHz, T 340K) 167.3 (s), 152.5 (s), 1'+3.9 (d), 
138.7 (s), 135.6 (s), 130.5 (d), 128.6 (d), 128.1 (d), 95.1 (s), 80.0 (s), 69.7 (t), 61.1 (t), 
57.8 (d), 28.9 (q), 27.4 (q), 24.9 (q), 14.4 (q); m/z (ES) Found: 439.2209 
([MNaMeCN]+ C23H32N20sNarequires 439.2209). 
(E)-(S)-tert-Butyl-4-(3-hydroxy-2-phenylp ropeny 1)-2,2-dimethy loxazo lidine-3-
carboxylate (322) 
HO 
Di-iso-butylaluminium hydride (0.31ml, l.5M in toluene, 0.46mmol) was added 
dropwise over 1 min to a stirred solution of the alkene (321) (69mg, 0.18mmol) in 
toluene (2ml) at -78°C, under an atmosphere of nitrogen. The solution was warmed to 
ambient temperature over 3 h, then methanol (lml) was added dropwise. The solution 
was poured onto a saturated aqueous solution of potassium sodium tartrate (5ml) with 
rapid stirring and the mixture was stirred at ambient temperature for 2 h. The mixture 
was extracted with ethyl acetate (4 x 10ml) and the combined organic extracts were 
dried (MgS04), then concentrated in vacuo to leave a residue which was purified by 
chromatography on silica, eluting with 35% ethyl acetate in petroleum ether (b.p. 
40-60°C), to give the alcohol (45mg, 75%) as a colourless oil which solidified on 
standing; m.p. 52-54°C; [a]D = -6.6 (c = l.0, CHCI3); Vmax (soln., CHCI3) 3.+15, 1290, 
1061cm- 1; bH (360MHz) 7.59 (2H, app. d, J 7.4, phenyl H2 and phenyl H6), 7.36 
(2H, app. t, J 7.3, phenyl H3 and phenyl H5), 7.29 (lH, app. t, J 7.2, phenyl H4), 5.85 
(lH, d, J 10.4, CHCHCH2), 5.00 (lH, dd, J lOA and 5.3, CHN), .+.86-.+.82 (2H. m, 
CH:20H), 4.17 (lH, dd, J 9.0 and 5.8, CHCH:2) , 3.85 (lH, dd, J 9.0 and 1.1. CHCH: J. 
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1.63 (3H, s, CCH3), 1.55 (3H, s, CCH3), 1.49 (9H, s, C(CH,h); be (90.6MHz) 1 5 ~ . ~ ~
(s), 141.5 (s), 141.1 (s), 128.2 (d), 127.9 (d), 127.3 (d), 126.1 (d), 93.4 (s). 81.0 (s). 
67.9 (t), 59.9 (t), 55.0 (d), 28.2 (q), 27.5 (q), 24.5 (q); m/z (ES) Found: 356.1858 
([MNa]+ C19H27N04Narequires 356.1838). 
(E)-(S)-tert -Butyl-4-[3-(2-iodophenoxy)-2-phenylpropenyl] -2,2-dimethyl 
oxazolidine-3-carboxylate (325) 
ceo I ~ ~ I 
Methanesulfonyl chloride (30/-!1, 0.37mmol) was added dropwise over 1 min to a 
stirred solution of the alcohol (322) (0.10g, 0.31mmol) and triethylamine ( 6 0 ~ 1 , ,
0.46mmol) in dichloromethane (2ml) at ooe, under an atmosphere of nitrogen. The 
solution was stirred at ooe for 80 min, then diluted with diethyl ether (5ml) and 
washed with a 50% saturated aqueous solution of sodium chloride (5ml) containing 
hydrochloric acid (lml, 2M), then a saturated aqueous solution of sodium 
hydrogencarbonate (5ml). The organic phase was dried (MgS04) and concentrated ill 
vacuo to leave the mesylate (0.13g, 100%) as a colourless oil, which was used 
immediately without characterisation. 2-Iodophenol (324) (68mg, 0.31mmol) and 
then potassium carbonate (65mg, 0.47mmol) were added to a stirred solution of the 
mesylate (323) (0.13g, 0.31mmol) in DMPU (0.2ml) and acetonitrile (3ml) at ambient 
temperature, under an atmosphere of nitrogen. The solution was stirred at ambient 
temperature for 19 h, then heated at reflux for 5 h. The solution was cooled to 
ambient temperature and diluted with ethyl acetate (lOml), then washed with water 
(lOml). The aqueous phase was extracted with ethyl acetate (lOml). then the 
combined organic extracts were dried (MgSO .. ) and concentrated in ,'([CIiO to lea\c a 
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residue which was purified by chromatography on silica, eluting with 10O/C ethyl 
acetate in petroleum ether (b.p. 40-60°C), to give the iodide (0.12g, 75o/c) as a 
colourless oil; [a]D = +8.2 (c = 1.0, CRCI3); Umax (soln., CRCI3) 1582, 1570, 1275. 
1060cm-1; DR (C6D 6' 360MRz, T 340K) 7.63 (lR, d, J 7.4, phenoxy H3), 7.39 (2H. 
app. d, J 7.0, Ar), 7.15-7.07 (3R, m, Ar), 6.94 (lR, t, J 7.4, phenoxy H5). 6.62 (lH, br 
d, J 7.4, phenoxy R6), 6.39 (lR, t, J 7.4, phenoxy H4), 6.08 (lH, d, ] 9.8, 
CHCRCR2), 5.16 (lR, br s, CHN), 4.76 (lH, br s, CH20), 4.65 (lR, d, J 10.9. CH-;.O), 
4.02-3.98 (lR, m, CH20), 3.78 (lR, dd, J 9.1 and 3.0, CH20) , 1.69 (3R, s, CCH3), 
1.54 (3R, s, CCH3), 1.39 (9R, s, C(CH3)3); Dc (C6D 6 , 90.6MHz, T 340K) 158.7 (s), 
152.8 (s), 142.3 (s), 140. 7 (d), 130.7 (d), 129.3 (d), 128.9 (d), 128.6 (s), 128.4 (d), 
127.5 (d), 123.7 (d), 113.9 (d), 94.9 (s), 87.8 (s), 80.2 (s), 69.7 (t), 68.4 (t), 56.6 (d), 
29.2 (q), 28.1 (q), 25.4 (q); mlz (ES) Found: 558.1093 ([MNa]+ C2sH30IN04Na 
requires 558.1117). 
(E)-(S)-2-Acetamido-5-(2-iodophenoxy )-4-phenyl-3-penten-l-ol (327) 
H 
ceo I ~ ~ I 
A solution of the iodide (325) (60mg, O.llmmol) in hydrogen chloride (lml, 4.0M 
solution in l,4-dioxane) was stirred at ambient temperature for 1.5 h, under an 
atmosphere of nitrogen. The solution was concentrated ill vacuo (1 mmHg) to leave 
the crude salt (67mg, 100%) as a white solid, which was used immediately without 
characterisation. Acetic anhydride ( l 0 ~ 1 , , 0.13mmol) was added dropwise over 1 min 
to a stirred solution of the salt (326) (67mg, O.llmmol) in pyridine (l ml) at ambient 
d atmosphere of nitrogen The solution was stirred at ambient temperature, un er an . 
temperature for 1 h, then 4-dimethylaminopyridine (9mg, 7 0 ~ m o l ) ) was added in a 
15.+ 
single portion and the solution was stirred at ambient temperature for 18 h. \\ith more 
acetic anhydride ( l 0 ~ 1 , , 0.13mmol) added after 2 h. The solution was diluted \\ ith 
ethyl acetate (5ml) and washed with hydrochloric acid (5ml, 2M), water (5ml) and 
brine (5ml), then dried (MgS04 ) and concentrated in vacuo to leave a residue which 
was purified by chromatography on silica, eluting with 2% methanol in ethyl acetate, 
to give the acetate (39mg, 81 %) as a white oil; [a]D = -2.5 (c = 1.1, CHCI); v max 
(soln., CHCI3) 3625, 3436, 1667, 1468, 1372, 1275, 1048cm- 1; bH (360MHz) 7.76 
(IH, dd, J 7.8 and 1.4, phenoxy H3), 7.48-7.45 (2H, m, Ar), 7.36-7.27 (4H, m, Ar), 
6.93 (IH, d, J 7.6, phenoxy H6), 6.73 (IH, app. td, J 7.4 and 0.9, phenoxy H4), 6.27 
(IH, d, J 7.1, NH), 6.02 (lH, d, J 9.5, CHCHCH2 ) , 5.13 (lH, d, J 10.5, CH20Ar). 
4.92-4.86 (lH, m, CHN), 4.85 (IH, d, J 10.5, CH20Ar), 3.84-3.77 (2H, m, CH20H), 
3.21 (IH, br s, OH), 1.94 (3H, s, CH3 ); be (90.6MHz) 170.6 (s), 157.0 (s), 140.5 (s), 
139.4 (d), 138.6 (s), 130.8 (d), 129.6 (d), 128.4 (d), 127.8 (d), 126.4 (d), 123.0 (d), 
112.5 (d), 86.4 (s), 67.0 (t), 65.5 (t), 50.4 (d), 23.3 (q); mlz (ES) Found: 460.0374 
(E)- (S)-N -[1- (tert -Butyldimethylsilanyloxymethyl)-4-(2-iodophenoxy )-3-
phenylbut-2-enyl]-acetamide (328) 
OTBS 
o C( 
tert-Butyldimethylsilyl chloride (l7mg, O.llmmol) and then 
4-dimethylaminopyridine (lmg, 1 0 ~ m o l ) ) were added in single portions to a stirred 
solution of the acetate (327) (39mg, 9 0 ~ m o l ) ) in dichloromethane (lml) at 0 C. under 
an atmosphere of nitrogen. The solution was stirred at OCC for 10 min. then 
1) was added dropwise at Oac. The solution \\as triethylamine ( 2 0 ~ 1 , , 0.14mmo 
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warmed to ambient temperature and stirred at ambient temperature for 20 h, then a 
saturated aqueous solution of ammonium chloride (3ml) was added. The aqueous 
phase was separated and extracted with diethyl ether (2 x 5ml), then the combined 
organic extracts were dried (MgS04) and concentrated in vacuo to leave a residue 
which was purified by chromatography on silica, eluting with 35% ethyl acetate in 
petroleum ether (b.p. 40-60°C), to give the silyl ether (34mg, 69%) as a colourless oil: 
[a]D = -2.6 (c = l.0, CHCI3); 'Umax (soln., CHCI3) 1097, 888, 839cm-1; bH (360MHz) 
7.76 (lH, dd, J 7.7 and l.5, phenoxy H3), 7.48-7.45 (2H, m, Ar), 7.37-7.27 (4H, m, 
Ar), 6.95 (lH, dd, J 8.3 and l.2, phenoxy H6), 6.72 (lH, app. td, J 7.6 and 1.2, 
phenoxy H4), 6.09-6.07 (lH, m, NH), 6.08 OH, d, J 9.2, CHCHCH2 ), 5.26 (lH, d, J 
10.6, CH20Ar), 4.93-4.86 (lH, m, CHN), 4.84 (lH, d, J 10.6, CH20Ar), 3.83 (2H, d, 
J 3.8, CH20Si), l.96 (3H, s, COCH3), 0.92 (9H, s, SiC(CH3 )3), 0.08 (3H, s, SiCH3 ), 
0.07 (3H, s, SiCH3); be (90.6MHz) 169.3 (s), 157.2 (s), 140.8 (s), 139.3 (d), 137.6 (s), 
13l.8 (d), 129.5 (d), 128.3 (d), 127.5 (d), 126.4 (d), 122.7 (d), 112.6 (d), 86.5 (s), 67.1 
(t), 65.5 (t), 49.0 (d), 25.9 (q), 23.3 (q), 18.3 (s), -5.3 (q); mlz (ES) Found: 552.1428 
([MH]+ C2sH3sIN03Si requires 552.1431). 
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4. APPENDIX 
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4.1 Contemporaneous Studies 
During the course of this research, four other groups have published their efforts 
towards a total synthesis of diazonamide A (1).173,196,230 The synthesis of the most 
relevant and advanced intermediates in each of these approaches has been 
summarised below. 
The research group of Moody were the first to disclose their strategy for a synthesis 
of diazonamide A (1).230b,230c The model benzofuranone unit (331) was prepared 
using an intramolecular rhodium carbenoid aromatic C-H insertion reaction. Thus, 
2-bromophenol (332) was first converted into the diazo ester (333), which next 
underwent rhodium(II)-catalysed decomposition in the presence of rhodium(II) 
perfluorobutyramide to afford the benzofuranone (334) (Scheme 32). Subsequent C-
acylation using ethyl chloroformate then gave the ester (331).231 
(f (f 11 iii Et02 - N2 ~ ~ Br - Br - Br ~ ~ Br p ~ o oOH 0 
0 
332 333 334 331 
Scheme 32 
Unfortunately, the bromides (331 and 334) failed to undergo Suzuki or Stille 
reactions202 ,204 with simple phenyl derivatives. As a result, the more robust 
3-arylbenzofuran (171) was prepared as the coupling partner. Alkylation of the 
phenoxide anion of 2-bromophenol (332) with 2-bromoacetophenone (78), followed 
by acid-induced cyclisation of the intermediate ketone, provided the benzofuran 
framework (171) (Scheme 33). Conversion of the bromide (171) to the corresponding 
boronic acid was followed by a Suzuki reaction202 with bromobenzene to gi \'e the 
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biaryl compound (335). A suitable indole coupling partner was prepared by acylation 
of 4-bromo indole (336)232 u d V'I' .. 
n er 1 smeler condlt1ons233 and subsequent protection 
of the indole nitrogen as the t-butyl carbamate (337) (Scheme 34). 
v)h h Y i,ii iii,i v • ~ ~ OH • ~ ~ 0 
Br Br Ph 
332 171 335 
Reagents: i, PhCOCH2Br, K2C03, acetone, 92%; ii, PPA, Ll, 80%; iii, n-BuLi. B(OMe)j, 80%; iv, 
Scheme 33 
1,11 
\ 
Boc 
336 337 
Reagents: i, Me2NCOCH3, POCI3, 70%; ii, (BochO, DMAP, MeCN, 94%. 
Scheme 34 
A successful Suzuki reaction202 between the boronic acid (338) and the 4-bromo 
indole (337)232 gave the biaryl compound (339), which underwent diazo-transfer 
under the conditions developed by Danheiser234 to give the diazo ketone (340) 
(Scheme 35). The attempted rhodium(II)-catalysed decomposition of 340 in the 
presence of acetonitrile failed to provide any of the desired oxazole (341). The major 
product from this reaction was the 3,4-bridged indole (342), the result of a formal 
intramolecular C-H insertion reaction at the C6 position of the benzofuran ring.235 
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- Ph 
338 
111// 
V" 
339 
341 
11 
N-Boc-
Ph 
Scheme 35 
Ph 
340 
342 
Konopelski et al used the copper(I)-promoted reaction of 2,6-dibromophenol (80) 
with dimethyl malonate (343) to construct the benzofuranone skeleton (344),173 An 
intermolecular arylation of the ester (344) with the aryllead triacetate reagent (345) 
then gave the benzofuranone (346),236 
Me02C Br)! MeOyyOMe CuBr, NaH 
+ .. 0 
HO ~ ~ 0 0 dioxane 
Br Br 
80 343 344 
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BocHN", C02Et 
H 
Me02C 
Py 
+ 0 • 
Pb(OAcb CRCl 3 
OMe Br 
Br 
344 345 346 
In an effort to prepare a suitable indole coupling partner for an intermolecular Somei 
reaction207 to construct the biaryl bond of diazonamide A (1), oxindole (347) was first 
converted to the aldehyde (348) using a Vilsmeier reaction (Scheme 36).233 Efficient 
thallation at the C4 position of the indole nucleus was achieved upon exposure of the 
aldehyde (348) to thallium trifiuoroacetate. 197a,198a The organothallium compound 
(263) was then coupled directly to the stannane (264) under Stille reaction 
conditions204 to provide the biaryl compound (265). 
CHO 
TI(OCOCF3)2 
CHO CO=o cO-CI 11 '\: • .. CI // N // N 
H H 
347 348 
elMe 1// SnBu3 MeO 
iii, 264 
.. CI 
Reagents: i, POC!), DMF, Py, 73%; ii, TTFA, TFA; iii, Pd(PPh3)4, dioxane, fl, 21 %. 
Scheme 36 
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The aldehyde function at the C2 position of the indole ring was elaborated to form the 
indolyl oxazole fragment of diazonamide A (1). Hence, the carbamate (349) 
underwent a C2 homologation with ethyl diazoacetate and boron trifluoride diethyl 
etherate, according to the Roskamp procedure,237 to give the ketone (350) (Scheme 
37). Treatment of the ketone (350) with 4-acetamidobenzenesulfonyl azide produced 
the desired a - d i a z o - ~ - k e t o o ester which was converted to the oxazole (188) with 
acetonitrile in the presence of boron trifluoride diethyl etherate. 
CHO 
~ C I I~ N r r
349 
\ 
Boc 
11,111 
Boc 
350 188 
61 %; iii, MeCN, BF3.0Et2, l',., 64%. 
Scheme 37 
Wipf et al recently published a synthesis of the benzofuranone indolyl oxazole unit of 
diazonamide A (1).196 They began by constructing the indolyl oxazole segment (351), 
starting from the carbamate (222). Removal of the benzyl carbamate protecting group 
and coupling of the resultant salt with O-protected glycolic acid in the presence of 
diethylphosphoryl cyanide238 afforded the amide (352) (Scheme 38). 
Cyclodehydration69 of 352 followed by protection of the indole nitrogen as an ethyl 
carbamate gave the indolyl oxazole (351). Palladium(O)-catalysed Stille coupling204 
between the indolyl oxazole (351) and the aryl stannane (353), with copper(I) iodide 
as a co-catalyst,239 next gave the biaryl species (354). Removal of the m c t h o \ ~ ~
methyl protecting group and acid condensation gave the ester (355) (Scheme 39), 
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which underwent an intramolecular Heck reaction 134f in the presence of (R)-BL'\:-\P 
to give the terminal olefin (356) with a poor 14% ee. 
NHCbz 
i,ii 
.. 
222 
, ~ ~ ~ ~
OTPS 1ll,lV 
352 
.. 
TPSO\ 
~ N N
O ~ ~
Reagents: i, HBr, AcOH; ii, H02CCH20TPS, DEPC, Et3N, THF, 82% (2 steps); iii, PPh3, C13CCCl3, 
Scheme 38 
T P S O ~ ~ I £OTPS 
-N 
O ~ ~ o "N I 
ClMOM I ~ ~ ... + 
SnBu3 
351 353 354 
-:?" 
£OTPS I £OTPS Ph 
Ar° o "N 0 o "N 0 Ph 11 0 111 
... 
... 
355 356 
. CHCl C I A Ph NMP' ii a) HCl Et20, MeOH, CH2CI2, 39% (2 s t e p ~ ) : : b) Reagents: 1, Pd2(dba)3. 3, u, s 3, " , 
CH3CHCPhC02H, EDC, DMAP, CH2C12, 96%; iii, Pd2(dba)3, (R)-BINAP, Ag3 P04, DMA, ~ . . -'-+( ( 
Scheme 39 
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Preliminary studies also showed that chlorination of the indolyl oxazole (351) could 
be achieved with N-chlorosuccinimide and benzoyl peroxide. 
TPSO, 
j:::::N 
° ....-::; 
351 
NCS, (PhCOh02 
.. 
TPSO, 
j:::::N 
0....-::; 
CI 
CI 
The work of Harran et al has concentrated on the synthesis of the northern 
macrocycle of diazonamide A (1).230a In this approach, the N-protected valine residue 
(357) was treated with aminomalononitrile p-toluenesulfonate and EDC to provide 
the amino oxazole (358), which was converted directly to the bromide (359) (Scheme 
40). 
Me Me 
• B O C H N ~ N » - C N N0-< 
NH2 
357 358 
11 
Me Me 
• B O C H N ~ C N N
Br 
359 
Reagents: i, aminomalononitrile p-toluenesulfonate, EDC, Py, 64%; ii, t-BuONO, CuBr2, MeCN, 50(i(. 
Scheme 40 
The bromide (359) underwent a Stille reaction204 with the alkenyl stannane (360) to 
provide the amine (361) after removal of the protecting groups (Scheme .n). Peptide 
coupling between the amine (361) and the tyrosine derivative (362) next gave the 
iodide (363), which participated in an intramolecular Heck cyclisation J3·H to give the 
macrocycle (364). 
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Me Me B O C H N ~ ~ C N N
o /; 
Br 
359 
362 I 
111, OBn 
IV 
:5) i,ii 
+ PMBO ~ ~ .. 
360 
Me Me H N ~ N N
BocHN" 0 /; 
eN 
H 
". 0 
I HO 
OBn 
363 
: : ~ ~
BocHN", /; 
. 0 
H 
eN 
HO 
OBn 
364 
Me Me ~ N NH2N ::.--- eN 
o /; 
361 HO 
Reagents: i, PdC12(CH3CNh, DMF, 94%; ii, BBr3, CH2C12, 91 %; iii, TBTU, DIPEA, MeCN, 89%; 
Scheme 41 
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